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Abstract 
Maedi-visna (MV), is a chronic wasting disease of sheep and 
goats caused by the small ruminant lentivirus (SRLV), maedi-
visna virus (MVV). With no known cure or treatment, an 
asymptomatic period of sometimes several years and an 
infection that ultimately results in death, the finding that 
prevalence is on the rise within the UK is of great concern.  
In this study, a diagnostic was developed for detection and 
quantification of as a yet unidentified SRLV strain circulating 
within the UK in 2014. Identification of the viral strain was 
attempted to characterise this current circulating strain. Tissues 
and blood samples were collected from 28 seropositive rams 
over a period 28 months as part of a longitudinal case study 
after which semen harvested from 13 of these rams was used 
in an artificial insemination (AI) trial to estimate the risk of MVV 
transmission within a natural mating model.  
The viral strain was partially characterised at the molecular 
level and found to show similarities with previously reported UK 
strain (EV1). A qPCR assay was developed and showed 
successful detection of virus within both blood and tissue 
samples of seropositive animals but failed to detect any viral 
sequences with inseminated naïve ewes 7 weeks post 
insemination. In addition, proviral loads within blood were 
shown to be higher than previous reported findings.   
Finally, regression modelling of milk production data collected 
from a UK dairy flock suggested an outbreak of MVV of an 
unknown strain to cause a reduction in milk yield within 
seropositive ewes.  Overall, this study demonstrates the impact 
of disease of a newly identified circulating strain of MVV within 
the UK.   
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Chapter 1: Literature Review 
Maedi-Visna (MV), also known as Ovine Progressive Pneumonia, 
Zwoergersiekte or Graaff-Reinet disease and caprine arthritis 
and encephalitis (CAE) are chronic wasting diseases affecting 
sheep and goats worldwide (Rovid Spickler 2015). They are the 
result of infection by the lentiviruses maedi-visna virus (MVV) 
and caprine arthritis encephalitis virus (CAEV), respectively. 
Affected animals are asymptomatic during the majority of 
infection (>2 years). The appearance of clinical signs occurs 
with a gradual onset which progressively worsens with time 
ultimately leading to a 100% fatality rate in infected individuals. 
This observation of prolonged infection was first described for 
MVV and resulted in the concept of ‘slow viruses’ (Bennet and 
Kimberlin 1976). 
1.1 Small Ruminant Lentiviruses 
1.1.1 Viral Taxonomy 
MVV and CAEV were originally regarded as two completely 
separate viral species. But recently, due to shared host species 
(sheep and goats) and genetic and phenotypical similarities 
these viruses are now widely regarded as a viral continuum 
under the grouping of small ruminant lentiviruses (SRLVs). 
These viruses are of the Retroviridae family and 
Orthoretrovirinae subfamily  and the genus Lentivirus which 
also includes human, simian, bovine and feline 
immunodeficiency viruses (HIV-1, SIV, BIV and FIV) and equine 
infectious anaemia virus (EIAV) (Figure 1.1.1.1) (ICTV 2015). 
Zanoni (1998) suggested a classification system consisting of 6 
clusters  (I,  II,  III,  IV,  V  and  VI)  based  on  the  phylogenetic  
 






































Figure 1.1.1.1 Phylogenetic tree of 33 full retrovirus 
genome sequences. 29 small ruminant lentiviral (maedi-visna 
virus (MVV) and caprine arthritis encephalitis (CAEV)), 3 lentiviral 
(human immunodeficiency virus type 1 (HIV-1), feline 
immunodeficiency virus (FIV) and equine infectious anaemia virus 
(EIAV)) and 1 retroviral (jaagsiekte retrovirus (JSRV)) sequences 
were aligned using MUSCLE software after which a phylogenetic tree 
was constructed by neighbour-joining.  
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analysis of 64 SRLV sequences ranging in size from 129 bp to 
3146 bp from various regions of the viral genome in addition to 
one full genome CAEV and three full genome MVV sequences. 
In 2004, a second study analysing 104 SRLV isolates made up 
of 284 bp gag, 1.2 kb pol and/or 1.8kb gag-pol fragments 
isolated from 91 seropositive goats and 13 seropositive sheep 
sourced from 115 swiss herds was completed (Table 1.1.1.2) 
(Shah et al. 2004b). From this, SRLVs were reclassified into four 
principal sequence groups: A-D. Between groups, a sequence 
variability of 25-37% was observed when comparing gag and 
pol sequences. In addition to these groups, A and B were 
divided into seven and two further subgroups, respectively, with 
a sequence variability of 15-27% seen between subgroups. 
Group A represents a clustering around MVV isolates kv1772, 
EV1 and SA-OMVV while group B sequences share high 
similarity to the CAEV Cork isolate (Sonigo et al. 1985; Braun 
et al. 1987; Querat et al. 1990; Saltarelli et al. 1990). Groups 
C and D represent more diverse sequences isolated during the 
Shah study that did not cluster with group A and B. Since the 
Shah reclassification, groups A and B have been further 
expanded upon with a current total of twenty-two and five 
subgroups, respectively. In addition, Ramírez et al. (2013) 
suggested group D to be in fact a part of group A exhibiting 
divergence within the pol gene. This was after phylogenetic 
analysis of the gag gene of group D sequences classified them 
as group A. This in tandem with the fact that said group has 
only been identified within one study may suggest an error in 
classification. Finally, a fifth group was added in 2007, E, which 
was later expanded to two subgroups in 2011 (Grego et al. 
2007; Reina et al. 2009a; Giammarioli et al. 2011). 
  
4 | P a g e  
 
Table 1.1.1.2 SRLV classification systems. Table illustrates the two recognised classification systems for SRLVs, stating the currently known locations of circulation and 
host species with source references. Adapted from (Shah et al. 2004b). 
 
 
Classification System   
Shah et al (2004) Zanoni (1998)   













































MVV-like from sheep and goats worldwide 
Sheep from North America, Spain and Turkey 
Sheep and Goats from Switzerland, Spain and Turkey 
Sheep and Goats from Switzerland and Germany 
Sheep and Goats from Switzerland, Germany, Turkey and Slovenia 
Sheep and Goats from France 
Goats from Switzerland 
Goats from Italy 
Sheep and Goats from Italy and Turkey  
Goats from Italy 
Sheep and goats from Italy, Germany and Turkey 
Sheep from Poland  
Sheep from Poland 
Goats from Slovenia 
Sheep from Slovenia 
Goats from Poland and Germany 
Goats from Poland 
Sheep from Poland 
Goats from Italy  
Sheep from Italy  
Sheep in Germany 
Sheep in Iran, Lebanon and Jordan 
[1] 
[2] 
(Shah et al. 2004b; Glaria et al. 2012; Muz et al. 2013) 
[3] 
[4] 
(Leroux et al. 1995) 
(Shah et al. 2004b) 
(Grego et al. 2007) 
(Grego et al. 2007; Giammarioli et al. 2011; Muz et al. 2013) 
(Pisoni et al. 2010; Molaee et al. 2020) 
(Giammarioli et al. 2011; Muz et al. 2013) 
(Olech et al. 2012)(Kuhar et al. 2013a) 
(Kuhar et al. 2013a) 
(Kuhar et al. 2013a) 
(Kuhar et al. 2013a) 
(Olech et al. 2018) 
(Olech et al. 2018) 
(Olech et al. 2019) 
(Colitti et al. 2019) 
(Colitti et al. 2019) 
(Molaee et al. 2020) 











CAEV-like from goats worldwide 
Sheep and Goats from France, Spain, Poland and Switzerland 
Sheep and Goats from Italy 
Goats from Canada 
Goats from Belgium 
[5] 
[6]  
(Bertolotti et al. 2011; Giammarioli et al. 2011) 
(Santry et al. 2013) 
(Michiels et al. 2020) 
C  III Sheep and goats from Norway (Gjerset et al. 2006; Gjerset et al. 2007; Gjerset et al. 2009) 





Goats from Italy 
Goats from Italy 
(Grego et al. 2007; Reina et al. 2009a) 
(Giammarioli et al. 2011) 
[1] (Sonigo et al. 1985; Querat et al. 1990; Sargan et al. 1991; Leroux et al. 1995; Gjerset et al. 2007; Grego et al. 2007; Olech et al. 2012) 
[2] (Woodward et al. 1995; Karr et al. 1996; Glaria et al. 2012; Fras et al. 2013; Muz et al. 2013; Santry et al. 2013) 
[3] (Shah et al. 2004a; Shah et al. 2004b; Cardinaux et al. 2013; Deubelbeiss et al. 2014; Blatti-Cardinaux et al. 2016; Molaee et al. 2020) 
[4] (Shah et al. 2004b; Kuhar et al. 2013a; Muz et al. 2013; Molaee et al. 2020) 
[5] (Chiu et al. 1985; Saltarelli et al. 1990; Zanoni et al. 1992; Leroux et al. 1995; Chebloune et al. 1996; Germain and Valas 2006; Grego et al. 2007; Giammarioli et al. 
2011; Olech et al. 2012; Fras et al. 2013; Kuhar et al. 2013a) 
[6] (Leroux et al. 1995; Shah et al. 2004b; Germain and Valas 2006; Grego et al. 2007; Glaria et al. 2009; Giammarioli et al. 2011; Crespo et al. 2012; Olech et al. 2012; 
Perez et al. 2015; Pérez et al. 2015) 
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1.1.2 Viral Structure 
The SRLV genome consists of two single-stranded positive-
sense RNA strands 9.2 kb in size. Each strand contains the full 
complement of genetic information and are often identical. The 
information present on these strands, codes for three structural 
genes (gag, pol and env) and three auxiliary genes (vif, vpr and 
rev) (Pépin et al. 1998). The organisation of these genes within 
the RNA strands is illustrated in Figure 1.1.2.1a. When 
comparing the genetic structure and organisation of SRLVs to 
other viruses of the lentiviral group several differences can be 
observed. Although the three structural proteins, gag, pol and 
env, are maintained throughout all lentiviruses, the number and 
composition of accessory genes varies greatly (Gifford et al. 
2012). An example of this, HIV-1 possesses six accessory 
genes; tat, rev, vpu, nef, vif and vpr, while EIAV only has four; 
ttm, tat, rev, and S2 (Beisel et al. 1993; Cullen 1998; Li et al. 
2000). These variations can be categorised according to clade 
of host species with lesser variations seen within these groups. 
Of the three structural genes, the gag (group-specific antigen) 
gene encodes for precursor Pr55gag which is cleaved into three 
proteins: capsid protein (CA), nucleocapsid protein (NC) and 
matrix protein (MA) (Figure 1.1.2.1b) which are responsible for 
the formation of the hydrophobic virion core, coating viral RNA 
and association of capsid with the viral membrane, respectively 
(Cheevers et al. 1988). In contrast to gag, which codes for the 
internal structural proteins of the virion, env (envelope) codes 
for two external glycoproteins scattered throughout the host 
cell derived lipid bilayer which forms the viral envelope. These 
glycoproteins: transmembrane (TM) and surface (SU) (Figure 
1.1.1.2b)  are  formed  upon  cleavage  of  the  Env  precursor 





Figure 1.1.2.1 Genomic and viral structure of small 
ruminant lentiviruses. (A) The structure of a small ruminant 
lentivirus (SRLV) RNA genome.  The genome is comprised of two long 
terminal repeat (LTR) regions found either end of the RNA strand 
(green region), 3 structural genes (blue; gag, pol and env) and 3 
accessory genes (red/orange; vif, vpr and rev). Adapted from 
(Minardi da Cruz et al. 2013). (B) The structure of a SRLV viral 
particle illustrating the individual protein components and enzymes 
present. Virus comprises an icosahedral nucleocapsid core containing 
two identical ssRNA viral genomes and multiple vital proteins 
surrounded by a capsid protein shell within a host derived viral 
membrane from which virus derived glycoproteins protrude. 
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coded for by the env gene and provide the epitopes required for 
interactions between the virus and the host receptors whilst 
also inducing neutralising antibodies. The final structural gene, 
pol (polymerase), codes for important enzymes critical for 
successful viral replication within a host cell. In total, five 
enzymes are produced from the pol portion of the initial gag-
pol polyprotein precursor; reverse transcriptase (RT), integrase 
(IN), protease (PR), RNase H and deoxyuridine 5’-triphosphate 
nucleotidohydrolyase (dUTPase) (Pépin et al. 1998). 
The vif (virion infectivity factor) gene, also known as Q or sor, 
is essential for infectivity of SRLVs in host target cells and 
present in all lentiviruses with the exception of EIAV 
(Kristbjörnsdóttir et al. 2004). One function of the Vif protein, 
a small basic protein rich in tryptophans (28 kDa), is the 
neutralisation of host-specific Apolipoprotein B mRNA-editing 
catalytic polypeptide-like 3 (APOBEC3) proteins. These 
polynucleotide cytosine deaminases attenuate virus through the 
production of G to A hypermutations in the viral plus strand, 
although this is not their only means of antiviral activity 
(Depboylu et al. 2007; Franzdóttir et al. 2016). In the case of 
MVV in sheep, ovine APOBEC3-Z3 (OaA3Z3) and ovine APOBEC-
Z2-Z3 (OaA3Z2-Z3) are the targets of Vif, with Vif deficient MVV 
being shown to be restricted by these proteins (Simon et al. 
1995). This neutralising ability of MVV and CAEV Vif is produced 
by utilisation of multiple host cellular proteins including 
cyclophilin A (CYPA), Cullin5 (CUL5) and Elongin B/C for the 
formation of the Vif-mediated E3 ubiquitin ligase complex which 
allows for degradation of APOBEC3 proteins via a 
ubiquitin/proteasome-dependent pathway (Zhang et al. 2014; 
Zhao et al. 2019). These co-factors have been found to vary 
between lentiviruses such as the primate lentivirus co-factor 
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core-binding factor beta (CBFB). This difference in co-factors 
has been associated with the high variability seen in vif genes 
between viruses (Yoshikawa et al. 2016). Secondary to this 
function, Fu et al. (2020) reported that Vif protein can produce 
a down regulation of interferon-β (IFN-β) production, thereby 
providing the virus a means of evasion from the host immune 
system. Finally, it has also been suggested that Vif can 
modulate autophagy within host cells, which could be linked to 
the ability of Vif to bind microtubule-associated protein 1A/1B-
light chain 3 (LC3), a central protein of the autophagy system, 
although further research is required to expand upon this 
(Aðalbjörnsdóttir 2016). 
In SRLVs, the vpr (viral protein R) gene was initially thought to 
code for a Tat-like protein and was correspondingly named as 
such until 2003 (Villet et al. 2003). Tat proteins, as seen during 
HIV-1 infection, have an important role in stimulating 
transcription from the LTR promotor, a function that did not 
align with that seen from the SRLV protein (Das et al. 2011). 
Following this, similarities were identified between this protein 
functionally and structurally to the HIV-1 Vpr protein (Villet et 
al. 2003). This, in addition to differences seen in localisation of 
protein during and after replication in host cells compared to 
HIV Tat during infection suggested the protein product of this 
gene to be Vpr-like. Since then, SRLV Vpr (10 kDa) has been 
shown to induce G2/M cell cycle arrest in transfected cells, also 
seen in HIV infection in humans which has been linked to 
interaction of Vpr with CRL4A (DCAF1), E3 ubiquitin ligase and 
SLX4 (Romani and Cohen 2012; Berger et al. 2015). This may 
also hold true for SRLV Vpr in sheep and goats but has yet to 
be confirmed. 
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The final accessory gene present in SRLVs, rev (regulation of 
virion protein expression), encodes a 19 kDa protein which 
ensures replication competency of virus in permissive cell lines 
(Toohey and Haase 1994; Pépin et al. 1998). This can be linked 
to the Rev protein’s function in expression of viral proteins. This 
is accomplished by it binding to the RRE (rev responsive 
element) present within the env gene in SRLVs close to the 
SU/TM cleavage site (Lesnik et al. 2002). This initiates a 
cascade that facilitates the movement of viral transcripts into 
the cytoplasm. 
1.1.3 Viral Lifecycle 
As seen with the majority of viruses, the lifecycle of SRLVs can 
be summarised in 5 key steps: cellular entry, genome 
replication, transcription and translation, maturation of virion 
and exit from the cell. 
To allow for entrance into cells, SRLV must first bind to specific 
receptors present on target cells. With regards to  other 
retroviruses, all have been shown to bind membrane bound 
glycoproteins (Weiss and Tailor 1995), with lentiviruses 
showing a requirement for the presence of 2 molecules (a 
receptor and co-receptor) to initiate entry (Broder et al. 1999). 
Currently no specific receptor for MVV or CAEV has been 
identified although based on their ability to infect a variety of 
cell lines in addition to target cells, it is suggested to be a 
commonly occurring cell membrane molecule (Brodie et al. 
1995). A number of candidates have been identified, such as 
major histocompatibility complex II (MHC-II), the mannose 
receptor (MR) and a variety of membrane proteins in sheep and 
goats ranging in size from 15 kDa to 50 kDa (Crane et al. 1991; 
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Dalziel et al. 1991; Barber et al. 2000; Bruett et al. 2000; 
Crespo et al. 2011; Crespo et al. 2012). 
Following receptor binding, viral fusion, entry and uncoating 
occur resulting in the release of the two identical strands of 
genomic RNA into the host cell cytoplasm. Currently, little is 
known about these processes during SRLV infection. Reverse 
transcription of ssRNA to dsDNA occurs next. Thought to occur 
via a similar mechanism seen in other retroviruses, it is initiated 
by tRNA lysine, an amino acid bound to the approximately 16 
bp primer binding site flanking the 5’ LTR of the ssRNA genome 
(Figure 1.1.3.1a) (Sonigo et al. 1985; Carey and Dalziel 1993; 
Burmeister 2001). RT then begins synthesis of the negative 
DNA strand from the primer binding site to the 5’ end (Figure 
1.1.3.1b). The RNA region of the resulting RNA-DNA hybrid is 
then removed from the RNA genome through RNase H activity 
(Figure 1.1.3.1c).   
➔ Figure 1.1.3.1 Reverse transcription of retroviral ssRNA 
genome to dsDNA. Depicts stages of retroviral reverse 
transcription of genomic RNA to dsDNA for integration into 
host genome. Initial binding of tRNA lysine to primer binding 
site for - DNA synthesis (a), elongation via RT of - strand to 5’ 
end (b), degradation of 5’ end of RNA strand by RNase H (c), 
annealing of - strand to 3’ R sequences of RNA strand (d), 
elongation of - DNA strand to 5’ end (e), degradation of RNA 
strand by RNase H and binding of PPT RNA to DNA strand to 
initiate synthesis of + strand (f), elongation of + strand by RT 
to 5’end (g), removal of RNA primer elements via RNase H 
degradation (h), + strand transfer and annealing to - strand 
via PBS region (i), final elongation of both DNA strands via RT 
activity resulting in formation of full viral genomic copy of 
dsDNA (j). Black font and light blue represent RNA while red 
font and dark blue represents DNA. Adapted from (Heaton et 
al. 2012). 
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The negative sense DNA strand next anneals to the 3’ end of 
either viral genome strand via the repeated (R) sequences 
present within the LTRs found at either end of the genome 
(Figure 1.1.3.1d). From here, RT elongates the DNA to form a 
complete DNA-RNA hybrid spanning from the PBS to the 3’ end 
(Figure 1.1.3.1e). RNase H mediated degradation of the RNA 
strand produces a single DNA strand to which the polypurine 
tract (PPT) binds to initiate synthesis of the positive DNA strand 
(Figure 1.1.3.1f). Following elongation, RNase H removes the 
initial RNA primers from both strands and the positive strand 
anneals to the 5’ end of the negative strand via the primer 
binding site, where the final elongation of each strand occurs 
producing a double stranded DNA copy of the viral genome 
(Figure 1.1.3.1g-j). 
Upon producing a dsDNA copy of the viral genome, the next 
step is integration into the host genome. The process for SRLVs 
has yet to be confirmed but in other retroviruses integration 
occurs in two steps: end processing and joining (Hindmarsh and 
Leis 1999). During end processing, 2 nucleotides are removed 
from the 3’ end of each strand within the U3 and U5 regions of 
the LTRs exposing 3’ hydroxyl groups through a reaction 
involving a nucleophile, commonly water. This reaction in HIV 
infection is mediated by the IN protein and has been found to 
be a site-specific hydrolysis of a phosphodiester bond which 
results in the release of 2 nucleotides (Vink et al. 1991). During 
joining, IN mediates a nucleophilic attack via the exposed 
hydroxyl groups of target DNA, resulting in a simultaneous 
cleavage of target DNA and joining of 3’ ends of viral DNA to 
the 5’ end of cleaved target DNA (Engelman et al. 1991). This 
process results in 2 nucleotide overhangs at the 5’ ends of viral 
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DNA and single stranded regions of the target DNA and upon 
removal and repair of these regions, integration is complete. 
Upon successful integration of viral DNA into the host genome, 
the next step in the viral life cycle is transcription, both for the 
production of viral proteins and to generate full length genomic 
RNA for packaging into virions. At this stage, the differences 
seen between in vitro and in vivo infection become more 
pronounced. In vivo, SRLV infection results in persistent 
infection suggesting a life cycle with minimal or no cell lysis. In 
comparison, in vitro, SRLV infection normally undergoes a lytic 
cycle which resolves within days of inoculation resulting in 
complete cell death. One reason for these apparent differences 
can be attributed to restrictions in expression of viral genes in 
vivo. This has been observed within immature monocytes 
harvested from the ventricles of experimentally infected sheep 
(Peluso et al. 1985). An increase in expression within these cells 
was observed following maturation of monocytes into 
macrophages (Gendelman et al. 1986). This change in 
expression level was partially linked to the LTR region of MVV, 
which can act to enhance expression. In another study, 
transgenic mice were used and showed that transcription 
directed by the LTR region was initiated following macrophage 
activation (Small et al. 1989). This therefore demonstrated a 
means by which MVV may be restricted during an infection 
which helps in maintaining persistent infection. The lytic cycle 
observed in vitro, suggests a lack of restrictive elements which 
can likely be attributed to the use of a single cell line. From 
these cells it has been shown that MVV has a temporally 
regulated pattern of transcription in which low levels of smaller 
mRNAs attributed to vpr and rev are produced early in infection 
(approximately 24 h.p.i.) with larger mRNA’s being produced 
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later in infection (approximately 72 h.p.i.) (Gourdou et al. 
1989). These larger species are believed to represent the 
structural genes (gag, pol and env) and vif. In addition, it has 
been reported that lytic infection results in high levels of 
amplification of viral genomes (Brahic et al. 1977). Crespo et 
al. (2013) looked at SRLV infection of two alternatively 
differentiated small ruminant macrophages, M1 and M2 cells, 
responsible for antimicrobial and pro-inflammatory responses 
short term or anti-inflammatory and immune suppressive 
responses long term, respectively. They found that SRLVs had 
reduced replicative ability in M1 cells and enhanced ability in M2 
cells. This block, found to occur post-entry, may be associated 
with the presence of APOBEC proteins which have been shown 
to be expressed by M1 cell stimuli in small ruminants, similar to 
that seen in HIV-1 infection in humans (Cassol et al. 2009). 
Finally, two copies of genomic RNA, structural proteins and 
essential proteins are packaged and leave the cell via budding 
either from the cell surface or into macrophage vacuoles 
(Georgsson et al. 1990). 
1.1.4 Cellular Tropism 
During natural infection in vivo, the monocyte/macrophage cell 
lineage and dendritic cells have been shown to be the main 
target of SRLVs (Ramírez et al. 2013). The 
monocyte/macrophage lineage appears to be a common target 
cell for the lentivirus genus, with some species also targeting 
lymphocytes (not a target of SRLVs). Initial infection by SRLVs 
occurs in monocytes where the virus becomes latent until cell 
differentiation into macrophages occurs. At this time, the 
expression of two cellular proto-oncogenic transcription factors, 
c-Fos and c-Jun, is enhanced. Previously, it has been shown 
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that these transcription factors bind to the AP-1 and AP-4 
promotor binding sites present within the LTR of the viral 
genome triggering expression of proviral DNA resulting in 
replication and productive infection (Narayan et al. 1983; Shih 
et al. 1992). Therefore, the replication of SRLVs is dependent 
on the maturation of monocytes into macrophages.  
The cellular receptors of SRLVs have been suggested to be a 
receptor (e.g. MHC-II or MR) present throughout the body, 
therefore the cell tropism of SRLVs is thought not to be solely 
determined by the presence of target receptors (Dalziel et al. 
1991; Crespo et al. 2011). In support of this, Agnarsdóttir et 
al. (2000) found that a 53 bp region of the LTR cloned into 
chimeric virus in either single or duplicate copies presented 
varying ability to replicate within permissive cell lines (e.g. 
sheep choroid plexus cells and sheep fibroblasts) with viruses 
containing a single copy showing reduced productive 
capabilities compared to viruses containing duplicates. This 
finding suggests that the LTRs of SRLVs provide at least one 
determinant of cell tropism during infection. 
1.1.5 Variability 
With the steady increase in number of SRLV sequences over the 
years, the large variability between SRLV strains, as seen in 
other lentiviruses, has become more apparent. This variation 
can be mainly attributed to three mechanisms: mutation, 
recombination and selective pressure. 
Mutations, whether they be missense, insertion, deletion etc. 
are critical for the persistence of lentiviruses within their host 
species as they give rise to the ability to evade the host’s 
immune system. Of these mutations, most occur during the 
reverse transcription phase of the viral life cycle. This is due to 
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the RT possessing no proof-reading function which results in a 
high error rate quantified as being 0.2-2 mutations per genome 
per cycle (Ramírez et al. 2013). One potential factor influencing 
this rate of mutation is dUTPase. In both CAEV and FIV it has 
been shown that inactivation of dUTPase results in an increase 
in the mutation rate with an accumulation in guanine to adenine 
mutations which can ultimately result in production of non-
viable viruses (Lerner et al. 1995; Turelli et al. 1997). In 
contrast to this, two SRLV isolates belonging to genotypes E1 
and E2, naturally lack the dUTPase coding region within their 
genome but showed no increased rate of mutations or 
accumulation of guanine to adenine mutations compared to 
other natural strains (Reina et al. 2009a; Reina et al. 2010).  
Recombination is the act of combining fragments of two 
different parental viruses into a new unique virus. This can 
occur both between two different strains of the same virus (e.g. 
MVV-MVV) and between two different viruses (e.g. MVV-CAEV). 
Within lentiviruses, recombination occurs in varying frequencies 
such as that seen between primate lentiviruses. Previously, 
recombination between HIV and SIV strains (HIV-1-SIV and 
HIV-2-SIV) has been shown to occur at high frequencies (Chen 
et al. 2006). While this recombination between viruses of 
different host species occurred at high frequencies, Motomura 
et al. (2008) reported recombination between HIV-1 and HIV-
2, two viruses afflicting humans, to occur at low frequency. The 
causes of these discrepancies have yet to be assessed. With 
regards to SRLVs, recombination was demonstrated within 
naturally MVV and CAEV co-infected dairy goats (Pisoni et al. 
2007b). Envelope sequence analysis clearly showed SRLV 
variants possessing sequence fragments belonging to both MVV 
and CAEV, shown by alignment of MVV and CAEV sequences 
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obtained from the same goat. In addition, Andrésdóttir (2003) 
has shown MVV strain 1514 to undergo frequent recombination 
within the envelope gene which has been suggested to 
contribute to antigenic variation of MVV. 
Selective pressure refers to that applied upon an infecting virus 
by the host immune system. This can be attributed to the 
presence of quasispecies. First proposed by Manfred Eigen, 
quasispecies are defined as a set of viruses found in an infected 
individual (Eigen 1971; Ojosnegros et al. 2011). With mutation 
and recombination occurring at a constant pace, new 
quasispecies are being constantly produced and dominating the 
‘unevolved’ previous species. But, these earlier forms are 
‘archived’ as integrated DNA in the host genome and therefore 
can re-emerge resulting in a further increase in diversity of 
quasispecies. Pasick (1998) proposed the idea of treating MVV 
and CAEV as quasispecies instead of distinct viruses. Arnarson 
et al. (2017) demonstrated selective pressure. They found that 
during natural transmission there was the occurrence of positive 
selection of quasispecies possessing mutations within the 
neutralising epitopes therefore providing antigenic variance 
allowing for persistence of infection by immune evasion. 
Taking the principal of quasispecies further, lentiviruses have 
been shown to compartmentalise within a single host with 
genetically different viruses present within different organs and 
systems of the body (Becquart et al. 2002). It has even been 
seen that quasispecies within these compartments to possess 
divergent cell tropisms and pathogenicity (Smit et al. 2004). 
Compartmentalisation of SRLVs has been suggested to occur 
within the peripheral blood and colostrum of goats and central 
nervous system (CNS), lungs and mammary glands of sheep 
(Pisoni et al. 2007a; Ramírez et al. 2012). 
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Despite these actions causing constant changes within the viral 
genomes of SRLVs there are regions highly conserved between 
strains present. These regions include the PBS, PPT and the RRE 
(Ramírez et al. 2013). 
1.2 Maedi-Visna and Caprine Arthritis and 
Encephalitis 
1.2.1 Natural History 
The first identified cases of MV were during the Icelandic 
epidemic, 1933-1965, following the importation of 20 sub-
clinically infected karakul sheep from Halle, Germany. These 
sheep sourced from a university farm were certified as being 
free from the known diseases of the time. Following a brief 
isolation period of 2 months, sheep were distributed across 
Iceland resulting in the spread of three untreatable, 
progressively fatal diseases: Jaagsiekte retrovirus (a beta 
retrovirus causing lung tumours), Mycobacterium 
paratuberculosis (Johnes disease, the cause of chronic 
gastrointestinal inflammation, diarrhoea and wasting) and MV. 
During the following years, jaagsiekte and paratuberculosis 
were detected in 1934 and 1938, respectively, while MV was 
not detected until 1939. Before this time, MV had never before 
been described and was found to present as two differing 
disorders: maedi and visna (‘dyspnea’ and ‘wasting’ in 
Icelandic, respectively) (Sigurdsson et al. 1952; Sigurdsson et 
al. 1957). In order to control and eradicate these diseases and 
therefore decrease the impact on its main source of agricultural 
trade; Iceland implemented quarantine zones and began an 
extensive depopulation and repopulation programme. These 
programmes resulted in the eventual eradication of jaagsiekte 
and MV from Icelandic sheep in 1952 and 1965, respectively, 
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which has since been maintained. In contrast, paratuberculosis 
has remained an issue to agriculture in Iceland. 
Prior to the Icelandic outbreak, clinical signs consistent with MV 
were described in South Africa, 1915 and USA, 1923 and 
termed Graaff-Reinet disease and Montana progressive 
pneumonia, respectively. In both cases symptoms described 
coincided with those associated with the respiratory form of the 
disease (maedi). During the Icelandic outbreak, cases similar to 
MV were described as ‘la bouhite’ in France, 1940 and 
‘zwoegersiekte’ in Holland, 1943.  
It was however not until 1960 that the actual virus (MVV) was 
isolated from affected sheep (Sigurdsson et al. 1960). 
With regards to CAEV, the disorder was initially observed in a 
herd of Toggenberg goats with adults suffering from an arthritic 
disorder and young kids with leukoencephalomyelitis (Cork et 
al. 1974). Initially, disorders were considered separate with 
further work into the disease in kids suggesting viral infection 
due to the transmissibility by inoculation with filtrate sourced 
from infected animals with the addition of the inability to isolate 
bacteria. Crawford et al. (1980a) later determined this virus to 
be a retrovirus and designated it CAEV with successful isolation 
of virus. 
1.2.2 Clinical Signs 
High genetic variability seen between SRLVs has contributed to 
the range of clinical signs seen in infected individuals. In sheep 
the clinical signs of MV are strain dependent while the 
presentation of caprine arthritis and encephalitis (CAE) in goats 
has been associated with the age of host animals. Despite this 
variation in clinical signs, it remains common that most infected 
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animals present as asymptomatic, especially in recent 
infections and upon appearance of clinical signs, disease 
progressively worsens to eventual death (Straub 2004).  
Two main presentations of MV have been characterised: maedi 
and visna (‘dyspnea’ and ‘wasting’ in Icelandic, respectively) 
depending on the infecting strain of MVV (Narayan and Cork 
1985). The most common form of MV, maedi, typically shows 
as wasting and progressive dyspnea with a possible dry cough. 
Less common signs associated with this form of disease include 
fever, bronchial exudates and depression (Sigurdsson 1954). 
Death of animals with this disease usually results from anoxia 
or secondary bacterial infections. In comparison, visna is less 
frequent, especially in the UK (although higher incidences seen 
in countries such as the USA). Onset normally begins insidiously 
with subtle neurological signs such as hind limb weakness, a 
trembling of lips or a head tilt (Sigurdsson et al. 1962). This is 
accompanied by a gradual loss in condition of the infected 
animal. Following this, disease progresses to ataxia, 
incoordination, muscle tremors, paresis and paraplegia. In rare 
instances, other neurological signs such as blindness are also 
seen. The clinical course of this form of MV from onset to severe 
neurological signs is approximately a year with animals, if 
unattended, usually dying of inanition. In addition to the clinical 
signs stated above, progressive arthritis with severe lameness 
and chronic indurative mastitis have been seen in animals 
affected by either form of MV (Sigurdsson et al. 1957). 
CAE, as with MV, normally presents as one of two forms: an 
arthritic form mainly seen in adults and a neurological form 
seen mostly in kids (Narayan and Cork 1985). In kids, the 
neurological form of disease primarily occurs in kids aged 
between 2-6 months old. Initial presentation can include 
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lameness, ataxia, hind limb placing deficit, hypertonia and 
hyperreflexia, despite which kids appear bright and alert with 
no changes in eating or drinking (Cork et al. 1974). Following 
this the disease worsens to paraparesis, tetraparesis or 
paralysis. Other signs observed in affected kids include 
depression, a head tilt, blindness and nystagmus. Infection will 
normally result in either death by secondary cause (e.g. 
pneumonia or exposure) or euthanasia due to economic or 
welfare concerns. The arthritic form of CAE, the main clinical 
form of disease seen in adults, is characterised by a chronic 
polyarthritis normally accompanied by synovitis and bursitis 
(Crawford et al. 1980b). During early infection, lameness and 
distension of the joint capsule is seen, especially but not 
exclusively in the carpal joint, with progressive worsening over 
time. A loss in condition and dull coats have also been 
associated with diseased animals. As with MV, chronic 
indurative mastitis has also been seen in affected does with 
some cases resulting in agalactia at parturition (Lara et al. 
2005). In addition, in cases in which goats have serological 
evidence of infection without any typical clinical signs, chronic 
interstitial pneumonia and progressive dyspnea have been 
observed, although, these cases may be associated with cross 
species transmission of MVV. 
1.2.3 Pathology  
Following successful infection, SRLVs locate to monocytes from 
where they are disseminated throughout the body and from 
which onset of disease begins. Unlike other viruses of the 
lentivirus group, including HIV, BIV and FIV, MVV and CAEV do 
not cause immunodeficiency. Instead, lesions caused by these 
viruses can be characterised by persistent inflammation and 
infiltration and proliferation of mononuclear cells in target 
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organs (Nathanson et al. 1976). In addition, high proviral loads 
have been found to correspond to lesions of higher severity. 
Animals suffering from the respiratory form of disease show 
pathology of firm, dense, enlarged lungs that fail to collapse 
following opening of the thoracic cavity (Spickler 2015). In 
addition, lungs are typically discoloured with areas of 
consolidation or small white foci, although, this discolouring 
may not be obvious during early infection. Enlargement of the 
neighbouring lymph nodes, which may become edematous, is 
also common in both infections. Histologically, some variation 
between viral diseases is observed. In MVV infection, thickening 
of the alveolar septa due to infiltration and hyperplasia of the 
smooth musculature of the septa and of the epithelium within 
the bronchi and bronchioles following increased proliferation 
occurs. Fibrosis can also occur, although, is more commonly 
observed in severe cases (Georgsson and Palsson 1971). For 
animals suffering CAEV infection, chronic interstitial pneumonia 
can occur (higher prevalence in younger animals) as can 
enlargement of the alveolar septa. In addition, 
bronchopneumonia, perivascular cuffing and pulmonary 
alveolar proteinosis have also been known to develop. 
The neurological forms of both diseases, with the exception of 
wasting of the carcass, typically will only show gross pathology 
within the brain and spinal cord. Macroscopically, focal 
brown/pink regions may be found within the white matter of the 
CNS and on the ventricular surfaces, although this is not always 
visible. In addition, the spinal cord may appear swollen and the 
meninges may show a cloudy discolouration. Histologically, 
inflammation and demyelination are common (Georgsson et al. 
1982). It was found that early in infection, intensive 
inflammation is expected with aggregation of leukocytes within 
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the perivascular spaces (perivascular cuffing) and evidence of 
glial cell proliferation (gliosis). As a result of this inflammation, 
demyelination can occur within the white matter which in severe 
cases can result in extensive destruction of white matter within 
the cerebrum, cerebellum and other parts of the brain.  
The arthritic form of disease is most common within adult goats 
suffering CAEV infection although MVV has also been shown to 
cause arthritis. Adams et al. (1980) studied the early stages of 
development of joint lesions following CAEV infection. One day 
post infection an increase in synovial fluid cell count was seen 
followed by the development of morphological changes in 
synovial membrane. Lesions then worsened from mild synovial 
cell hyperplasia and perivascular mononuclear cell infiltration to 
severe synovial cell hyperplasia and mononuclear cell 
infiltration with villous hypertrophy. In addition, CAEV has been 
shown to mainly target the carpal joints within goats with the 
tarsal joints being targeted less frequently. Ultimately, infection 
can lead to severe destruction of cartilage, ruptured ligaments 
and tendons and the formation of periarticular osteophytes 
(bone spurs). In comparison, SRLV associated arthritis in 
infected sheep has been shown to be much milder. 
Indurative mastitis in infected animals has been characterised 
by mononuclear infiltration of the periductular stroma which 
results in the destruction of normal mammary tissue. 
Interestingly SRLVs have been shown to be associated with 
mammary epithelial cells within tissue with the permissive 
nature of these cells being confirmed in primary culture and 
immortalised cell lines (Lerondelle et al. 1999; Mselli-Lakhal et 
al. 2001; Bolea et al. 2006). 
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Lesions have also been noticed to be present within the kidneys 
of infected animals with evidence of vasculitis upon microscopic 
analysis (Angelopoulou et al. 2006). Finally, Pálfi et al. (1989) 
characterised lesions within testicles of MVV infected rams. In 
this study infiltration of the interstitium of the testicles by 
lymphocytes, histiocytes and plasma cells, fibrosis and atrophy 
of seminiferous tubules with resultant impacts on 
spermatogenesis were suggested to be associated with MVV 
infection. Interestingly, despite disturbances in 
spermatogenesis, semen was still demonstrated to be capable 
of transmitting MVV (Cutlip et al. 1981). 
1.2.4 Treatment 
To date, no successful treatment option has been recognised 
for MV or CAE. It is possible to ease the clinical signs associated 
with disease by supportive therapy, but this would not be able 
to treat the causal agent, SRLV infection and cannot prevent 
disease progression. With HIV in humans, the use of 
antiretroviral therapies (ARTs) maintains viral suppression, 
preventing propagation of virus and progression of disease and 
has been largely successful in controlling clinical signs and 
prolonging life expectancy to near normal (Raffi et al. 2016). 
The expense and difficulty of using these drug therapies has 
however largely precluded their use in domestic animals.  
1.2.5 Vaccines 
The inability to treat SRLV infection within small ruminants 
highlights the importance of preventative measures. One of the 
most commonly used examples of these are vaccines, used to 
prime the host immune system, providing protection against 
future infection. Unfortunately for SRLV, successful vaccines 
have proved elusive.  There have been many studies attempting 
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to identify functional vaccines that provide reliable protection 
against SRLV infection. To date, multiple vaccine production 
systems have been tested including inactivated or attenuated 
virus, viral clones and recombinant plasmids (Reina et al. 
2009b). 
Two of the first vaccines tested for both MV and CAE were 
inactivated virus vaccines (McGuire et al. 1986; Cutlip et al. 
1987). In both studies the vaccines did not provide protection 
following challenge with virus, with data from the CAEV vaccine 
trial suggesting that vaccination facilitated infection with 
animals developing arthritis more rapidly. This ability to aid viral 
infection was also seen in a MVV vaccine containing the MVV 
gag gene (Torsteinsdóttir et al. 2007). Animals were vaccinated 
a total of 8 times over 30 months after which they were 
challenged with MVV intratracheally. All animals showed a 
strong rise in antibody titres indicative of infection 2-3 weeks 
post challenge, much sooner than expected suggesting that 
vaccination may have again facilitated infection in host animals. 
Another vaccine trialled in goat was a recombinant vaccinia 
virus expressing CAEV surface and transmembrane envelope 
glycoproteins but provided no protection from intravenous 
challenge (Cheevers et al. 1994). Partial protection has been 
demonstrated for an attenuated MVV clone mucosal vaccine 
(Pétursson et al. 2005). Partial protection was characterised by 
superinfection following challenge after which a reduced 
frequency in isolation of virus from the blood and lungs was 
seen in vaccinated animals compared to unvaccinated. This 
inability to provide complete protection from SRLV infection 
further limits the preventative tactics available in reducing 
prevalence.  
26 | P a g e  
 
1.2.6 Genetic Susceptibility 
Absence of a curative treatment or available vaccines requires 
other means of controlling SRLV infection. The identification of 
genetic traits that provide improved resistance against infection 
could provide one such avenue. It has long been recognised 
that the rate of transmission of MVV is lower in particular breeds 
of sheep. Studies in Iceland identified that specific bloodlines 
within the Icelandic breed possessed resistance to disease 
expression, this resistance was more pronounced following 
cross breeding of the Icelandic breed with Border Leicester 
breeds (Pálsson 1976). This resistance was not against infection 
but to the onset of disease with these breeds showing slower 
disease progression. Following this, Cutlip et al. (1986) 
compared the susceptibility of two breeds, Border Leicester and 
Columbia. By comparison of the frequency and severity of 
clinical signs and lesions attributed to infection it was found that 
Border Leicester were more susceptible to infection when 
compared to Columbia sheep. The underlying reasons for these 
apparent differences are still yet to be fully understood, 
however modern molecular methods are shedding some light 
on this. 
Following a genome wide association study (GWAS) of naturally 
infected ewes with the intent of identifying any genetic 
associations with SRLV infection, the transmembrane protein 
gene (TMEM154) was identified (Heaton et al. 2012). The role 
of TMEM154 has yet to be ascertained, although a GWAS in 
humans looking at asthma severity identified a SNP within the 
TMEM154 gene that was associated with an increase severity 
(Li et al. 2010). This link to asthma may suggest a link between 
TMEM154 and airway immunity in humans. As the human 
protein shares only 67% amino acid identity with the ovine 
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protein it is also possible that this link may not be present within 
sheep. Analysis at the nucleotide level within 40 breeds of sheep 
revealed ten missense and two frameshift mutations that occur 
within the TMEM154 gene. In combination these mutations 
result in 12 different haplotypes (1-4, 6, 9-15) which have 
currently been identified (Table 1.2.6.1). Since then, Yaman et 
al. (2019) has recently identified a 13th haplotype within 
german flocks (will be referred as 16). Of these, the impact on 
susceptibility is only known for three (1, 2 and 3) (Heaton et al. 
2013). Haplotype 3 was reported as being the ancestral allele, 
this is apparent upon comparison of haplotype sequences in 
which all variations deviate from the ancestral sequence by a 
maximum of two mutations (Table 1.2.6.1). Leymaster et al. 
(2015) compared the incidence of MVV infection between ewes 
with TMEM154 diplotypes “1 1”, “1 3” and “3 3” in a natural 
exposure setting. It was found that after a period of 39 months 
approximately 10% of animals with diplotype “1 1” were 
infected compared to the approximate 90% prevalence seen in 
the remaining two groups. TMEM154 diplotype “1 1” therefore 
seems to provide resistance to infection. At the amino acid 
level, haplotype 1 differs from haplotype 3 by a missense 
mutation causing a change from glutamate (E) to lysine (K) at 
position 35. As this is the only difference between haplotypes 
this suggests that this change from E to K is key for resistance 
to MVV infection. In addition to haplotype 1, this missense 
mutation is also present within haplotype 10 which might 
suggest that this haplotype also provides resistance, but this is 
yet to be tested. Heaton et al. (2012) also sequenced TMEM154 
genes from domestic and mountain goats. These sequences 
showed no variation from the ancestral sheep haplotype at the 
locations previously mentioned. This in combination with the 
high similarity of CAEV and MVV suggests 





  TMEM154 aa Position 
 Exon 1   Exon 2 
Haplotype 4 13 14 25   31 33 35 38 44 70 74 82 102 
3 R A L T  E D E G T N I E I 
1 - - - -  - - K - - - - - - 
2 - - - -  - - - - - I - - - 
4 AΔ - - -  - - - - M - - - - 
6 - - - I  - - - - - - - YΔ - 
9 - - - -  - N - - - - - - - 
10 - - H -  - - K - - - - - - 
11 - - - I  - - - - - - - - - 
12 - - - -  - - - - - - F - - 
13 - V - -  - N - - - - - - - 
14 - - - -  - - - - - - - - T 
15 - - - -  Q - - - - - F - - 
16 - - - -  - - - R - - - - - 
Table 1.2.6.1 Amino acid sequence mutations in TMEM154 
haplotypes against ancestral sequence. Missense and 
frameshift mutations present in 12 TMEM154 amino acid 
sequences (1, 2, 4, 6 and 9-16) when compared against the 
ancestral haplotype (3). All haplotype variation deviates from the 
ancestral sequence by a maximum of 2 mutations. Blue region 
denotes the amino acid position associated with resistance to 
SRLV infection as seen in haplotype 1. Adapted from (Heaton et 
al. 2012). 
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that TMEM154 does not provide resistance in goats although 
this might not be representative of the global population.  
The frequency of TMEM154 genotypes was determined for 2759 
sheep representing 74 breeds worldwide (Heaton et al. 2013). 
From this data, a predicted value for the susceptibility to MVV 
infection was determined for these breeds. Those with the 
highest predicted susceptibility included Deccani, Chios and 
Scottish Texel Breeds while breeds with the lowest predicted 
susceptibility included animals of Valley Red Sheep, Rambouillet 
and Dorset Horned breeds. Multiple studies have attempted to 
quantify the relative risk of infection when comparing diplotypes 
(Heaton et al. 2012; Molaee et al. 2018; Yaman et al. 2019). 
These studies suggested on average an infection risk 2-3 fold 
lower in animals with resistant diplotypes when compared to 
those possessing 1 or more susceptible haplotypes. Greater 
variation within these studies has been suggested to be due to 
experimental factors such as sheep breed and circulating virus 
strain. 
C-C chemokine receptor type 5 (CCR5), is a G protein-coupled 
receptor (GPCR) with roles in chemotaxis and immunity. In 
humans, it has been identified as a co-receptor for HIV-1 
infection alongside the cluster of differentiation 4 (CD4) 
glycoprotein (Deng et al. 1996; Dragic et al. 1996). 
Interestingly, a 32bp deletion was identified that gave 
resistance to HIV-1 infection in those homozygous for this 
mutation (Liu et al. 1996). This deletion occurs within the 
transmembrane domain of CCR5 causing a frameshift at amino 
acid 185 which produces a premature stop codon that results in 
the formation of a non-functional protein. Initially thought to 
provide almost complete protection against protection, cases of 
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HIV infection within homozygous individuals have since been 
reported (Balotta et al. 1997; O’Brien et al. 1997).  
White et al. (2009) determined the sequence for ovine CCR5 
using primers derived from the bovine CCR5 sequence and 
found it to share 83.5% identity with human CCR5. They also 
identified a 4bp deletion within the octamer protein binding site 
within the promotor region which they found in homozygous 
individuals and resulted in reduced proviral loads during 
infection. This interaction requires further investigation, 
especially for the reason that CCR5 has been previously ruled 
out as a potential receptor for MVV infection (Lyall et al. 2000; 
Hötzel and Cheevers 2002). Later work has thus far failed to 
confirm a link between this ovine CCR5 deletion and reduced 
proviral loads, in fact the opposite was seen with increased 
infection risk in certain breeds (Alshanbari et al. 2014; Molaee 
et al. 2018). Research has since continued into the relationship 
of CCR5 and SRLV infection due to lack of a definitive answer, 
resulting in the recent discovery of a single nucleotide 
substitution within caprine CCR5 associated with an increased 
proviral load within goats infected by CAEV (Colussi et al. 
2019). The caprine CCR5 amino acid sequence showed 98% 
identity with ovine CCR5. This in conjunction with the high 
similarity between SRLVs as a group suggests this variant 
nucleotide sequence influencing CAEV infection may be present 
within sheep and MVV infection. 
1.2.7 Transmission 
Asymptomatic persistent infection associated with SRLVs 
highlights the importance of preventative measures to limit the 
risks of infection of healthy animals. In order to develop such 
strategies, the dynamics by which viruses are transmitted must 
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be understood. For SRLVs, the routes of transmission from 
infected individuals to naïve animals currently identified include 
inhalation of respiratory secretions, ingestion of colostrum or 
milk and faecal contamination of drinking water (Brodie et al. 
1998; Blacklaws et al. 2004). 
The respiratory route has traditionally been regarded as the 
main route by which horizontal SRLV transmission occurs within 
sheep and goats. Close contact between individuals is required 
to allow for successful transmission, with confined unventilated 
spaces as seen in indoor housing providing optimal conditions 
(Leginagoikoa et al. 2010). To reduce this, it has been shown 
that for outdoor enclosures a gap of two metres between 
infected and non-infected animals is sufficient in preventing 
transmission. McNeilly et al. (2007) demonstrated that cell-free 
MVV was sufficient in transmitting infection especially when 
instilled into the lower lung. Following this it was also found that 
MVV associated with alveolar macrophages was able to transmit 
infection but only following instillation into the lower lung 
(McNeilly et al. 2008). This same study also looked at the role 
of alveolar macrophages in transmission of the virus from the 
lung to the rest of the body. From this it was found that alveolar 
macrophage migration after infection did not play a role in 
transferring virus to the rest of the body suggesting that this 
occurred via an intermediate route.  
The next major mode of transmission of SRLVs is the ingestion 
of colostrum or milk from infected ewes/does. As previously 
described SRLV infection can target mammary tissue causing 
chronic mastitis in both sheep and goats (Cutlip et al. 1985; 
Gregory et al. 2009). In addition, multiple studies have also 
demonstrated the presence of SRLVs within colostrum and milk 
within both cell-free milk and milk derived cells (Adams et al. 
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1983; Leroux et al. 1997; Álvarez et al. 2006). It is suggested 
that this route of transmission is of more significance in SRLV 
infections when compared to other lentiviruses such as SIV and 
HIV due to the increased permeability of the kid/lamb’s 
digestive tract following birth (Preziuso et al. 2004; Pisoni et al. 
2010).  The cells responsible for harbouring virus within milk 
have been suggested as being macrophages and epithelial cells, 
two cells previously described as being permissive to SRLV 
infection. Transmission via colostrum or milk has been 
demonstrated for both MVV and CAEV (Adams et al. 1983; 
Pépin et al. 1998). Interestingly, when comparing SRLV strains 
A10 and B1, Pisoni et al. (2010) found differing efficiencies 
between strains for transmission by milk or colostrum. Álvarez 
et al. (2005) quantified the significance of colostrum in 
transmission of MVV, comparing lambs suckling from 
seropositive dam or bottle-fed colostrum from seropositive 
ewes. When comparing percentage of seropositive animals to a 
control group fed bovine colostrum, a 16% increase in the 
number of seropositive animals was seen when lambs were 
suckled by dams whilst those bottle fed showed an increase of 
29-61%. It was suggested that this greater risk in bottle fed 
animals may be due to bottle fed animals having a larger 
colostrum intake compared to those suckling or due to bottle 
feeding increasing the risk of inhalation of colostrum leading to 
respiratory transmission of MVV (Houwers 1990). Cutlip et al. 
(1981) have also proposed transplacental transmission to occur 
within animals following isolation of virus from ovine fetuses 
and newborn lambs which may also play a part in the previous 
study’s findings.  
Following the identification of pathological lesions within the 
testes of rams infected with MVV, the possibility of sexual 
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transmission was raised (Pálfi et al. 1989). Sexual transmission 
is not a new concept in lentiviruses and is a common occurrence 
in primates infected with SIV or HIV-1 (Zhang et al. 1999; 
Haase 2011). In addition, there is evidence suggesting 
occurrences within feline immunodeficiency virus (FIV) infected 
cats (Jordan et al. 1995). Sexual transmission of SRLV in sheep 
and goats was further supported by the finding of proviral DNA 
within semen and the reproductive tract of infected rams and 
bucks (Ali Al Ahmad et al. 2008; Peterson et al. 2008). Further, 
Ali Al Ahmad et al. (2012) artificially inseminated seronegative 
does intrauterine with semen containing CAEV with virus being 
subsequently detected in uterine smears, flushing media and 
uterine swabs suggesting again the potential for sexual 
transmission. This finding was later confirmed in a study that 
saw 60% of intrauterine inseminated does seroconverting thirty 
days post insemination (Souza et al. 2013). It is important to 
note that intrauterine insemination bypasses many innate 
defences present within the reproductive tract that may prevent 
transmission. Therefore, further study is required to confirm the 
potential risks of sexual transmission both with artificial 
insemination (AI) and with natural mating. In addition, the 
possibility of sexual transmission alongside the observed 
seroconversion of artificially inseminated animals, the potential 
transmission of virus when using reproductive biotechnologies 
such as embryo transfer and IVF is a concern (Cortez-Romero 
et al. 2013).  
1.2.8 Diagnostic Tests 
Accurate diagnostic tools are critical for the efficient 
identification of infected animals and are essential for an 
effective control strategy. The two currently prescribed tests for 
international trade are the agar gel immunodiffusion (AGID) 
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and a variety of enzyme-linked immunosorbent assays (ELISA) 
for serological diagnosis (OIE 2016). While the AGID is specific, 
reproducible and easy to perform, interpretation of results can 
be difficult without experience. In contrast, ELISA’s are more 
economical and quantitative with an ability to be automated 
providing an advantage when testing large quantities of sera. 
Both tests detect the presence of specific anti-viral antibodies 
with their specificity and sensitivity directly linked to the viral 
strain used for the assay, the viral antigens used and the 
standard of the comparison assay used (e.g. western blot or 
radio-immunoprecipitation). Other laboratory techniques 
employed for diagnosis include polymerase chain reaction 
(PCR), western blot and radioimmunoprecipitation (RIPA) with 
the latter two being implemented mostly as confirmatory tests 
(Herrmann-Hoesing 2010). 
In the UK, the current commercially used testing kits are the 
CAEV/MVV p28 Antibody Screening Kit (IDEXX), an indirect 
ELISA (iELISA) based on the immunogenic peptide, TM, and the 
recombinant protein, CA. The CAEV/MVV Total Antibody Test 
(IDEXX) and the ID Screen® MVV/CAEV Indirect ELISA Test 
(ID.VET) which targets a panel of TM peptides, the envelope 
glycoprotein gp135 and major core protein, p25. In addition, 
there have been over 30 different ELISAs reported for SRLV 
diagnosis. Of these the majority are iELISAs with a few 
examples of competitive ELISAs (cELISAs) using monoclonal 
antibodies being reported (Houwers and Schaake 1987; Schalie 
et al. 1994; DeMartini et al. 1999; Fevereiro et al. 1999). The 
ability of ELISAs to detect CAEV and MVV in milk also potentially 
enables a less invasive sampling strategy than the blood tests 
currently used in most programmes (Plaza et al. 2009; Brinkhof 
et al. 2010). 
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PCR can also be a reliable tool for diagnosing SRLVs from a 
variety of sources including blood, tissue, milk and semen (Ali 
Al Ahmad et al. 2008; Brinkhof et al. 2010). The limitations with 
PCR relate to the specificity of primers required for successful 
amplification. These require an up to date sequence of the 
infective strain to maximise probability of detecting virus. In 
addition, the constant mutations occurring within the SRLV 
genome can prevent primer binding and therefore prevent any 
amplification and subsequent diagnosis. Currently PCR is mainly 
used as a confirmatory test following ELISA or AGID (de Andrés 
et al. 2005). Carrozza et al. (2010) have designed two probe 
based real time PCR assays targeting the gag and pol genes of 
the EV1 strain of MVV. 
These diagnostic tools are critical for the control of SRLV spread 
as they allow identification of infected animals which enables 
quick actions to be put in place to limit the impact of infection 
on a flock/herd. 
1.2.9 Control Programmes 
Due to the lack of vaccine or treatment available for SRLV 
infection, governments and producer bodies worldwide have 
introduced control schemes to limit transmission and reduce 
national prevalence. Countries included in this number are the 
UK, Germany, Norway, Switzerland, Canada and the USA.  
The MVV and CAEV accreditation schemes (MVAS and CAEAS), 
currently in place within the UK, are completely voluntary 
schemes which aim to help reduce the prevalence of disease 
(SRUC 2020). However, Ritchie et al. (2010) when comparing 
seroprevalence within the country from 2010 to those recorded 
in 1995 found that individual animal prevalence had 
quadrupled, suggesting the current accreditation scheme to be 
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ineffective. It is worth noting that the farms sampled during 
these surveys were mostly a part of the accreditation scheme 
therefore producing bias towards virus free flocks which may 
have resulted in an under estimation of the actual UK 
prevalence. In addition, the voluntary nature of the schemes 
results in the majority of participating farms holding high value 
flocks e.g. rare breeds or breeding stocks. This is due to higher 
degree of economic impact on these farms with smaller holdings 
declining testing due to the monetary requirements necessary 
to take part in the schemes. This therefore means that viral 
presence is unchecked within these animals resulting in 
persistence within the national flock/herd.  
This is similar to the situation previously seen in Switzerland 
who implemented a CAEV eradication programme in 1984 on a 
voluntary basis (Peterhans et al. 2004). The scheme was made 
mandatory as of 1998 and involved annual serological testing 
for all goats. Seropositive animals were culled, and the source 
farms quarantined until three consecutive negative results from 
all adult animals. The scheme resulted in the initial flock 
prevalence of 83% dropping to 1% in 2002. This therefore 
suggests that a mandatory scheme is necessary in the UK to 
truly combat the prevalence of SRLV infection.   
For MV, flocks wishing to join the MVAS must be situated in 
Great Britain and must ensure that the flock meets and abides 
by the strict requirements and rules of the MVAS. For a flock to 
be accredited they must initially undergo two qualifying ELISA 
tests carried out 6-12 months apart with all animals older than 
12 months being tested. Upon accreditation, flocks must be 
tested within 12 months, after which, providing results are 
negative, the next periodic testing must occur within 2 years. 
Following this the time interval between testing is dependent on 
37 | P a g e  
 
the presence of non-accredited animals on holdings. The 
number of animals tested following accreditation is dependent 
on flock size (Table 1.2.9.1). In situations where contact occurs 
with non-accredited animals, the MVAS requires isolation of any 
such individuals for a period of 6 months and subsequent 
testing to ensure negative status. In cases in which an animal 
shows seroconversion, removal and a further 6 months of 
isolation is required for those remaining. Should any animals be 
returned to flock without adhering to these terms then 
accredited status is removed. Further to these terms, the MVAS 
requires strict animal handling conditions, especially in holdings 
possessing both accredited and non-accredited animals. These 
include boundaries to prevent any stray animals from coming 
into contact with the flock, no shared unventilated spaces (e.g. 
barns), a 2 metre divide between accredited and non-accredited 
animals, no use of shared equipment between groups and only 
embryos/semen from accredited animals can be used for 
impregnation/insemination. Transport of animals is also highly 
regulated; accredited and non-accredited animals cannot be 
transported in the same vehicle, with vehicles previously used 
to transport animals having to be cleaned and disinfected before 
use by accredited flock. For goats, the CAEAS is identical to the 
MVAS except in that it refers to goats, accredited and non-
accredited animals must be separated by a distance of 3 metres 
and at temporary locations a 3 metre tall solid barrier is 
required to separate animals. 
1.2.10 Geographical Distribution 
Following initial discovery in 1939 and 1974, SRLV infection has 
since   been  shown  to   be   present   worldwide,  affecting   all 








Table 1.2.9.1 Sample sizes based on flock size for regular 
testing as part of the MVAS. 
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continents apart from Antarctica. In addition, the distribution 
demonstrated by available reports appears random with 
countries showing varied presences of virus (Figure 1.2.10.1). 
Excluding Iceland, which has reported eradication of SRLVs 93 
countries have reported cases of SRLV infection (16 MVV, 32 
CAEV and 45 both). It is important to note that no reports do 
not mean that SRLVs are not present within these countries, as 
many do not test. Testing might not be carried out for varying 
reasons such as low economic importance, absence of clinical 
signs or lack of awareness of the disease.   
1.2.11 Economic Impact 
Several studies have characterised the impacts of SRLV 
infection on small ruminant production systems. Within milk 
production systems research has shown contradicting impacts 
on milk yield with studies reporting decreased, unchanged or 
increased milk yield within differing populations of sheep and 
goats during SRLV infection (Nord and Dnøy 1997; Leitner et 
al. 2010; Lipecka et al. 2010). Therefore, the true impact of 
SRLV on milk yield during SRLV infection is unclear and requires 
further investigation. 
SRLV infection in young animals is also an important aspect of 
disease impact. Kids suffering from CAE can develop 
neurological disease which, depending on severity can lead to 
the culling of kids on the grounds of welfare. This therefore 
leads to a loss in future profit associated to these animals. In 
MV, disease in lambs is less pronounced with infected animals 
presenting with a reduced growth rate (Keen et al. 1997).    




Figure 1.2.10.1 Worldwide distribution of small ruminant lentiviruses. World map illustrating countries with reported evidence of small ruminant lentiviruses (SRLV) 
presence. Colours denote viral species reported; maedi-visna virus (green), caprine arthritis encephalitis virus (orange) or both (blue). Evidence sourced from (Straub 1970; Wandera 1970; Süveges 
et al. 1973; Hugoson 1978; Crawford and Adams 1981; Eguiluz and Aluja 1981; Oliver et al. 1982; Adams et al. 1983; Caporale et al. 1983; Snyder et al. 1983; Adams et al. 1984; Belino and Ezeifeka 1984; Gonzalez Angulo et al. 1984; Mahin et al. 1984; Dawson and 
Wilesmith 1985; Adair 1986; Payne et al. 1986; Agrimi et al. 1987; Gonzalez et al. 1987; Houwers et al. 1987; Houwers and van der Molen 1987; Surman et al. 1987; Grant et al. 1988; Mogollon Galvis et al. 1989; Pereira et al. 1989; Alluwaimi et al. 1990; Baumgartner et al. 
1990; Kita et al. 1990; Krieg and Peterhans 1990a; Sargan et al. 1991; Giangaspero et al. 1992; Giangaspero et al. 1993; Hötzel et al. 1993; Burgu et al. 1994; H. 1994; Leroux et al. 1995; Celer and Ni~mcova 1997; Sung and Chol 1997; Valas et al. 1997; Nord et al. 1998; 
Daltabuit Test et al. 1999; Masalski et al. 1999; Sihvonen et al. 1999; Masalski 2000; Schaller et al. 2000; Ayelet et al. 2001; Ravazzolo et al. 2001; Fevereiro et al. 2002; Robles and Layana 2003; Barros et al. 2004; Konishi et al. 2004; Sz. Kusza 2004; Karanikolaou et al. 
2005; Al-Qudah et al. 2006; Christodoulopoulos 2006; Shuljak 2006; Vidic et al. 2008; Fallas et al. 2009; Ghanem et al. 2009; Hananeh and Barhoom 2009; Kaba et al. 2009; Mitrov et al. 2009; Sidelnikov et al. 2009; Elfahal et al. 2010; Noordin et al. 2010; Lin et al. 2011; 
Sakhaee et al. 2011; Huang et al. 2012; Oem et al. 2012; Paethaisong et al. 2012; Tageldin et al. 2012; Gudnadóttir et al. 2013; Kuhar et al. 2013b; Max et al. 2013; Muz et al. 2013; Santry et al. 2013; Tolari et al. 2013; Zhang et al. 2013; Oguma et al. 2014; Norouzi et al. 
2015; Padiernos et al. 2015; Tabet et al. 2015; Tariba et al. 2015; Villagra-Blanco et al. 2015; Waseem et al. 2015; Enache et al. 2016; Gumusova and Memıs 2016; Linderot de Cardona et al. 2016; Hamza and Özkan 2017; Tabet et al. 2017; YANG et al. 2017; Barták et al. 
2018; Michiels et al. 2018; Davaasuren et al. 2019; Enache et al. 2019; Idres et al. 2019; Cana et al. 2020; Itzcoatl Martínez-Herrera et al. 2020)     
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In addition, SRLV infection has been shown to reduce fertility 
within infected does and ewes, impacting both dairy and meat 
production markets (Burmeister 2001). In cases of successful 
pregnancy and birth SRLV infection has then been shown to 
impact upon birth weight and subsequent growth rate of the 
offspring, by reducing both (Dohoo et al. 1982; Arsenault et al. 
2003; Peterhans et al. 2004).  
Gibson et al. (2018) investigated further the monetary losses 
that could be attributed to an outbreak of SRLV infection in 
sheep. The study followed an outbreak in a flock of 825 
breeding stock in size. Over a four-year period following initial 
outbreak, the study reported a cumulative loss of £131,953. It 
is important to note that these costs may be further enhanced 
depending on purpose of flock (i.e. dairy, meat or breeding).
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1.3 Aims and Objectives 
Over the course of this project, four aims were put forward for 
investigation: 
1. Development of a more reliable and cost-effective 
diagnostic for detection of MVV strains within the UK. 
2. Quantification of the risk of MVV transmission following 
intravaginal insemination using semen collected from 
naturally MVV infected rams. 
3. Longitudinal case study of morbidity and mortality due to 
MVV infection in naturally infected rams. 
4. Estimation of the impact of MVV infection on milk 
production and SCC within a UK dairy flock. 
 
Development of a more reliable and cost-effective 
diagnostic for detection of MVV strains within the UK 
Despite current schemes in place to control the spread of MV 
and CAE in the UK, Ritchie et al. (2010) calculated the 
prevalence of MV to have nearly quadrupled over the course of 
15 years (1995-2010). Although this can in part be associated 
to the voluntary nature of the scheme it can also be attributed 
to the inability of current diagnostic tests to identify all strains 
of MVV due to the high variability, characteristic of lentiviruses. 
To try and combat this the first aim of this project was to 
develop a more reliable and cost-effective PCR based diagnostic 
test for the detection of MVV infection. 
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Quantification of the risk of MVV transmission following 
intravaginal insemination using semen collected from 
naturally MVV infected rams. 
Ali Al Ahmad et al. (2012) previously demonstrated 
transmission of SRLV via intrauterine insemination with semen 
proven to contain virus. Although this highlights the risk of 
sexual transmission, intrauterine insemination bypasses the 
natural innate defences of the reproductive tract and therefore 
cannot be used as a reliable model for natural mating. 
Therefore, the second aim of this study was to quantify the risk 
of MVV transmission following intravaginal insemination of a 
group of naïve ewes using semen from naturally infected rams. 
Longitudinal case study of morbidity and mortality due 
to MVV infection in naturally infected rams. 
In 2015, the University of Nottingham acquired 28 naturally 
MVV infected rams. Over the course of 2 years, blood samples 
and tissue samples following sudden death/euthanasia were 
collected. Using these samples, the third aim of this study was 
to quantify the long-term impact of MV by a longitudinal case 
study of morbidity and mortality due to disease within these 
individuals. 
Estimation of the impact of MVV infection on milk 
production and SCC within a UK dairy flock. 
Finally, an opportunistic data set was received from a flock of 
319 dairy ewes identified as MVV infected during routine 
serological screening. Data provided included milking history, 
somatic cell counts (SCCs) and individual ewe characteristics. 
To date, conflicting reports have been made regarding the 
impact of SRLV infection on milk production (Nord and Dnøy 
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1997; Leitner et al. 2010; Martínez-Navalón et al. 2013). In 
addition, SRLV have been shown to cause variation in SCC 
between seronegative and seropositive individuals with further 
differences between breeds (Lipecka et al. 2010). Therefore, 
the final aim of this study was to estimate the impact of SRLV 
infection on milk production and SCC within this flock by way of 
multivariable regression modelling. 
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Chapter 2: Development of qPCR Protocol 
for Quantification of Maedi-Visna Virus 
2.1 Introduction  
A previous study into the prevalence of SRLV infection within 
the UK has suggested that the number of infected individuals to 
be on the rise (Ritchie et al. 2010). Between 1995 and 2010, 
seroprevalence of MVV was reported to have nearly quadrupled 
(0.19% -> 0.74%), a rate of increase that if sustained would 
result in a seroprevalence of 1.11% in 2020. Despite this 
dramatic increase in prevalence rates no further studies of 
current seroprevalence have been published within recent 
years.  
Introduced in 1982, the current MVV/CAEV accreditation 
scheme within the UK is not efficient enough in preventing this 
increase in prevalence (SRUC 2020). The degree to which the 
scheme reduces the rate of spread is unknown but the current 
rise in seroprevalence suggests a need for enhancement 
(Ritchie et al. 2010). Several factors can be identified that may 
contribute to this inability to reduce prevalence such as the 
voluntary nature of the current scheme, lack of reports on 
quantification of cost benefits, or viral strain variability (Ramírez 
et al. 2013; Ogden et al. 2019).  
As of 2017, 6056 sheep flocks and goat herds are listed as 
participating in the scheme within the UK (SRUC 2017). In 
comparison, the total number of sheep holdings in the UK in 
2015 was 72,272 (NFU 2017). This difference, likely due to the 
scheme being voluntary is likely a large contributor to 
persistence of SRLV presence within the UK, with unaccredited 
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flocks and herds acting as viral reservoirs. Farmer perspective 
is of great importance in this regard. One such factor of 
importance to individuals is the costs associated with acquiring 
accreditation as opposed to the benefits of being free of virus. 
One recent study quantified the losses associated with MVV 
breakdown and found losses of £132,000 over a 5-year period 
in a flock originally consisting of 800 individual breeding ewes 
(Gibson et al. 2018).  
Accreditation provides several benefits including entrance to 
accredited only shows and sales, advertisement of accredited 
status to purchasers, increased value of accredited stock and 
allowance for export to certain MV/CAE free countries (SRUC 
2020). These benefits are likely to be of more advantage to 
larger, high value flocks such as pedigrees flocks with limited 
interest for small holdings such as hobbyists. These small 
isolated flocks can act as viral reservoirs which will not be 
detected using a voluntary accreditation scheme and therefore 
can contribute to viral persistence on a national level.  
To date, only a single full genome MVV sequence has been 
reported within the UK (EV1 strain) (Sargan et al. 1991). Initial 
identification occurred in 1991, approximately 30 years ago. 
Given the rate of mutation and ability of virus to recombine, it 
is possible that this strain as sequenced in 1991 is no longer 
circulating naturally within the UK population (Ramírez et al. 
2013). Therefore, diagnostics designed targeting this strain of 
virus may prove ineffective and provide false results 
highlighting the importance of identifying viral strain within 
outbreaks for such variable viruses as SRLVs. Further to this, 
the most commonly used diagnostic tests, ELISA, AGID and PCR 
each require specific components designed to work at peak 
efficiency with a specific strain of virus (Fevereiro et al. 1999; 
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Carrozza et al. 2010). This may be combated through 
production of multiple testing kits for detection of differing 
strains, testing of larger sample sizes per flock (to account for 
strains that are detected sub-optimally by the current tests) or 
constant adaptation of current diagnostic tests to match 
circulating strains at specific times. Although it is important to 
note the costs associated with such changes which in many 
cases render this economically unfeasible.  
In this chapter, the objective was to design and develop a qPCR 
based diagnostic assay for detection and quantification of SRLV 
viral loads within a naturally infected group of breeding rams 
within the UK. The virus strain was unknown and therefore deep 
sequencing technologies were implemented to allow for 
identification and classification of circulating virus within these 
animals. This work also allowed for the assessment of feasibility 
for design and creation of a broad-spectrum qPCR for efficient 
and reliable detection of all circulating SRLV strains.  
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2.2 Materials and Methods 
2.2.1 DNA Extraction 
DNA was extracted from blood using the Nucleospin® Tissue Kit 
(Macherey-Nagel) for detection of MVV using PCR based 
methods.  
Blood clots were processed by following the supplementary 
protocol for extraction of genomic and viral DNA from blood 
samples. Before the protocol was carried out, a small amount 
(approximately 25 mg) of blood clot was added to 200 µl of 
PBS. A sterile 5mm steel bead was then added and mixture 
homogenised by a Retsch MM300 bead mill (Qiagen) at a 
frequency of 25/s for 2 minutes. The protocol was then followed 
substituting homogenised blood clot and PBS for 200 µl of fresh 
blood. DNA was eluted from the column in a final volume of 60 
µl.  DNA was stored at -20 ̊C until use.  
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific, UK).  
2.2.2 Primer Design - 1 
Primers were designed for PCR and qPCR and sequencing using 
primerBLAST software (NCBI). Reference viral sequences were 
attained from the GenBank genetic sequence database (NCBI). 
Twenty-two full length SRLV sequences and 681 partial 
sequences were aligned as whole virus and by gene segment 
by MUSCLE using CLC sequence viewer software (Appendix 1). 
From this, alignment primers were designed based on regions 
conserved between sequences. Degenerate primers were 
designed where necessary due to the high variability between 
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viral strains. Primers were produced by Sigma Aldrich or 
Eurofins. 
2.2.3 PCR 
Amplification of desired DNA sequences for the determination 
of the ability of specific primers to amplify these sequences was 
carried out by PCR. For template, 1 µl of DNA extracted from 
the blood of MVV seropositive rams was used in a reaction 
mixture of 25 µl. Each reaction contained 5 units of Taq DNA 
Polymerase, 1x standard Taq (Mg-free) reaction buffer (NEB), 
3mM magnesium chloride (MgCl2) (NEB), 0.04 pmol of forward 
and reverse primers (Table 2.2.3.1) and 0.4mM 
deoxynucleotide (dNTP) solution mix (Thermo Scientific). 
Standard PCR cycling conditions consisted of an initial 
denaturation phase of 95oC for 5 minutes followed by 45 cycles 
of 95oC, 45-68oC and 68oC, each for 15-60 seconds depending 
on expected product size. Reactions were carried out within a 
Thermal cycler Life ECO (Bioer Technology). Primers were 
tested over a gradient of annealing temperatures determined 
by primer melting temperature to allow for optimum conditions 
for amplification. Successful amplification was determined by 
gel electrophoresis of PCR products. Primers used are listed 
within Table 2.2.3.1 stating target gene, sequence and source. 
2.2.4 Gel Electrophoresis 
To allow identification of products produced by PCR, gel 
electrophoresis was utilised. Expected PCR products were 
smaller than 1000 bp, therefore, a 2% Agarose gel was 
prepared to which 1 µl of Nancy-520 (Sigma Aldrich) per 20 ml 
Tris/acetate/EDTA solution (TAE) had been added. Products 
were loaded  on  the gel  alongside  a  100bp DNA  ladder (NEB) 
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Primer  Target Gene Sequence  Reference 
EV1 POL F 
EV1 POL R 
EV1 POL Probe 






MVV pol q F1 
MVV pol q R1 
MVV pol RGARGATGCDGGVTATGA 
CYTGATAYCCHGARTCTA  
* 
MVV pol q F2 
MVV pol q R2 
MVV pol BAARTGGCATCARGATGC 
TCYACYTGCCARTGRTCTA 
* 
MVV pol q F3 
MVV pol q R3 
MVV pol GTVTGGRTAGAAACAAATTC 
GCTTGHGAYTGNGGRTTCCA 
* 
MVV pol q F4a 
MVV pol q F4b 
MVV pol q F4c 
MVV pol q F4d 
MVV pol q R4a 
MVV pol q R4b 
MVV pol q R4c 
MVV pol q R4d 
MVV pol q R4e 
MVV pol q R4f 











MVV gag q F1 
MVV gag q R1 
MVV gag TTGACDGAAGGRAAYTGT 
GTYTCDGGYTTCATNCCCAT 
* 
MVV gag q F2  
MVV gag q R2 
MVV gag MWGTDGCWATGCCARCAT 
DATATCYTTRCTWGTCCA 
* 
MVV gag q F3 
MVV gag q R3 
MVV gag NCARGCHAAYATGGATCA 
TGACARTCTGYRCTDGCAT 
* 
MVV env q F1 
MVV env q R1a 
MVV env q R1b 




MVV env q F2 
MVV env q R2a 
MVV env q R2b 




CAEV pol q F1a 
CAEV pol q F1b 
CAEV pol q R1a 
CAEV pol q R1b 





*Primers designed in this study   
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and run at 100 V and for 45 minutes. Gels were viewed and 
photographed by ImageQuant LAS 400 (GE Healthcare Life 
Science, UK) under ultraviolet (UV) light. Confirmed products 
for which the nucleotide sequence was required were prepared 
for sequencing using the Nucleospin® Gel and PCR Clean-up kit 
(Macherey-Negal) following the recommended protocol for PCR 
clean-up. 
2.2.5 Sanger Sequencing and Analysis 
Nucleotide sequences were acquired by Sanger sequencing 
carried out by Source BioScience. 5 µl of product to be 
sequenced was prepared at 10 ng/µl per 5 µl of primer, at a 
concentration of 3.2 pmol/µl. Sequence analysis was completed 
using BioEdit v7.2 and CLC Sequence Viewer software v8.0 
(Qiagen).  
2.2.6 RNA Extraction 
RNA for next generation sequencing (NGS) was extracted from 
6 seropositive ram (3 alive at project commencement and 3 
which died at differing time points before) lung and mediastinal 
lymph node tissues. The RNeasy Mini Kit (Qiagen) following the 
recommended protocol for extraction of total RNA from animal 
tissue was used. Final RNA was eluted in a total volume of 100 
µl. Successful extraction was confirmed using the NanoDropTM 
8000 Spectrophotometer (Thermo Fisher Scientific). The 
quantity and quality of RNA extracted was determined using the 
2100 Bioanalyzer system (Agilent) following the manufacturer’s 
recommended protocol. The ram’s (Ram 8, Ram 13 and Ram 
26) RNA which showed best quality and yield from both tissue 
sources were selected for NGS.   
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2.2.7 Next Generation Sequencing 
NGS was carried out by the Imperial BRC Genomics Facility of 
Imperial College, London. An initial quality check of samples 
was carried out by the facility and library preps completed 
targeting total RNA with additional ribosomal RNA depletion. 
Library preps were then quantified before sequencing. Utilising 
the Illumina NextSeq 500 system (Illumina), the 6 pooled 
samples were run over two lanes at MID output. Paired end 
reads of 150bp in length were sequenced with an estimated 36-
42 million fragments per sample produced. Data files were 
returned for analysis. 
2.2.8 Next Generation Sequencing Analysis 
NGS data was analysed for acquisition of maedi-visna strains. 
Analysis was carried out using the Cloud Infrastructure for 
Microbial Bioinformatics (CLIMB) a cloud-based cyber-
infrastructure developed as a collaboration between Warwick, 
Birmingham, Cardiff, Swansea, Bath and Leicester universities 
(Connor et al. 2016). The process of analysis is illustrated in 
Figure 2.2.8.1. 
Initial raw data obtained from Imperial BRC Genomics Facility 
was compiled by ram and tissue before being checked for 
sufficient quality and removal of labelling barcodes through 
skewer software. Sequences were then aligned against the 
sheep genome (v3.1, accession number GCA_000298735.1) at 
which point sequences which successfully aligned were 
removed from the sequence pool using HISAT2 software 
(Archibald et al. 2010; Kim et al. 2015). Next, non-sheep 
sequences were classified against a reference database using 
Kraken2 software (Wood and Salzberg 2014). Reference 
database  of   Archaea,   bacteria   and   virus   sequences  was 






Figure 2.3.8.1 Next generation sequencing analysis flowchart. 
Chart illustrating the step by step analysis of data for acquisition of 
maedi-visna strain sequence. 
  
Sequence Acquisition
Visualised virus sequences compiled for downstream use using 
Tablet sequence viewing software 
Alignment to Viral Genome
Alignment of Maedi-Visna virus sequences against ref database 
using Bowtie2 software
Classification
Non sheep sequences classified against Archaea, Bacteria and 
Virus reference databases using Kraken2 software
Alignment to Sheep Genome
Sequences aligned against sheep genome v3.1 using HISAT2 
software
Quality Check and Trimming
QC and trimming using Skewer software
Sequence Compilation
Sequences compiled by ram and tissue
Initial Data
Raw data receieved from Imperial BRC Genomics Facility, 
London
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compiled using free to use kraken database. To improve 
detectability for SRLV sequences, a further 22 full genome and 
681 partial sequences (Appendix 1) were added to the reference 
database. Sequences that were successfully classified as SRLV 
were removed from the sequence pool and aligned against a 
custom reference database exclusively consisting of the SRLV 
sequences using Bowtie2. Finally using Tablet sequence viewing 
software, alignments were viewed for read depth and 
localisation within the viral genome (Milne et al. 2013). 
2.2.9 Primer Design – 2 
Compiled virus sequences acquired from NGS were used for the 
design of qPCR primers using primerBLAST software (NCBI), 
targeting the three structural proteins of SRLVs; Env, Gag and 
Pol (Appendix 2). Regions targeted were determined by  a read 
depth of >2 with a target product size approximately 100bp 
(Table 2.2.9.1). Ability to amplify viral sequences was 
confirmed by end point PCR. Amplification of correct product 
was confirmed by Sanger sequencing. 
Table 2.2.9.1 PCR primers designed from sequences acquired 
by NGS 
 
2.2.10 qPCR Design 
A Sybr green based qPCR procedure was designed for detection 
of the SRLV strain in this study. Each of the 3 primer sets 
previously shown to successfully amplify viral sequences were 
Primer  Target Gene Sequence  Product Size 
NGS Env1 F 
NGS Env1 R 
SRLV env GACTAGGCATTGTGCTTGCT 
ATGACTGCTGCACGGCATTA 
84 bp 
NGS Gag1 F 
NGS Gag1 R 
SRLV gag CAAGCCACATTGGCATGCTT 
TTATTCCCCTTGCTGCCTGC  
76 bp 
NGS Pol1 F 
NGS Pol1 R 
SRLV pol AGGGGATGCATACTTTACTATACCA 
TCTTGTGCATGGCCCTAAAT 
97 bp 
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tested for potential use in this diagnostic assay. For initial 
testing,  standards were created using large overlapping 
primers approximately 50bp in length  covering the target viral 
sequence (Table 2.2.10.1). 
Table 2.2.10.1 PCR primers for synthesis of standard products 
 
In addition to the standard acting as a positive control, the 
primers were tested against ram blood DNA from a seropositive 
animal, ewe blood DNA from a naïve animal and water, which 
acted as a negative control. From these tests, the most suitable 
primer pair was selected for downstream testing.  
Reaction mixtures for initial tests consisted of 1x qPCRBIO 
SyGreen Mix Lo-ROX master mix (PCR Biosystems), 0.04µM 
forward and reverse primers and 1µl of test DNA or standard in 
a total volume of 20 µl. Reaction conditions consisted of a 
starting incubation of 95oC for 15 minutes followed by 45 cycles 
of 95oC for 5 seconds, 60oC for 30 seconds and 72oC for 10 
seconds. After cycle completion a melt curve was carried out 
ranging from 65oC to 95oC. All reactions were carried out within 
a CFX Connect Real-Time PCR Detection System (Biorad 
Laboratories). 
Following primer selection, optimization of primer concentration 
and annealing temperature were carried out to determine 
optimal conditions. Primer concentrations tested were 0.02µM, 
0.04µM, 0.08µM and 0.4µM. Annealing temperatures tested 
ranged from 55oC to 65oC.  
Primer  Sequence  
NGS Env Std F 
NGS Env Std R 
GACTAGGCATTGTGCTTGCTATCATGGCAATAATAGCTGCTGCAGGAGCTGG 
ATGACTGCTGCACGGCATTAGCAACCCCGAGTCCAGCTCCTGCAGCAGCTATT 
NGS Gag Std F 
NGS Gag Std R 
CAAGCCACATTGGCATGCTTAATGTGTAGTCAAATGGGAATGAAGC 
TTATTCCCCTTGCTGCCTGCACTGTCTCGGGCTTCATTCCCATTTGA 
NGS Pol Std F 
NGS Pol Std R 
AGGGGATGCATACTTTACTATACCATTATATGAACCCTATAGACAATATACATGC 
TCTTGTGCATGGCCCTAAATTATTCGGACTTAGCAGAGTGAAGCATGTATATTGTC 
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For analysis, a standard curve was produced for each reaction. 
A 1:10 standard dilution series of PCR product derived 
standards was carried out on each plate ranging in 
concentration from 2.41 x 1011 copies/µl to 2.41 x 104 copies/µl. 
All analysis of results was carried out using Bio-Rad CFX 
Maestro software.  
2.2.11 Sequence Analysis 
To characterise sequences obtained through next generation 
sequencing and to identify viral strain present within 
seropositive rams, sequences were analysed using MEGA X 
software (Kumar et al. 2018). Phylogenetic trees were 
constructed using the Maximum likelihood method and Tamura-
Nei model (Tamura and Nei 1993). The percentage of bootstrap 
values was based on 500 repititions. 
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2.3 Results 
2.3.1 Primer Testing 
Primers listed in Table 2.2.3.1 were tested for ability to amplify 
SRLV present within samples collected from known seropositive 
rams, with focus on potential use for a diagnostic test. The 
results from these PCR reactions were collated within Table 
2.3.1.1.  
Of the primers targeting the pol gene, 3 of 5 primer sets showed 
successful amplification of plasmid DNA constructed from the 
pol gene of the EV1 strain (UK strain) of MVV. Despite this, no 
primer set targeting the pol gene showed amplification of any 
product when run using DNA extracted from seropositive ram 
lung and lymph tissue. Primers targeting the env and gag genes 
in addition showed no successful amplification.  
Primers designed to target the pol gene of CAEV were also 
tested. PCR reactions resulted in the amplification of multiple 
bands which upon sequencing were confirmed not to be SRLV 
sequence.  
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Table 2.3.1.1 SRLV PCR results following initial primer design for viral detection.  
 
➔ Figure 2.3.1.2 Gel electrophoresis images of SRLV primer results. Images of gels ran using PCR 
products obtained from testing of SRLV primers targeting the (A+B) MVV pol gene, (C+E) MVV env gene, 
(D) MVV gag gene or (F) CAEV pol gene. Primers were run against DNA extracted from lung tissue of 
seropositive rams. MVV pol primers were additionally ran against plasmid DNA encoding the pol gene of 
a previously identified UK strain of MVV (EV1). 
 
Primer  Target Gene Sequence  PCR – EV1 Plasmid PCR – Ram DNA Gel* 
EV1 POL F 
EV1 POL R 
EV1 POL Probe 
MVV pol AGATTGGGGAAATAAAGCAATAGAAT 
TTATTACCTCTTGTGTAAGCTTTTGT 
6-FAM-CGCTTTAATGCTCTGCTGTGCTTGAC-BHQ1a 
Positive  Negative  - 
MVV pol q F1 
MVV pol q R1 
MVV pol RGARGATGCDGGVTATGA 
CYTGATAYCCHGARTCTA  
Positive Negative  A 
MVV pol q F2 
MVV pol q R2 
MVV pol BAARTGGCATCARGATGC 
TCYACYTGCCARTGRTCTA 
Negative Negative  A 
MVV pol q F3 
MVV pol q R3 
MVV pol GTVTGGRTAGAAACAAATTC 
GCTTGHGAYTGNGGRTTCCA 
Positive  Negative  A 
MVV pol q F4a 
MVV pol q F4b 
MVV pol q F4c 
MVV pol q F4d 
MVV pol q R4a 
MVV pol q R4b 
MVV pol q R4c 
MVV pol q R4d 
MVV pol q R4e 
MVV pol q R4f 










Negative  Negative  B 
MVV gag q F1 
MVV gag q R1 
MVV gag TTGACDGAAGGRAAYTGT 
GTYTCDGGYTTCATNCCCAT 
- Negative  D 
MVV gag q F2  
MVV gag q R2 
MVV gag MWGTDGCWATGCCARCAT 
DATATCYTTRCTWGTCCA 
- Negative  D 
MVV gag q F3 
MVV gag q R3 
MVV gag NCARGCHAAYATGGATCA 
TGACARTCTGYRCTDGCAT 
- Negative  D 
MVV env q F1 
MVV env q R1a 
MVV env q R1b 
MVV env TGTGARGARTGGTGYTGGTA 
TTTTCCCAATATACCCGCTG 
TTYTCCCAATATACYCTTTG 
- Negative  C 
MVV env q F2 
MVV env q R2a 
MVV env q R2b 
MVV env RGAYTCNYTRTAYATAGC 
YTGRTGCATCATYCCATC 
YTGRTGCATCATACTATC 
- Negative  E 
CAEV pol q F1a 
CAEV pol q F1b 
CAEV pol q R1a 
CAEV pol q R1b 






















































MVV pol q F4b + R4a 
env F1+R1a 
MVV gag q 1 MVV gag q 2 MVV gag q 3 
Plasmid Plasmid Plasmid Ram Ram 
MVV pol q 1 MVV pol q 2
 
MVV pol q 3 
Ram 
env F1+R1a 
F1a+R1a F1a+R1b F1b+R1a F1b+R1b 
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2.3.2 Bioinformatic Analysis 
RNA isolated from both lung and lymph tissue from 3 
seropositive rams was sequenced by NGS to allow for 
identification of viral sequence present in rams. Bioinformatic 
analysis carried out is outlined in Figure 2.3.2.1.  
Alignment of compiled sequences to the sheep genome (v3.1) 
identified 74106108 ‘non sheep’ sequences. Kraken2 classified 
115114 of these sequences successfully to reference database 
of which 4052 were classified as SRLV. Of this number, 3242 
(85%) were assigned to CAEV sequences with the remaining 
810 (15%) sequences assigned to MVV and ovine lentiviral 
sequences. Of this number, 312 (7.7%) were successful aligned 
to SRLV sequence database which provided 2046bp of sequence 
supported by a read depth >2 (Appendix 2). Acquired sequence 
consisted of 10 fragments spanning over three genes (Gag = 4, 
Pol = 2 and Env =4). Most sequences obtained lay within the 
Gag and Env genes (862 bp and 859 bp, respectively), double 
that obtained from the Pol gene (325 bp). Alignment of obtained 
sequences to EV1 strain (Accession No. S51392) showed 84.5% 
nucleotide identity. Nucleotide identity within individual genes 
Gag, Pol and Env when compared to EV1 was 86.33%, 83.79% 




































classified by kraken2 against 
reference database of 
archaeal, bacterial and viral 
sequences. 115114 (0.16%) 




Sequences compiled from RNA 
extracted from lung and mediastinal 
lymph node of 3 MVV seropositive 
rams. Quality check and trimming 
completed using skewer 
Data Handling 
 
Sequence data aligned to sheep 
genome v3.1 using HiSat2. Sheep 
and non-sheep sequences were 
separated for classification.  
74106108 non-sheep sequences 
were isolated 
Alignment to Sheep Genome 
Sheep Non-Sheep 
Classification 
Pie chart of composition of 
4052 sequences classified as 
SRLV using kraken2  
Table of classified sequences 
 




















4052 sequences aligned against database 
of SRLV full genome and partial sequences 
using Bowtie2.  
Acquired reads were included in final 
sequence following a read depth >2. 312 
sequences were successfully aligned 
against SRLV sequences. 
Alignment to Viral Genome 
Sequence reads were compiled and 
ordered by alignment against EV1 strain 
of MVV (Accession No. S51392). 
2046 bp of the unknown strain was 
obtained, which shared 1736 bp (84.5%) 
identity with EV1 strain. Sequence 
amounts to approximately 21.5% of viral 
genome (Appendix 2). 
Differences in unknown strain consist 318 








 Sequencing  
Data 
Table of gene composition 
 





















Figure 2.3.2.1 Outline of bioinformatic analysis for 
identification of SRLV strain. Description and results of 
bioinformatic analysis of NGS data set obtained from 3 
SRLV seropositive rams for identification of infecting viral 
strain. 
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2.3.3 qPCR Design 
Three primer sets were tested for suitability for use in a qPCR 
assay for detection of the partially sequenced strain of SRLV 
within seropositive rams. Primer sets were designed targeting 
three structural genes (Gag, Pol and Env). Testing of primers 
against synthesised positive controls gave successful 
amplification of a single product in Gag and Pol primers (Figure 
2.3.3.1a). Negative control showed no amplification with any 
primers (Figure 2.3.3.1b). All primer sets showed amplification 
of DNA extracted from seropositive ram blood, but only Pol 
showed amplification of a single product of expected melting 
temperature (Figure 2.3.3.1c). Finally, qPCR testing of DNA 
extracted from the blood of seronegative ewes showed marginal 
amplification using Gag and Env primers, whilst no amplification 
was seen with Pol primers (Figure 2.3.3.1d).  
Amplification of a single product of equal melting temperature 
in positive control and seropositive ram DNA whilst showing no 
amplification in negative controls and seronegative ewe DNA led 
to selection of Pol primers for use in qPCR assay. The reaction 
efficiency when using Pol primers was calculated as 85.5%. 
During DNA/RNA testing, samples were determined to be 
positive when fulfilling three criteria: a Ct value <40, a correct 
































Figure 2.3.3.1 Melt Curves for testing of qPCR primers. 3 primer 
sets were designed targeting the 3 structural genes of SRLVs: Gag 
(green), Pol (blue) and Env (red). Primers were tested against 
synthetic oligo positive control (a), negative water control (b) and 
DNA extracted from the blood of seropositive rams (c) and 
seronegative ewes (d).
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2.3.4 Sequence Analysis  
Fragmented sequences of an unknown circulating strain of SRLV 
were analysed in an effort to characterise viral strain with 
regard to previously reported sequences. Phylogenetic trees 
were generated based on comparison to 2046 bp genome 
sequences (Figure 2.3.4.1), 862 bp of Gag gene (Figure 
2.3.4.2), 251 bp of Gag gene (Figure 2.3.4.3), 325 bp of Pol 
gene (Figure 2.3.4.4) or 859 bp of Env gene (Figure 2.3.4.5).  
Obtained sequences were found to be strongly related with 
genotype A sequences in all trees. Trees comparing the full 
2046 bp of obtained sequence to available full genome 
sequences showed affiliation with subtype A19, although, 
multiple subtypes (A: 2, 3, 5-7, 9-18, 20-22; B: 4, 5) were not 
represented in this tree due to lack of full genome sequences 
(Figure 2.3.4.1). Phylogenetic trees constructed with 862 bp of 
the Gag gene and 325 bp of Pol gene showed closest association 
with sequences of the A1 subtype (Figure 2.3.4.2+4). Again 
many genotype A sequences were not included due lack of 
classified sequences spanning these regions of the viral 
genomes (Gag: A3, 5-7, 9-11, 14-15, 18, 21, 22; Pol: A6, 9-
13, 15-19, 21, 22). The phylogenetic tree of 251 bp region of 
Gag spanned sequences of all genotype subtypes with the 
exception of A6 (Figure 2.3.4.3). The sequences obtained in this 
study were found to be affiliated with a cluster of sequences 
consisting of 5 subtypes (A1, 2, 13, 18 and 21). Env sequences 
closest match was found to be the UK strain of MVV (EV1).  
 

























Figure 2.3.4.1 Phylogenetic tree of 2046 bp spanning across 
SRLV genome. Phylogenetic tree was generated using the Maximum 
Likelihood method and Tamura-Nei model and assessed by bootstrap 
method. Tree comprises unknown strain and 29 publicly available 






























Figure 2.3.4.2 Phylogenetic tree of 862 bp spanning across 
SRLV Gag gene. Phylogenetic tree was generated using the 
Maximum Likelihood method and Tamura-Nei model and assessed by 
bootstrap method. Tree comprises unknown strain and 25 publicly 
available SRLV genomes listed in Appendix 1. Analysis was carried 
out using MEGA X. 
 



























Figure 2.3.4.3 Phylogenetic tree of 251 bp spanning across 
SRLV Gag gene. Phylogenetic tree was generated using the 
Maximum Likelihood method and Tamura-Nei model and assessed by 
bootstrap method. Tree comprises unknown strain and 50 publicly 
available SRLV genomes listed in Appendix 1. Analysis was carried 
out using MEGA X. 
 
























Figure 2.3.4.2 Phylogenetic tree of 325 bp spanning across 
SRLV Pol gene. Phylogenetic tree was generated using the Maximum 
Likelihood method and Tamura-Nei model and assessed by bootstrap 
method. Tree comprises unknown strain and 22 publicly available 
SRLV genomes listed in Appendix 1. Analysis was carried out using 
MEGA X. 
 






















Figure 2.3.4.2 Phylogenetic tree of 859 bp spanning across 
SRLV Env gene. Phylogenetic tree was generated using the 
Maximum Likelihood method and Tamura-Nei model and assessed by 
bootstrap method. Tree comprises unknown strain and 16 publicly 
available SRLV genomes listed in Appendix 1. Analysis was carried 
out using MEGA X. 
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2.4 Discussion 
In this chapter a qPCR assay for detection of an unknown strain 
of MVV within a group of seropositive rams was designed. A 
Sybr green based assay targeting the Pol gene was designed 
and shown to effectively target viral sequences present within 
DNA of infected individuals.  
Blood was selected during testing phase due to high use in 
commercial diagnostics (e.g. PCR, qPCR, ELISA and AGID), and 
was found to support quantification of viral loads within tested 
samples. Previous studies evaluating SRLV PCR based 
diagnostics have investigated the efficiency of viral detection 
when sampling milk (Extramiana et al. 2002a; Brinkhof et al. 
2010; Barquero et al. 2011). Although findings from such 
studies has failed to produce a conclusive answer, with varying 
degrees of agreement reported between blood and milk testing. 
The ability to collect samples in a less invasive manner than 
blood sampling whilst not requiring a qualified practitioner does 
provide advantages for future testing strategies. Even if just as 
an indicator of circulating virus within a flock. Unfortunately, 
due to seropositive animals in this study being rams, milk 
samples could not be tested with the devised assay to 
determine efficiency.  
Acquisition of NGS sequencing data allowed for identification of 
21.5% of the unknown strain of virus. This allowed for 
comparison of sequence to previously reported and 
characterised strains of SRLV. Phylogenetic trees designed 
based on all or a selection of segments of obtained sequence 
suggest strongly that the strain belongs to genotype A. The 
subgroups with which the sequence from this project clustered 
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consisted of A1 and A19. A1 sequences have been identified 
worldwide with infection seen in both goats and sheep, in 
comparison, A19 sequences have only been reported in goats 
of Italy (Shah et al. 2004b; Colitti et al. 2019). True 
classification is not currently possible with the limited sequence 
data available, as was seen with the previously suggested 
genotype D which was designated on solely the sequence of the 
Pol gene. Ramírez et al. (2013), later suggested genotype A as 
a classification following sequencing of the Gag gene showed 
clustering within genotype A.  
Despite inability to fully characterise the sequence identified in 
this study, clustering within phylogenetic trees with subgroup 
A1 is interesting. The previously reported full genome SRLV 
sequence for the UK (EV1) is also classified as A1 sequence 
(Sargan et al. 1991). During initial testing of primers for 
detection of virus, the previously reported EV1 primers and 
primers designed for broad spectrum detection of SRLVs with a 
particular focus on EV1 consistently failed to amplify our virus 
isolate, despite detecting sequence of the the original EV1 
isolate reliably (Figure 2.3.1.1) (Carrozza et al. 2010). 
The differences observed here in detectability of virus when 
comparing strains of the same genotype and potentially of the 
same subgroup, illustrates one of the key difficulties in 
diagnosing SRLV infections. Variation in SRLVs is high, which 
can in part be attributed to the high frequency of mutations 
occurring (Ramírez et al. 2013). Inclusion of an additional 
ability to produce recombinant virus in cases of co-infecting 
strains means that SRLV sequences are ‘fluid’ and constantly 
changing with time (Pisoni et al. 2007b).  
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Initially, one of the objectives for this study included the design 
of a universal diagnostic assay for UK strains of SRLVs. Inability 
to design an assay for detection of merely 2 of these circulating 
strains suggests that such the development of such a diagnostic 
test may not be feasible. Such a qPCR-based assay would likely 
be required to be multiplex to ensure amplification of all 
possible strains. In addition, monitoring of circulating viral 
strains would be vital to ensure introduction of a strain 
undetectable by existing qPCR assays does not occur.  
Following on from this study, it would be useful to fully identify 
the strain of the currently circulating SRLVs within the UK, 
especially as the only UK strain reported prior to this study was 
sequenced nearly 30 years ago (Sargan et al. 1991). 
Identification of 21.5% of the genome over 10 fragments 
spanning the whole genome provides a helpful scaffold to build 
upon. Methods that could be utilised include the use of PCR 
based assay to ‘bridge’ the gaps between fragments to acquire 
the whole genome. In addition, sequences obtained within this 
study could be fed back into the NGS pipeline to attempt to fish 
out further fragments of sequence. Finally, a de novo assembly 
could be attempted using sequence data following removal of 
sheep genomic sequence. Time constraints however precluded 
the completion of this work within this study.  
The qPCR assay designed in this study allows for the detection 
of a newly identified circulating strain of SRLV within the UK. 
Although identification is currently limited to one group of 
animals, identification of this new strain highlights the need for 
further investigation into the current state of SRLV prevalence 
within the UK.   
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Chapter 3: AI Model to Estimate Risk of 
Sexual Transmission During Natural Mating 
3.1 Introduction  
SRLV outbreaks within sheep flocks and goat herds can be a 
costly situation for many farmers, especially those accredited 
under the UK MVV/CAEV accreditation scheme. The current 
response stipulated within the regulations for participation 
within the scheme states that following identification of 
seropositive animals, accredited status is suspended (SRUC 
2020). In addition, all confirmed positive sheep and lambs 
suckling from seropositive ewes are to be removed (preferably 
slaughtered to remove risk of further transmission) from the 
flock. Accreditation status cannot be restored until diagnostic 
testing has been carried out twice with clear results with a 
period of 6-12 months between each test, with the first being 
carried out at the earliest of 6 months post-outbreak. Therefore, 
a minimum period of 1 year is required to restore accredited 
status (SRUC 2020).  
Following this scenario, financial losses to farmers can be 
attributed to veterinary fees, replacement of infected animals, 
loss of at-risk offspring (when applicable), loss of sales and loss 
in value of infected animals (Anderson et al. 1985; Keen et al. 
1997; Peterhans et al. 2004). This in addition to the production 
losses induced by the actual disease. The value attached to 
individual animals can greatly vary with both breed and function 
of a flock. In addition to monetary losses, outbreaks within 
breeding ram flocks and other high value breed flocks result in 
the loss of valuable genetics. Theoretically, these genetics could 
be rescued through harvesting of semen before removal of an 
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animal from a flock. A difficulty arises then however, as there 
exists a risk of transmission of virus through the use of semen 
from infected rams for insemination within naïve ewes 
(Travassos et al. 1999; Peterson et al. 2008).  
The main routes of transmission of SRLVs have long been 
identified as being via the ingestion of infected milk/colostrum 
and inhalation of respiratory secretions in conjunction with close 
proximity (Brodie et al. 1998; Blacklaws et al. 2004). Sexual 
transmission has been clearly demonstrated within the 
Lentivirus genus of viruses, but it’s role in SRLV transmission in 
sheep and goats has yet to be fully investigated (Marks et al. 
2006; Haase 2011). As natural mating would require exposure 
of naïve ewes to seropositive rams, therefore putting animals 
at risk of horizontal transmission via droplet transmission, 
sexual transmission was investigated in this study in relation to 
AI techniques.  
Within sheep, two insemination techniques that can be used are 
vaginal insemination and laparoscopic intrauterine 
insemination, with the latter preferred due to increased success 
rates (Gourley and Riese 1990; Paulenz et al. 2003; Anel et al. 
2005). Transcervical insemination is another technique carried 
out in other ruminants such as cows. This technique has been 
shown to have difficulties when attempted in sheep and 
regularly results in cervical trauma, reduced fertility and failed 
pregnancy (Wulster-Radcliffe and Lewis 2002; Moutou et al. 
2004). Studies into the occurrence of sexual transmission 
during SRLV following AI have been carried out in goats (Ali Al 
Ahmad et al. 2012; Souza et al. 2013). During these studies 
naïve does were inseminated by laparoscopic intrauterine 
insemination and transcervical insemination depositing semen 
directly into the upper reproductive tract, within the uterus. 
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These studies demonstrated successful transmission of 
infection to inseminated ewes and does suggesting therefore, 
that sexual transmission can occur in SRLV infection. However, 
by inseminating animals directly into the uterus, the lower 
reproductive tract is bypassed, which in turn bypasses both the 
physical and immune defences present within the tract. It does 
not necessarily follow that sexual transmission under natural 
mating or vaginal insemination conditions will also occur. 
In this chapter, a pilot scale study was carried out to assess the 
risk of SRLV transmission via natural mating (using intravaginal 
insemination as a proxy for this) within a group of naïve ewes 
following vaginal insemination with semen harvested from 
seropositive rams. The project aimed to look at both horizontal 
transmission to inseminated ewes and vertical transmission to 
any successfully conceived foetuses.  
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3.2 Materials and Methods  
3.2.1 Ethical Approval 
Prior to implementation, all animal and trial procedures were 
reviewed and approved by the Home Office under the ‘Animals 
(Scientific Procedures) Act 1986’ (Licence no. PPL 30/3367). 
3.2.2 Animals 
13 seropositive rams (6 Aberfield and 7 Abermax) and 30 naïve 
Exlana ewes participated in this study. Rams were 1 year old 
when they identified as being MVV positive during routine 
testing as part of the MVAS after which they were acquired by 
the University of Nottingham in 2015. Ewes were purchased 
from an MVV free flock. All animals were retested (as described 
below) before entering the trial. Ewes and Rams were separated 
with appropriate husbandry practice to prevent MVV 
transmission. Animals were held at pasture with available 
shelter and supplementary rations and separated from other 
sheep by more than 2 m. In addition, animals were monitored 
and treated for any signs of clinical disease (including diseases 
such as foot-rot) and received routine husbandry and 
preventative treatment. Animals with illness were assessed by 
a veterinary surgeon.  
3.2.3 Blood Collection 
Blood was collected in 10ml vacutainer blood tubes and taken 
from the jugular vein by a qualified veterinarian or home office 
approved technician. For separation of sera from blood, samples 
were left at room temperature overnight to allow for clotting 
after which sera was removed via pipetting. Sera and blood 
clots were stored at -20oC. 
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3.2.4 ELISA 
Sera was tested for the presence of SRLV specific antibodies 
using the MVV/CAEV p28 Antibody Screening Test (IDEXX) 
following the manufacturer’s recommended protocol. Repeated 
in triplicate, seroprevalence was determined by a minimum of 
two consistent results. Inconclusive results were subjected to 
further testing.  
3.2.5 Hormonal Preparation of Ewes 
Synchronisation of the ewe’s oestrus cycles was carried out 
prior to insemination. Progesterone sponges were inserted 
within the vaginal canal and left in place for 14 days. Following 
removal of sponges, 3ml of pregnant mare's serum 
gonadotropin (PMSG) at a concentration of 200 iu/ml was 
administered intramuscularly in the rump. Insemination was 
then carried out two days after. 
3.2.6 Semen Collection 
MVV positive rams were introduced to 3 ‘teaser’ ewes 
(hormonally prepared as per the trial ewes) to stimulate mating 
behaviour. Before collection, an artificial vagina was heated to 
between 40oC and 50oC, which was maintained between rams. 
Next, one at a time rams were allowed to mount ewes at which 
time semen was collected by intercepting the penis and 
redirecting to within the artificial vagina. Upon depositing of 
semen rams were removed from the ewes. Of the semen 
collected, up to 400 µl from each ram was stored in RNAlater 
(Sigma-Aldrich) for nucleic acid extraction at room temperature 
for 24 hours, after which samples were moved to -20oC. 
Remaining semen was pooled for insemination and maintained 
at a temperature of 37oC by use of a water bath. In addition, a 
sample of pooled semen was stored in RNAlater (Sigma-
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Aldrich). Teaser ewes were rehomed in accordance with 
‘Animals (Scientific Procedures) Act 1986 Amendment 
Regulations 2012’. 
3.2.7 Artificial Insemination 
Pooled semen collected from MVV positive rams was used to 
inseminate 12 hormonally prepped ewes with an additional 12 
ewes mock inseminated as a control. Following successful 
semen collection, semen was immediately transported to the 
location of naïve ewes whilst being maintained at 37oC 
(approximately 15-30 minutes). Pooled semen was then 
prepared by the addition of ultra-high temperature processed 
(UHT) milk in equal quantities. Mock inseminated ewes were 
inseminated first with UHT milk containing no semen. To 
inseminate, the cervix as located using a speculum and 500-
750 µl of UHT milk and semen mixture was expelled into the 
cervix using an insemination pipette heated to a temperature 
between 40oC and 50oC. Following insemination, groups were 
separated to remove risk of transmission via other routes and 
blood collected weekly up to 7 weeks post insemination. Blood 
collected was tested by ELISA for detection of seroconversion 
and by qPCR following nucleic acid extraction to detect presence 
of viral genomic material. 
3.2.8 Post-mortem (PM) 
Following semen collection and 7 weeks of blood collection rams 
and ewes, respectively, were euthanised by captive bolt. Visible 
pathology was documented with blood and tissue samples 
collected. Table 3.2.8.1 lists tissue samples collected from rams 
and ewes. Two samples of each tissue were collected, stored in 
either 500µl RNAlater (Sigma-Aldrich) or 500 µl Formalin at 
room temperature for 24 hours and then placed at -20oC or 
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room temperature, respectively. Epididymal washes were 
obtained by submerging and rinsing a segment of epididymis in 
RNAlater at least five times after which the segment of 
epididymis was discarded. Epididymal washes were then stored 
at room temperature for 24 hours, after which they were stored 
at -20oC.  
 
 
Table 3.2.8.1 Tissues sampled from rams and ewes at PM. 
Listed tissues collected from 13 MVV seropositive rams and 24 naïve 



















Histological analysis was carried out on lung tissue sampled 
from seropositive rams and trial ewes. Formalin fixed tissue 
sections were processed and embedded in wax cassettes. Slides 
were prepared by the University of Nottingham Pathology 
Service. Slides were wax embedded, sectioned and then 
hematoxylin and eosin stained.  




























* Any additional sites of pathology observed 
at PM were sampled  
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3.2.10 DNA Extraction – Blood 
DNA was extracted from blood using the Nucleospin® Tissue Kit 
(Macherey-Nagel) for detection of MVV using PCR based 
methods.  
Blood clots were processed by following the supplementary 
protocol for extraction of genomic and viral DNA from blood 
samples. Before the protocol was carried out, a small amount 
(approximately 25 mg) of blood clot was added to 200 µl of 
PBS. A sterile 5mm steel bead was then added and mixture 
homogenised by a Retsch MM300 bead mill (Qiagen) at a 
frequency of 25/s for 2 minutes. The protocol was then followed 
substituting homogenised blood clot and PBS for 200 µl of fresh 
blood. DNA was eluted from the column in a final volume of 60 
µl.  DNA was stored at -20 ̊C until use.  
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific).  
3.2.11 DNA Extraction – Tissue 
DNA was extracted from tissues using the Nucleospin® Tissue 
Kit (Macherey-Nagel) for detection of MVV using PCR based 
methods.  
Approximately 25mg of tissue was processed following the 
manufacturers recommended protocol. Following addition of 
buffer T1 and proteinase k (pre-lyse step) an added step was 
added. To samples, a sterile 5mm steel bead was added, and 
mixtures homogenized by Retsch MM300 bead mill (Qiagen) at 
a frequency of 25/s for 2minutes. Following this, manufacturers 
protocol was followed as recommended. DNA was eluted from 
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the column in a final volume of 60 µl.  DNA was stored at -20 ̊C 
until use. 
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific).  
3.2.12 RNA Extraction  
RNA was extracted from sera isolated from blood and 
epididymal washes using the QIAamp Viral RNA Mini Kit 
(Qiagen) for detection of MVV using PCR based methods. 
Extraction was carried out following the manufacturer’s 
recommended protocol. RNA was eluted within a final volume 
of 60 µl. RNA was stored at -20oC  
3.2.13 cDNA Synthesis 
Conversion of RNA to cDNA for PCR detection was carried out. 
One of two RTs were used per reaction; moloney murine 
leukemia virus (M-MLV) (Promega) and avian myeloblastosis 
virus (AMV) (Promega) RTs. Reaction mixtures and conditions 
varied with RT, described in Table 3.2.13.1. Reagents were 
random hexamer primers (Thermo Scientific), dNTP mix 
(Thermo Scientific) appropriate buffers supplied by RT 
manufacturers. Synthesised cDNA was stored at -20oC. 
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Table 3.2.13.1 cDNA synthesis reaction conditions. 
Mixtures and reaction conditions for cDNA synthesis from RNA using 
two RTs; M-MLV and AMV. 
3.2.14 qPCR 
For detection of MVV sequences from extracted nucleic acids, a 
Sybr green based qPCR procedure was carried out. Reaction 
mixtures consisted of 1x qPCRBIO SyGreen Mix Lo-ROX master 
mix (PCR Biosystems), 0.04µM forward and reverse primers 
(Sigma-Aldrich) (Table 3.2.14.1) and 1µl of test DNA or 
standard in a total volume of 20 µl. Reaction conditions 
consisted of a starting incubation of 95oC for 15 minutes 
followed by 45 cycles of 95oC for 5 seconds, 60oC for 30 seconds 
and 72oC for 10 seconds. A melt cycle was carried out at 
reaction end ranging from 65oC to 95oC. Reactions were carried 
out within a CFX Connect Real-Time PCR Detection System 
(Biorad Laboratories). A 1:10 standard dilution series of a 
synthesised PCR product positive control. Analysis was carried 
out using Biorad CFX Maestro software.  
 
RT M-MLV AMV 
Primer Binding Step: 
    RNA Template 
    Primers (1 pmol/µl) 
    Nuclease Free Water 
 
1 µl 
1 µl (per primer) 
Up to 15 µl 
 
1 µl 
1 µl (per primer) 
Up to 15 µl 
Denaturation              70oC for 5 minutes 
    Store on ice and centrifuge briefly 
Synthesis Step: 
    Buffer 
    RT 
    dNTPs (2mM) 
    Nuclease Free Water 
 
Total Reaction Volume 
 
5 µl (x5 Conc.) 






5 µl (x8 Conc.) 





Incubation 37oC - 60 minutes 42oC - 60 minutes 
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Table 3.2.14.1 qPCR primer sequences. qPCR primers for 
detection of SRLV, targeting the Pol gene. 
  
 
Primer  Target Gene Sequence  Product Size 
NGS Pol1 F 
NGS Pol1 R 
SRLV pol AGGGGATGCATACTTTACTATACCA 
TCTTGTGCATGGCCCTAAAT 
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3.3. Results 
3.3.1 Pre-Trial Testing of Ewes and Rams 
To confirm MVV status of the 30 naïve ewes and 13 
‘seropositive’ rams taking part in this study, blood was tested 
for MVV infection. Tables 3.3.1.1+2 shows the results from two 
diagnostic assays carried out, ELISA and qPCR. Of 13 rams, all 
tested positive by ELISA whilst only 8 and 10 tested positive for 
DNA and RNA by qPCR, respectively (Table 3.3.1.1). In 
contrast, all 30 ewes tested negative by both ELISA and qPCR 
of DNA and RNA extracted from blood samples (Table 3.3.1.2). 
In preparation of the trial, the 30 ewes were randomly allocated 
to three groups, ewes to be mock inseminated, ewes to be 
inseminated with semen harvested from seropositive rams and 
teasers ewes to be used in semen collection. Age distribution 
was dissimilar between inseminated and mock inseminated 





Table 3.3.1.1 Pre-trial diagnostic results of seropositive 
rams. ELISA and qPCR results for 13 rams to confirm seropositive 
status prior to start of AI trial. 
 
 

























































Table 3.3.1.2 Pre-trial diagnostic results of naïve ewes. 
ELISA and qPCR testing of 30 ewes pre-trial to confirm maedi-visna 
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3.3.2 Semen Collection and Testing 
To assess the risk of sexual transmission of MVV, semen was 
collected from 13 seropositive rams for insemination of naïve 
ewes. Through use of teaser ewes, semen was successfully 
collected from 11 of 13 rams. At introduction to teaser ewes, 
rams 4 and 6 showed lack of interest.  
DNA and RNA tested by qPCR for the presence of MVV tested 
negative in all semen samples tested (Table 3.3.2.1). RNA 
extracted from epididymal washes obtained at day of slaughter 
(the day after semen collection) tested positive in 6 of 13 rams. 
Five of these rams had successful semen collection while 1 did 




Table 3.3.2.1 MVV qPCR testing of DNA and RNA extracted 
from semen and epdidymal washes.  Semen tested intended for 
insemination of naïve ewes. Epididymal washes were collected the 
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3.3.3 A.I. Trial – Blood Sampling 
Inseminated ewes were blood sampled weekly up to 7 weeks 
post-insemination to detect for seroconversion. Animals 
inseminated with semen from infected rams showed no 
seroconversion with consistently low antibody titres observed 
(Figure 3.3.3.1a). Control group animal titres showed greater 
variation when compared to inseminated ewes. Of these 
animals, 05296 consistently showed higher antibody titres, 
within the limits of seronegative results, while 8629J showed a 
false positive result in week 6 confirmed by a repeat test (Figure 
3.3.3.1b). The following week, the sample for this animal was 
negative. 
In addition to ELISA, DNA and RNA extracted from blood was 
tested for the presence of MVV. All ewes during all three tested 
weeks (1, 4 and 7) were confirmed negative for both DNA and 
RNA (Table 3.3.3.2+3). Blood collected from 8628J at week 6 
(tested positive by ELISA), when tested by qPCR, tested 
















































Figure 3.3.3.1 Maedi visna virus serum antibody titres 
determined by ELISA in ewes. Antibody titres for 12 ewes 
inseminated (a) with semen from naturally infected rams or (b) 12 
mock inseminated ewes over 7 weeks post insemination obtained by 























Table 3.3.3.2 Blood DNA qPCR results from inseminated ewes. 
qPCR results for detection of MVV in DNA extracted from blood 
samples collected at four time points (week 1, 4, 6 and 7) from 12 
ewes mock inseminated and 12 ewes inseminated with semen 









































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.3.3.3 Blood RNA qPCR results from inseminated ewes. 
qPCR results for detection of maedi visna virus in RNA extracted from 
blood samples collected at four time points (week 1, 4, 6 and 7) from 
12 ewes mock inseminated and 12 ewes inseminated with semen 
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3.3.4 PM Findings of Ewes 
Following euthanasia, PM and sample collection was carried out 
on trial animals to look for indicators of MVV infection. Of 24 
ewes, only two (05377 and 02542) showed any signs of gross 
pathology (Figure 3.3.4.1). Both ewes showed pathology in the 
lungs. 05377 (mock inseminated group) showed extensive 
fibrosis of dorsal medial surface of both lungs, in addition, there 
were small gritty nodules upon the surface of both lungs. 02542 
(inseminated group) had areas of consolidation on 
approximately a third of the caudal dorsal surface of both lungs 
(Figure 3.3.4.1). 
Histology of lungs was assessed for histopathology indicative of 
MVV infection. Slides were prepared for four inseminated ewes 
(00779, 01120, 02542 and 05010) and four mock inseminated 
ewes (01073, 03730, 05377 and 8628J). No signs indicative of 
MVV infection were seen in any of the ewe slides, however other 
pathology (such as evidence of lung worm scarring) was evident 
(Figure 3.3.4.3). 
In addition, during sample collection, the uterus of each animal 
was inspected for the presence of a foetus. Of 12 inseminated 
















































Figure 3.3.4.1 Lung pathology of ewes 05377 and 02542. (A) 
Pathology observed following euthanisation of 24 ewes 7 weeks post 
mock insemination (n=12) or insemination (n=12) with semen 
collected from known MVV seropositive rams. Pathology was seen in 
two ewes: (B) 05377 (inseminated group) and (C) 02542 (mock 
inseminated group). 
 Animal Location Picture Description 
   05377 
 
 















Extensive fibrosis of dorsal medial 
surface of both lungs, presence of 
small gritty nodules 
 
Areas of consolidation on caudal 
dorsal surface of both lungs 
 











































Figure 3.3.4.2 Histology of MVV seropositive rams indicative 
of infection. Histology observed with lung tissue of seropositive 
rams known to be associated with infection: (A) thickening of alveolar 
septa, (B) obliteration of alveolar structures and (C) lymphoid 
infiltration with occurrence of formation of lymphoid-like follicle. 











































Figure 3.3.4. Lung histology of 8 trial ewes. Histology observed 
in lungs of ewes mock inseminated (n=4) and inseminated (n=4) with 
semen collected from MVV seropositive rams 7 weeks prior to 
euthanasia. (A) healthy lung, (B) presence of lung worms, (C) region 
of scarring and (D) areas of bleeding.   
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3.3.5 qPCR Testing of Tissue 
To detect for any presence of MVV within trial ewes, DNA was 
extracted from lung, mediastinal lymph node and uterus tissue. 
All ewes in both groups tested negative for all tissue types when 






Table 3.3.5.1 qPCR results for DNA extracted from tissue of 
ewes. Lung, mediastinal lymph node and uterine tissue collected 
following euthanasia 7 weeks post mock insemination (n=12) or 
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3.4 Discussion 
Ewes naïve to MVV infection in this study were inseminated with 
semen collected from known seropositive rams to estimate the 
risk associated with sexual transmission of MVV. Testing prior 
to the beginning of the trial confirmed the MVV status of all 
animals. Following this, after a period of 7 weeks post 
insemination no ewes showed sign of seroconversion by ELISA 
or presence of viral genome when tested by qPCR. The lack of 
detectable MVV infection within these ewes, could suggest that 
the risk of viral transmission following intravaginal insemination 
to be low. It is important to note that this finding can only be 
applied in cases where seropositive rams are showing 
undetectable viral levels within semen. Taking this stipulation 
into consideration, movement from intrauterine insemination to 
intravaginal could allow for use of semen collected from 
seropositive rams (with undetectable semen viral loads) with 
low risk of transmission. This would potentially allow for genetic 
rescue of valuable genetics from infected individuals reducing 
the economic impact of MVV infection on farmers. 
It is important to note that both previous studies investigating 
sexual transmission in SRLVs did not use semen collected from 
naturally infected animals (Ali Al Ahmad et al. 2012; Souza et 
al. 2013). Instead, both studies spiked semen samples collected 
from seronegative animals with virus to a concentration of 102-
106 TCID50/ml. In addition, previous studies that have identified 
the presence of virus within semen have not reported 
associated viral loads (Ali Al Ahmad et al. 2008; Paula et al. 
2009). Therefore, it is unknown if the viral loads utilised within 
the previously reported insemination trials was indicative of 
natural levels in infected animals and therefore risk of sexual 
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transmission by intrauterine insemination using semen from 
naturally infected bucks/rams could be reduced compared to 
previous reports. 
The seropositive status of the 13 rams was confirmed by ELISA 
and qPCR. Despite discrepancies in results of qPCR testing of 
DNA and RNA extracted from ram blood, the results collectively 
demonstrate infection in all animals. Semen collected from 
rams and epididymal washes collected at time of euthanasia 
were tested to discern if MVV was present. While all semen 
samples tested negative when testing either DNA or RNA, RNA 
extracted from epididymal washes tested positive in 6 of 13 
rams. As testing was carried out on RNA, viral genetic material 
detected likely represents free virions present within the 
epididymis. As the epididymis plays a role in sperm transport 
and maturation, detection of MVV within epididymal washes 
would therefore suggest the presence of virus within semen, 
but likely below the detectable threshold for the qPCR assay due 
to the diluting effect of fluids from the extraseminal vesicles 
added during natural ejaculation and the pooling of the samples 
for use in the actual insemination (Cornwall 2009).  
Intermittence of detection of MVV within infected hosts has 
previously been reported (de Andrés et al. 2005; Ali Al Ahmad 
et al. 2008; Peterson et al. 2008). Discrepancies in detection of 
MVV in blood by qPCR vs ELISA and the inability to detect virus 
within DNA and RNA extracted from semen may be attributed 
to this. In relation to the finding of this study, results suggest 
low level shedding in semen. Therefore, periods of high 
shedding may still occur and rams would require further testing 
over longer time periods to estimate the longer term risk of 
sexual transmission. In cases of lactogenic transmission, Pisoni 
et al. (2010) proposed a threshold viral load necessary to 
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facilitate successful transmission. Further investigation into 
sexual transmission would be required to ascertain the presence 
of such a threshold associated with this route of transmission. 
Insemination of hormonally prepared ewes with semen 
collected from seropositive rams did not result in successful 
conception in any of the 12 ewes. Semen was pooled from 11 
rams and the volume increased to by addition of UHT milk 
before insemination. Success rates of vaginal insemination has 
reported to vary with breed in the range of approximately 30-
65% (Anel et al. 2005; Paulenz et al. 2007). It is not impossible 
with the small cohort of ewes present within this study for all 
12 to have naturally failed to conceive without any external 
contributary factor. In contrast, random selection of ewes at 
time of insemination resulted in a large proportion of ewes 
within the inseminated group being between the ages of 3 and 
5 (9 out of 12). This has previously been reported as the age at 
which ewe fertility is highest and therefore should have aided 
towards successful conception (Aktas et al. 2015). External 
factors that could contribute to failure to conceive within this 
study include, improper insemination, miss handling of semen 
between collection and insemination or semen viability. The 
insemination was however conducted by an experienced small 
ruminant veterinarian. A further external factor potentially 
contributing to the low conception rates was also the circulation 
of Schmallenberg virus, an insect borne abortogenic virus of 
small ruminant that is suspected to also cause failures to 
conceive during acute infections,  during the period of the trial 
(and detected in these animals) (Veldhuis et al. 2014; Jones et 
al. 2019). 
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Unfortunately, the lack of fetuses in this study prevented 
further investigation of the risk of vertical transmission from the 
seropositive rams.  
During the trial one mock inseminated ewe (8628J) showed a 
positive result by ELISA at week 6 confirmed by repeat testing. 
Testing the following week and qPCR testing of DNA and RNA 
extracted from blood throughout the trial was negative. 
Together, these results suggest that 8628J showed a false 
positive result at week 6. Testing further than week 7 was not 
carried out as ewes were euthanised at week 7 due to 
insufficient funds and time constraints. In support of this, no 
gross or histopathological lesions of MVV were seen at PM and 
no tissue samples from this animal had detectable virus. Souza 
et al. (2013) reported seroconversion within 30-60 days post-
insemination within all trial animals, therefore it is possible that 
7 weeks was not sufficient to allow for seroconversion. In 
addition, as previously stated it is possible that said study 
utilised significantly enlarged viral loads within semen used 
which would aid in reduced time for seroconversion. Together 
this suggests that 7 weeks is in sufficient time to conclusively 
state transmission has not occurred, but this would require 
more thorough testing to corroborate.  
Overall, the findings of this study suggest the risk of sexual 
transmission following vaginal insemination in naïve ewes with 
semen collected from seropositive rams to be low (at least when 
rams are excreting low levels of virus). As this study 
represented a pilot scale study, next steps would be to increase 
the size of the trial cohort whilst also increasing the period of 
repeated testing following insemination to be longer than 7 
weeks. Of most importance, the findings of these results show 
promise for reducing the impact of MVV infection on farmers of 
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breeding rams or high value breeds by demonstrating that 
rescue for genetics from valuable rams without perpetuating 
virus infection is possible.  
100 | P a g e  
 
Chapter 4: Longitudinal Study of 28 MVV 
Seropositive Rams over a 28-Month Period 
4.1 Introduction  
To sheep and goats, SRLV infection is a lifelong sentence. An 
approximate asymptomatic period of around 2 years post 
infection can result in significant flock wide infection before any 
indicators are observed. in addition, with clinical signs 
overlapping with other respiratory conditions, infection can go 
unnoticed unless specifically looked for (Sigurdsson 1954).  
To date, SRLV infection is typically confirmed by ELISA, AGID 
or PCR based assays targeting specific antibodies or viral 
nucleotides present within blood and milk samples (Herrmann-
Hoesing 2010; OIE 2016). Although effective, such sampling 
techniques hold limitations in their requirement of licenced 
technicians for collection (blood) and limitation to females 
postpartum (milk). Palsson (1972) once showed successful 
isolation of virus from nasal swabs taken from seropositive 
sheep, however, with varying degrees of success between 
individuals. Such a finding begs the question of whether using 
present day diagnostics, could virus be detected in such swabs 
(for which collection can be easily accomplished by farmers 
themselves) and with what efficacy and reliability.  
Diagnostic testing of infected animals following death or 
euthanasia has detected proviral DNA within a wide range of 
host tissues such as liver, heart, kidneys, bone marrow, ovaries 
and even third eyelid tissue (Capucchio et al. 2003; Grossi et 
al. 2005; Angelopoulou et al. 2006; Brellou et al. 2007; Cortez-
Romero et al. 2011). Despite this abundance of virus 
throughout the body, pathology is typically localised to three 
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regions of the body: respiratory tract, CNS and mammary 
glands. In the UK, circulating strains of virus usually present as 
respiratory and mammary conditions. As such, lungs are 
typically observed as being noticeably larger (2-3 times) with a 
slight rigidity (Cutlip et al. 1979). Varying degrees of greyish 
discoloration can be present, normally localised to coalescing 
multifocal spots along the surface with areas of consolidation 
seen on the dorsal surface of both lungs. Adhesion of lung to 
the thoracic wall and 1-2mm grey fibrous nodules have also 
been reported, but in less frequency (Christodoulopoulos 2006).   
Histologically, significant lymphoid infiltration is often seen in 
lungs associated with bronchioles and blood vessels (Ellis and 
DeMartini 1985). In severe cases formation of lymphoid follicle-
like structures is seen. This in turn results in thickening of the 
alveolar septa and obliteration of the alveolar structures present 
within the lung (DeMartini et al. 1993). 
Herrmann-Hoesing et al. (2009) reported that the severity of 
lesions observed in infected animals is proportional to the 
provirus load, with high blood proviral levels found in animals 
showing lesions of greater severity. Interestingly, higher viral 
loads were shown in blood and tissues of individuals with 
concurrent inflammatory conditions, such as parasitism and 
bronchitis in the lungs or orchitis within testicles in a recent 
study (Grego et al. 2018). In line with this, two studies reported 
detection of virus within the epididymis or semen only in 
animals suffering concurrent infections of Brucella ovis (B. ovis) 
(de la Concha-Bermejillo et al. 1996; Preziuso et al. 2002). 
From this it could be proposed that secondary infection resulting 
in an inflammatory response, could lead to recruitment of 
infected macrophages and subsequent ‘activation’ of latent 
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virus within these cells, resulting in increased viral loads within 
cells and surrounding tissues. 
In contrast to these findings, it has been suggested that sheep 
homozygous for TMEM154 haplotype 1 (K35), in addition to 
having increased resistance to SRLV infection, are also able to 
control viral replication once infected (Alshanbari et al. 2014). 
This is following comparison of viral loads in resistant and 
susceptibles animals, showed significantly reduced viral loads 
in resistant animals. Together this suggests that resistant 
animals would not only be more resistant to intial infection, they 
are likely to have reduced viral loads if infected and are 
probably less likely to develop severe lesions. Genetic selection 
of animals with the MV resistant alleles of TMEM154 is likely to 
reduce the potential impact of infection on farms and aid in 
control of infection.   
In this chapter, a longitudinal study was carried out within a 
group of 28 MVV seropositive rams following diagnosis during 
routine testing as part of the MVAS/CAEAS. Rams were 
maintained for a period 28 months. The study aimed to quantify 
the long-term impact of MV by a case study of morbidity and 
mortality due to the disease in these individuals. 
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4.2 Material and Methods  
4.2.1 Ethical Approval 
All animal management and procedures were reviewed and 
approved by the Home Office under the ‘Animals (Scientific 
Procedures) Act 1986’ (Licence no. PPL 30/3367). 
4.2.2 Animals  
28 Aberfield and Abermax MVV seropositive rams were included 
in this study. Rams were identified as being MVV positive during 
routine testing as part of the MVAS after which they were 
acquired by the University of Nottingham in 2015. Animals were 
held at pasture with available shelter and supplementary 
rations. In addition, animals were monitored and treated for any 
signs of clinical disease (including diseases such as foot-rot) and 
received routine husbandry and preventative treatment. 
Animals with illness were assessed by a named veterinary 
surgeon. Animals found to have significant drop in condition 
likely associated to clinical disease, were humanely euthanised. 
A number of animals were also culled for flock management 
purposes. In addition, instances of sudden death were noted. 
Finally, 13 surviving rams participated in an AI trial study before 
being euthanised. At time of euthanasia or sudden death, PMs 
were carried out. Appropriate blood and tissue samples were 
collected, and any pathology recorded. Tissue samples were 
collected in 500 µl RNAlater or 500 µl formalin and were then 
stored at room temperature for 24 hours and then stored at -
20oC or room temperature, respectively. Formalin samples were 
transferred into 70% ethanol after three months. Tissues 
*/collected are  listed  in Table  4.2.2.2. Rams 1-13  refer to  
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Table 4.2.2.1 Timetable of longitudinal study. Timetable 
covering the period of 2014-2016 of (black) initial MVV diagnosis and 
sample collection and (red) date of sudden death/euthanasia of rams 
and subsequent post-mortem. 
 2014 2015 2016 
Jan    
Feb   Rams 20 + 21 










 Rams 24-27 
Jul  Ram 16  
Aug    
Sep Ram 14   




Nov  Ram 17  
Dec Ram 15 
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Rams alive at onset of insemination trial whilst rams 14-27 refer 
to those euthanised/expired prior to study start (Table 4.2.2.1). 
4.2.3 Blood Collection  
For detection of MVV, blood was collected from seropositive 
rams April 2015, December 2015 and at time of 
death/euthanasia (Table 4.2.2.1). Blood was collected in 10ml 
vacutainer blood tubes and taken from the jugular vein by a 
qualified veterinarian or home office licenced technician. For 
separation of sera from blood, samples were left at room 
temperature overnight to allow for clotting after which sera was 
removed via pipetting. Sera and blood clots were stored at -
20oC. 
4.2.4 ELISA 
Sera was tested for the presence of SRLV specific antibodies 
using the MVV/CAEV p28 Antibody Screening Test (IDEXX, 
Netherlands) following the manufacturer’s recommended 
 


































* Sites of pathology observed at post mortem were 
sampled  
** Tissues collected not consistent between animals 
Table 4.2.2.1 Tissues collected from expired/euthanised 
rams. 
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protocol. Repeated in triplicate, seroprevalence was determined 
by a minimum of two consistent results. Inconclusive results 
were subjected to further testing.  
4.2.5 DNA Extraction – Tissue 
DNA was extracted from tissues using the Nucleospin® Tissue 
Kit (Macherey-Nagel, Hoerdt, France) for detection of MVV 
using PCR based methods.  
Approximately 25mg of tissue was processed following the 
manufacturers recommended protocol. Following addition of 
buffer T1 and proteinase k (pre-lyse step) a step was added 
with a sterile 5mm steel bead added to the samples. The 
mixtures were then homogenized by Retsch MM300 bead mill 
(Qiagen) at a frequency of 25/s for 2minutes. Following this, 
manufacturers protocol was followed as recommended. DNA 
was eluted from the column in a final volume of 60 µl.  DNA was 
stored at -20 ̊C until use. 
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific, UK). 
4.2.6 DNA Extraction – Blood  
DNA was extracted from blood using the Nucleospin® Tissue Kit 
(Macherey-Nagel, Hoerdt, France) for detection of MVV using 
PCR based methods.  
Blood clots were processed by following the supplementary 
protocol for extraction of genomic and viral DNA from blood 
samples. Before the protocol was carried out, a small amount 
(approximately 25 mg) of blood clot was added to 200 µl of 
PBS. A sterile 5mm steel bead was then added and the mixture 
homogenised by a Retsch MM300 bead mill  (Qiagen) at a 
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frequency of 25/s for 2 minutes. The protocol was then followed 
substituting homogenised blood clot and PBS for 200 µl of fresh 
blood. DNA was eluted from the column in a final volume of 60 
µl.  DNA was stored at -20 ̊C until use.  
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific, UK).  
4.2.7 DNA Extraction – Nasal Swabs 
DNA was extracted from nasal swabs using the Nucleospin® 
Tissue Kit (Macherey-Nagel, Hoerdt, France) for detection of 
MVV by PCR based methods.  
For extraction from nasal swabs, the supplementary protocol 
for purification of genomic DNA from buccal swabs was 
followed. Following addition of proteinase k and PBS, a sterile 
5mm steel bead was added and the mixture placed in a Retsch 
MM300 bead mill  (Qiagen) at a frequency of 25/s for 2 minutes. 
For separation of lysate from swab, alternative C of the 
supplementary protocol was carried out. DNA was eluted in a 
final volume of 60 µl and stored at -20oC. 
Successful DNA extraction was confirmed by quantification of 
DNA content using the NanoDropTM 8000 Spectrophotometer 
(Thermo Fisher Scientific, UK). 
4.2.8 RNA Extraction 
RNA was extracted from sera isolated from blood, epididymal 
washes and supernatant of nasal swabs using the QIAamp Viral 
RNA Mini Kit (Qiagen, Manchester, UK) for detection of MVV 
using PCR based methods. Extraction was carried out following 
108 | P a g e  
 
the manufacturer’s recommended protocol. RNA was eluted 
within a final volume of 60 µl. RNA was stored at -20oC  
4.2.9 cDNA Synthesis 
Conversion of RNA to cDNA for PCR detection was carried out. 
One of two RTs were used per reaction; M-MLV (Promega) or 
AMV (NEB). Reaction mixtures and conditions varied with RT, 
described in Table 3.2.13.1. Reagents were random hexamer 
primers (Thermo Scientific), dNTP mix (Thermo Scientific) 
appropriate buffers supplied by RT manufacturers. Synthesised 
cDNA was stored at -20oC. 
 
Table 4.2.8.1 cDNA synthesis reaction conditions. Mixtures and 
reaction conditions for cDNA synthesis from RNA using two RTs; M-
MLV and AMV. 
 
4.2.10 qPCR 
For detection of MVV sequences from extracted nucleic acids, a 
Sybr green based qPCR procedure was carried out. Reaction 
mixtures consisted of 1x qPCRBIO SyGreen Mix Lo-ROX master 
mix (PCR Biosystems), 0.04µM forward and reverse primers 
(Sigma-Aldrich) (Table 3.2.14.1) and 1µl of test DNA or 
standard in a total volume of 20 µl. Reaction conditions 
 
RT M-MLV AMV 
Primer Binding Step: 
    RNA Template 
    Primers (1 pmol/µl) 
    Nuclease Free Water 
 
1 µl 
1 µl (per primer) 
Up to 15 µl 
 
1 µl 
1 µl (per primer) 
Up to 15 µl 
Denaturation              70oC for 5 minutes 
    Store on ice and centrifuge briefly 
Synthesis Step: 
    Buffer 
    RT 
    dNTPs (2mM) 
    Nuclease Free Water 
 
Total Reaction Volume 
 
5 µl (x5 Conc.) 






5 µl (x8 Conc.) 





Incubation 37oC - 60 minutes 42oC - 60 minutes 
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consisted of a starting incubation of 95oC for 15 minutes 
followed by 45 cycles of 95oC for 5 seconds, 60oC for 30 seconds 
and 72oC for 10 seconds. A melt cycle was carried out at 
reaction end ranging from 65oC to 95oC. Reactions were carried 
out within a CFX Connect Real-Time PCR Detection System 
(Biorad Laboratories). A 1:10 standard dilution series of a 
synthesised PCR product positive control was prepared for use 
as a standard. Analysis was carried out using Biorad CFX 
Maestro software.  
Table 4.2.10.1 qPCR primer sequences. qPCR primers for 
detection of SRLV, targeting the Pol gene. 
 
4.2.11 PCR – TMEM154 Genotyping 
Amplification of desired TMEM154 sequences for the 
determination of TMEM154 genotypes present in seropositive 
rams was carried out by PCR. For template, 1 µl of DNA 
extracted from the lung tissue of MVV seropositive rams was 
used in a reaction mixture of 25 µl. Each reaction contained 5 
units of Taq DNA Polymerase, 1x standard Taq (Mg-free) 
reaction buffer (NEB), 3mM magnesium chloride (MgCl2) (NEB), 
0.04 pmol of forward and reverse primers (Table 4.2.11.1) and 
0.4mM deoxynucleotide (dNTP) solution mix (Thermo 
Scientific). Standard PCR cycling conditions consisted of an 
initial denaturation phase of 95oC for 5 minutes followed by 45 
cycles of 95oC, 56/60oC and 68oC, each for 15-60 seconds. 
Reactions were carried out within a Thermal cycler Life ECO 
(Bioer Technology). Successful amplification was determined by 
gel electrophoresis of PCR products. Primers used are listed 
 
Primer  Target Gene Sequence  Product Size 
NGS Pol1 F 
NGS Pol1 R 
SRLV pol AGGGGATGCATACTTTACTATACCA 
TCTTGTGCATGGCCCTAAAT 
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within Table 4.2.11.1 stating target gene and sequence (Heaton 
et al. 2013). 
Table 4.2.11.1 Primers for TMEM154 genotyping. 
2.2.4 Gel Electrophoresis 
To allow identification of products produced by PCR, gel 
electrophoresis was utilised. Expected PCR products were 
smaller than 1000 bp, therefore, a 0.8% Agarose gel was 
prepared to which 1 µl of Nancy-520 (Sigma Aldrich) per 20 ml 
Tris/acetate/EDTA solution (TAE) had been added. Products 
were loaded on the gel alongside a 100bp DNA ladder (NEB) 
and run at 100 V for 45 minutes. Gels were viewed and 
photographed by ImageQuant LAS 400 (GE Healthcare Life 
Science, UK) under ultraviolet (UV) light. Confirmed products 
for which the nucleotide sequence was required were prepared 
for sequencing using the Nucleospin® Gel and PCR Clean-up kit 
(Macherey-Negal) following the recommended protocol for PCR 
clean-up. 
4.2.12 Sanger Sequencing and Analysis 
Nucleotide sequences were acquired by Sanger sequencing 
carried out by Source BioScience. 5 µl of product to be 
sequenced was prepared at 10 ng/µl per 5 µl of primer, at a 
concentration of 3.2 pmol/µl. Sequence analysis was completed 




Primer  Target Exon Sequence  Amplicon Length 
84253 
83023 





Exon 2 TCCATTTCCTTTACCTAAAAGT 
ACTGGCCCAAATTACATAAG 
1048 bp 
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4.3 Results 
4.3.1 Rams  
28 MVV seropositive rams were reared together to the age of 1 
before they were obtained by the University of Nottingham 
following diagnosis during routine testing. Thirteen of these 
rams participated in an AI trial (Chapter 3) which commenced 
October 2016. Prior to trial commencement 15 rams either died 
or were euthanised. Of this number, 3 were recorded as sudden 
death and 10 were euthanised following a drop in body 
condition. Two rams (14 and 28) were not recorded as either. 
Of these rams that died or were euthanised, no individual was 
of the Aberfield breed. 
Rams were identified by laboratory number (1-28) or by 
personal I.D. number (e.g. 00605) (Table 4.3.1.1). Cross 
referencing of numbers was recorded where possible but loss of 
ear tags and recording errors resulted in 8 laboratory numbers 
and I.D. numbers being unable to be paired. Due to labelling at 
time of collection all results for blood samples will refer to 
individuals by I.D. number whilst remaining results will refer to 
laboratory number.   
 





Table 4.3.1.1 Identification of rams. Cross referenced laboratory 
number and individual ID of 28 rams. Breed and date of death are 
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4.3.2 Pathology and Histopathology 
At time of death following either sudden death or euthanasia, 
PMs were carried out to assess for pathology indicative of MVV 
infection. In addition, sections of lung were prepared from 15 
rams (Ram 1-13, 26 and 27) for histology. Table 4.3.2.1 and 
Figure 4.3.2.2 describe and illustrate observed pathology, 
respectively. Ten rams showed pathology of the lung, with 
pathology of liver, kidney, trachea and heart identified in a 
single ram each.  
Of 10 lungs, 8 showed consolidation over the dorsal surface of 
lungs in varying severities. Gray colouration was noted in 
multiple lungs (n=7), degree of colouration varied, with colour 
localised to coalescing multifocal spots along the surface of 
most affected lungs. One ram showed marked increase in size 
of the right lung in comparison to a normal sized left lung. 
Finally, one lung was found to be adhered to the thoracic wall 
at time of PM.     
Histologically, four main abnormalities were clear in the 
majority of slides prepared (Table 4.3.2.3). Infiltration of 
immune cells in lung tissue was observed in 14 rams with the 
formation of lymphoid follicle-like structures being found in 8 
rams (Figure 4.3.2.3a). Thickening of the alveolar septa and 
destruction of alveolar structures was also observed in 11 and 
8 rams, respectively (Figure 4.3.2.4b+c). Interestingly, 11 
rams showed evidence of lung worm infection (Figure 4.3.2.4c).       
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Table 4.3.2.1 Gross pathology of rams at PM. Table describes the 
observed pathology of 11 of 28 rams MVV seropositive following 
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Figure 4.3.2.2 Pathology picture of 
rams. Pathology pictures of trachea (A) 
and lungs (B-L) taken from 9 of 28 MVV 
seropositive rams at time of euthanasia 
or sudden death. Descriptions available 
in Table 4.3.2.1. 
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Table 4.3.2.3 Histopathology of rams in lungs. Table describes 
the observed histopathology within slides of fixed lung tissue from 15 
rams (Ram 1-13, 26, 27) MVV seropositive following euthanasia in 
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Figure 4.3.2.4 Histopathology of lung tissue from rams 
seropositive for MVV. (A) Lymphoid follicles with distinct 
germinal centres present within the lung, (B) thickening of the 
interalveolar septa, (C) Lung worm larvae within the lung and (D) 
obliteration of the alveoli structures. Magnification is marked on 
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4.3.3 qPCR and ELISA Testing of Blood 
Testing for presence of MVV was carried out on blood samples 
collected from seropositive rams over a period of 18 months at 
three time points (April 2015, December 2015 and October 
2016) (Table 4.3.3.1). Twenty-five blood samples were 
collected in April 2015 with the majority of animals testing 
positive by all diagnostics. Negative results were obtained for 4 
rams by ELISA, 2 by DNA qPCR and 1 by RNA qPCR, of which 
no ram tested negative for multiple diagnostics.  
December 2015, 19 blood samples were collected, again the 
majority tested positive. Negative results were seen for 3 rams 
using ELISA, 2 rams using DNA qPCR and 1 ram using RNA 
qPCR. Of those testing negative only one showed multiple 
negative results between diagnostic tests, 02227, which tested 
negative in December 2015 by all three tests. Comparison of 
April and December results only showed 2 rams to test negative 
by ELISA for both dates (02227 and 02550). Remaining 
negative results were not consistent between dates for any 
diagnostic test.  
Thirteen blood samples were collected in October 2016. All rams 
tested positive by ELISA, while 5 and 3 rams tested negative by 
DNA and RNA qPCR, respectively, with the remainder testing 
positive. Three rams showed consistent negative results by DNA 
and RNA qPCR (01016, 01017 and 02371). One ram (01017) 
showed negative results for both December 2015 and October 
2016 when tested by DNA qPCR. 
Copy numbers were calculated for DNA (copies per ng of DNA) 
and RNA (copies per µl of sera) qPCR results in rams that tested 
positive (Table 4.3.3.2). Copy numbers for RNA loads of rams 
119 | P a g e  
 
00605 and 02332 at time points April 2015 and October 2016, 
respectively, could not be calculated due to presence of 
additional unknown product (as evidenced by melt curve peak) 
in qPCR results. Copy counts in DNA showed lesser variation in 
number ranging from 2.27 x 102 to 3.95 x 104 copies per ng 
DNA than RNA copies which ranged from 2.22 x 102 to 4.44 x 
1010 copies per µl of sera.  
Figure 4.3.3.3 presents heat maps for antibody titres deduced 
from ELISA results and calculated copy numbers for DNA and 
RNA qPCR results for all blood samples collected. Figure 4.3.3.4 
shows ten graphs plotting these three values for 10 rams which 
had values for all three time points.  
Overall, no universal trend was observed in the 28 rams of this 
study. When considering animals present for the full duration of 
the study, no pattern in antibody or copy numbers was seen 
between April and December 2015. Between December 2015 
and October 2016 copy numbers either dropped or maintained 
an approximated number uniformly in both DNA and RNA of 
individual rams. ELISA results also showed this pattern but 
individual ram ELISA results did not necessarily show 
concurrence with copy numbers.  
 
 
→ Table 4.3.3.1 MVV diagnostic results of blood samples 
collected from 28 rams over an 18 month period. ELISA 
and qPCR diagnostics tested for the presence of MVV within 
sera, DNA and RNA obtained from blood samples collected at 
3 three time points (April 2015, December 2015 and October 
2016). ‘No Tag’ refers to one unidentifiable ram at each time 
point due to loss of ear tag, ‘?’ denotes possible ram identity 
at each relative time point. 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.3.3.2 MVV copy numbers in DNA and RNA extracted 
from blood of seropositive rams. Copy numbers calculated from 
qPCR results for detection of MVV in DNA and RNA extracted from 
blood collected at 3 time points (April 2015, December 2015 and 
October 2016). ‘No Tag’ refers to unidentifiable ram at each time 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































123 | P a g e  
 
← Figure 4.3.3.3 Heat map of MVV antibody titres and copy 
numbers in seropositive rams. Antibody titres and copy 
numbers for DNA (copies per ng of DNA) and RNA (copies per 
µl of sera) determined by ELISA and qPCR, respectively for 3 
time points (April 2015, December 2015 and October 2016). 
‘*’ denotes rams that were present, but no sample of blood 
was collected. ‘**’ refers copy numbers that could not be 
calculated due to unknown additional product in sample when 
























→ Figure 4.3.3.4 Graphs of MVV antibody titres and copy 
numbers in RNA of DNA of ten rams. Antibody titres (blue) 
and copy numbers for DNA (orange: copies per ng of DNA) and 
RNA (green: copies per µl of sera) determined by ELISA and 
qPCR, respectively for 3 time points (April 2015, December 
2015 and October 2016).    
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4.3.4 qPCR Testing of Tissue  
Tissue and semen samples were collected from 26 seropositive 
rams shortly prior or at time of death for diagnostic testing for 
detection of MVV infection by qPCR. All samples were tested for 
presence of proviral DNA with the exception of epididymal 
washes, for which viral RNA was tested for. Semen samples 
were tested for both proviral DNA and viral RNA.  
Positive results were obtained from, samples of lung, 
mediastinal lymph node and testicle. Twenty-five lung samples 
were tested of which 19 tested positive and 6 negative (Table 
4.3.4.1). In addition, lung pathology samples from 5 rams (2, 
3, 7, 8 and 12) were tested of which all bar one (Ram 7) tested 
positive. Both lung samples tested for Ram 7 tested negative 
by qPCR. Mediastinal lymph node samples tested by qPCR 
showed positive results in 22 rams and 3 negative results. 
Interestingly, all rams that tested negative in lymph node also 
tested negative in lung. To estimate viral loads within these 
tissues, copy numbers were calculated. Due to presence of an 
unknown additional product when testing tissue DNA by qPCR, 
copy numbers could only be calculated for 10 samples (5 lung 
samples and 5 lymph node samples) (Table 4.3.4.2). Unknown 
product was not detected when testing DNA and RNA extracted 
from blood samples (Chapter 4.3.3). sanger sequencing of this 
secondary product failed (likely due to the short length of the 
amplicon). 
Testing of DNA extracted from testicles demonstrated proviral 
DNA in 3 rams out of 11 tested (Rams 17, 22 and 25). Of 11 
semen samples tested, no virus was detected in extracted DNA 
of any ram. In addition to DNA, RNA was also extracted from 
semen and tested for detection of virus, but again all samples 
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tested negative (Table 4.3.4.3). Interesting, epididymal washes 
obtained from these same rams, from which RNA was extracted 
and tested, were shown to be positive for virus in 6 rams. Copy 




Table 4.3.4.1 MVV qPCR results for DNA extracted from tissues 
of seropositive rams. Results from qPCR testing of samples 
collected from four sources (lung, mediastinal lymph node, testicles 
and semen). Additional samples were collected from any areas of 
observed pathology at time of PM. 
 
 
Animal ID  Lung 
Lung 
Pathology 















































































































































































Table 4.3.4.2 MVV proviral copy numbers in DNA extracted 
from tissues. Calculated copy numbers for samples showing single 
confirmed product by qPCR. Copy numbers calculated as copies per 











Table 4.3.4.3 MVV qPCR results for RNA extracted from semen 
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  DNA 
(copies per ng of DNA) 











 2.54 x 101 
3.19 x 102 
- 
- 
4.30 x 101 
- 
- 







1.66 x 103 
- 
3.81 x 102 
4.32 x 101 
5.56 x 101 
5.37 x 104 
7.94 x 102 
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4.3.5 qPCR Testing of Nasal Swabs 
To assess the feasibility of nasal swabs as a sampling method 
for successful virus detection, swabs were taken from 13 known 
seropositive rams and tested for detectability of MVV. Both DNA 
and RNA showed detectable virus from swabs but with varying 
detection rates (Table 4.3.5.1). Virus was detectable in RNA 
extracted from all rams whilst DNA was detectable in only 6 of 
13 rams. Copy numbers were calculated where possible and 
showed greater RNA copy numbers in all rams. Copy number 
for DNA extracted from the nasal swab of Ram 11 could not be 
calculated due to presence of unknown additional product 





Table 4.3.5.1 MVV qPCR results of DNA and RNA extracted 
from nasal swabs of 13 seropositive rams. Copy numbers were 
calculated where possible. ‘*’ denotes a positive result where copy 
number calculation could not be carried out due to presence of 











  Nasal Swabs 
Animal ID 
 DNA  
(copies per 
ng of DNA) 
RNA 

















7.02 x 101 




3.38 x 101 
Negative 
1.34 x 102 
* 
Negative 
5.08 x 101 
2.01 x 104 
2.27 x 104 
1.46 x 104 
8.42 x 103 
1.40 x 104 
9.80 x 104 
6.89 x 103 
3.91 x 104 
4.05 x 103 
2.36 x 105 
5.64 x 103 
2.95 x 104 
5.00 x 103 
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4.3.6 TMEM154 Genotyping of Rams 
To identify potential presence of MVV resistant genotypes of 
TMEM154, genotyping was carried out on DNA extracted from 
seropositive rams. Exon 2 of 26 rams was successfully 
classified, of which 20 were identified as heterozygous for 
glutamate (E) to lysine (K) substitution at amino acid position 
35. Of this number, 11 were also found to be heterozygous for 
a substitution of asparagine (N) to isoleucine (I) at position 70. 
The N70I substitution was also present in a ram (Ram 9) which 
did not possess the E35K substitution. One other heterozygous 
substitution was identified in Ram 2 at position 44 of methionine 
(M) to threonine (T).  
Only one ram (Ram 27) was homozygous for substitution at 
position 35 (E to K) indicative of an increased resistance to MVV. 
Unfortunately, Exon 1 could not be genotyped to confirm the 
diplotype of individual rams due to laboratory difficulties. 
Suspected diplotypes were determined based on the known 
substitution present and previously described haplotypes in 














Table 4.3.6.1 TMEM154 genotyping of 26 rams. Exon 2 was 
successfully genotyped for 26 rams to assess for presence of 
glutamate (E) to lysine (K) substitution at amino acid position 35, 
which provides resistance to MVV infection. Exon 1 (orange) could not 
be genotyped due to laboratory difficulties.    
  TMEM154 aa Position 
Suspected 
Diplotype 
  Exon 1  Exon 2 
Ram Breed 4 13 14 25  31 33 35 44 70 74 82 102 
Ancestral  R A L T  E D E T N I E I  
1 Abermax        E/K  N/I    1, 2 
2 Aberfield         M/T     3, 4 
3 Aberfield        E/K      1, 3 
4 Abermax        E/K  N/I    1, 2 
5 Aberfield        E/K      1, 3 
6 Aberfield        E/K  N/I    1, 2 
7 Abermax        E/K      1, 3 
8 Abermax        E/K  N/I    1, 2 
9 Aberfield          N/I    2, 3 
10 Aberfield              3, 3 
11 Abermax              3, 3 
12 Abermax        E/K  N/I    1, 2 
13 Abermax        E/K      1, 3 
14 Abermax        E/K  N/I    1, 2 
15 Abermax        E/K      1, 3 
17 Abermax        E/K  N/I    1, 2 
18 Abermax        E/K      1, 3 
19 Abermax              3, 3 
20 Abermax        E/K      1, 3 
21 Abermax        E/K      1, 3 
22 Abermax        E/K  N/I    1, 2 
23 Abermax        E/K  N/I    1, 2 
24 Abermax        E/K  N/I    1, 2 
25 Abermax        E/K      1, 3 
26 Abermax        E/K  N/I    1, 2 
27 Abermax        K      1, 1 
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4.4 Discussion 
In this chapter a longitudinal study was carried out over a period 
of 28 months including 28 MVV seropositive rams diagnosed in 
June 2014 following routine testing. Testing of blood and tissue 
samples collected confirmed MVV status in all rams with 
exception of one (Ram 28) from which no blood or tissue 
samples were obtained. Consideration of blood and tissue 
collection records suggest Ram 28 to have died or been 
euthanised prior to April 2015.  
Difficulties in analysis of results was found when trying to cross 
reference tissue and blood samples due to a lack of conformity 
of labelling and loss of ear tags. At each time point of blood 
collection, one ram was present that could not be successfully 
identified (Table 4.3.3.1). Should such a study be repeated in 
the future, emphasis should be made on uniformity of sample 
labelling and regular checking of animals for lost ear tags. 
Pathology observed at PM was mostly localised to the lungs of 
the rams. Areas of consolidation (n=8), enlargement of lungs 
(n=1), grey discolouration (n=5), multifocal grey-white nodules 
(n=1) and adhesion of lung to the thoracic wall (n=1) observed 
in 9 out 10 rams showing pathology is consistent with that 
previously reported as being associated with MVV infection 
(Cutlip et al. 1979; Christodoulopoulos 2006; Gomez-Lucia et 
al. 2018). Interestingly, 3 of these rams (Ram 5, 7 and 15) 
presenting with pathology indicative of MVV infection tested 
negative when extracted DNA was tested by qPCR. In addition, 
2 of these rams (Ram 5 and 7) had slides prepared from 
sections of lung tissue. Again, both rams showed histopathology 
indicative of MVV infection. This clear presentation of MVV 
pathology with an inability to detect proviral DNA in blood is in 
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contrast to previous work which supported severity of lesions in 
infected rams to be proportional to viral loads within peripheral 
blood (Herrmann-Hoesing et al. 2009). 
Instances of lymphoid infiltration with intermittent formation of 
lymph follicle-like structures (n=14), thickening of alveolar 
septa (n=11) and obliteration of alveoli structures (n=8) were 
found in histological sections of lung tissue collected from 15 
rams (Georgsson and Palsson 1971; Lairmore et al. 1986). 
Eleven rams also showed infestation with lungworm, which has 
also been previously reported to be histologically characterised 
by marked lymphoid infiltration and thickening of alveolar septa 
(Chanie and Ayana 2013). Infestation with lungworm then 
highlights the question of whether pathology seen in slides can 
be attributed to lungworm, MVV infection or both. Four rams 
which showed no sign of infestation, still showed pathology 
despite no evidence of lungworms supporting that pathology 
can in part be attributed to MVV infection. In addition, due to 
the respiratory nature of both conditions, clinical signs are also 
similar with coughing, increased respiratory rate, dyspnea, 
nasal discharge, weight loss and fever being reported for both 
conditions (Chanie and Ayana 2013). The confusion between 
the two infections clinical signs and pathology has complicated 
this study’s conclusion. Given the prevalence of both infections 
in the UK this overlap is also likely in many flocks and may well 
lead to under estimation of MV infection if flocks are being 
tested on clinical suspicion of lungworm alone.  
Testing of blood samples by ELISA and qPCR over three time 
points showed no trend in changes in antibody titres and copy 
numbers between time points. 
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Throughout the study only one ram (02227/Ram 27) was found 
to test negative by both ELISA and qPCR of DNA and RNA from 
blood at a single time point (December 2015). Interestingly, 
TMEM154 genotyping identified Ram 27 to be the only ram 
homozygous for the substitution of glutamate (E) to lysine (K) 
at amino acid position 35. This deviation from the ancestral 
sequence has been reported to convey resistance to MVV 
infection (Heaton et al. 2012). The presence of only one ram 
homozygous for a resistance marker within this group is likely 
to be due the selection criteria of being positive by ELISA during 
a routine test for the MVAS/CAEAS. Heaton et al. (2012) 
reported increased resistance in K35 homozygous sheep, 
therefore the likelihood of seroconversion and detection by 
ELISA is markedly less than susceptible genotypes. 
qPCR testing of DNA and RNA extracted from blood collected in 
April 2015 tested positive for Ram 27. Copy numbers of 6.93 x 
102 copies per ng of DNA and 1.06 x 104 copies per µl of sera 
were calculated for viral loads in DNA and RNA, respectively. 
Proviral DNA copy numbers were lower than the average seen 
for rams in April 2015 while RNA load was within average values 
(DNA: mean = 5.67 x 103, median = 1.94 x 103) (RNA: mean 
= 1.33 x 106, median = 5.68 x 103). Transition from positive 
qPCR results in April 2015 to negative results in December 2015 
and negative ELISA results at both times suggests that MVV 
resistant TMEM154 haplotypes may allow for increased ‘control’ 
of infection within such host sheep as has been previously 
suggested (Alshanbari et al. 2014).   
Despite only one ram being homozygous for MVV resistant 
TMEM154 haplotypes, 20 rams were found to be heterozygous 
for this haplotype. Although, heterozygous animals have been 
reported to not benefit from resistance to infection, the 
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presence of these haplotypes in such frequency indicates that 
selective breeding could be successful to increase flock 
resistance to MVV infection, therefore reducing the risk of 
associated economic impacts (Yaman et al. 2019).   
In addition to blood, MVV was also detected in DNA extracted 
from several tissues (lung, mediastinal lymph node and 
testicle). MVV was most successfully detected in DNA extracted 
from lymph node (n=22/25). It was noted that rams that tested 
negative in DNA, were consistently negative in all tissues tested 
for that ram. Considering the cellular tropism of MVV to the 
monocyte/macrophage cell lineage and dendritic cells and their 
roles during infection, an inability to detect virus within the 
mediastinal lymph node and subsequent lack of detection in 
other tissues would not be unexpected (Ramírez et al. 2013).  
Interestingly, proviral DNA loads calculated within this study 
were markedly higher than those previously reported. Within 
these studies blood proviral DNA loads were reported to range 
from 1 x 10-2 to 1.6 x 101 copies per ng of DNA (Herrmann-
Hoesing et al. 2007; Crespo et al. 2016; Grego et al. 2018). In 
comparison, the lowest load within the rams of the current 
study throughout all three time points was 2.27 x 102 copies per 
ng DNA, with the highest load seen 3.95 x 104 copies per ng 
DNA. This large difference seen in proviral DNA loads could be 
attributed to the lung worm infestation diagnosed by histology. 
Such infestation would typically result in an inflammatory 
response, resulting in recruitment of latently infected 
monocyte/macrophages. Such an immune response has 
previously been suggested to stimulate virus present within 
these cells resulting in increased replication and proviral loads 
within surrounding cells and blood (Grego et al. 2018). 
Alternatively, discrepancies in reported proviral DNA loads may 
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be the results of differing diagnostics, as qPCR used in this study 
was designed to target sequences of the Pol gene, whilst the 
studies mentioned previously, utilised diagnostics targeting the 
Gag gene.  
Testing of DNA extracted from tissues highlighted one limitation 
of the MVV qPCR designed previously (Chapter 2). Whereby 
testing of DNA and RNA extracted from blood resulted in 
amplification of a single correct product, testing of DNA 
extracted from tissues in addition to producing the correct 
amplicon, also produced an unknown amplicon consistently in 
nearly all samples tested (Figure 4.4.1). Attempts at 
sequencing failed to identify this product, but uniform presence 
in both positive and negative samples suggests that it is DNA 
already present within the sheep genome. Therefore, 
adjustments to this qPCR would be required for future testing 
of nucleic acids extracted from tissues.  
Palsson (1972) reported successful isolation of virus from nasal 
swabs taken from seropositive animals, but since then and with 
the rise of PCR diagnostics, the detectability of virus within 
nasal swabs has not be assessed. In this study, DNA and RNA 
was extracted from nasal swabs of 13 rams (Rams 1-13) and 
tested by qPCR. Interestingly, all RNA samples tested positive 
for MVV whilst only 6 tested positive for DNA samples. Copy 
numbers were calculated for both and copy numbers in RNA 
were found to be greater than those in DNA by a minimum 
factor of 10. The lower copy numbers in DNA may explain the 
varied ability to detect virus, with viral loads with negative 
samples being outside of the detection range of the qPCR assay 
used in this study. 
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The 100% detection of virus in RNA could therefore provide a 
new potential sampling technique for MVV diagnostics in 
addition to blood and milk. Advantages of this sampling 
technique being taking swabs is less invasive that blood 
collection and does not require a trained technician. It has an 
advantage over milk and colostrum testing in that non-lactating 
and male animals can also be tested. One consideration that 
should be made is that the 13 swabbed rams were known to 
have been seropositive for a period of 28 months. Therefore, 
sufficient levels of virus within nasal swabs for detection of virus 
may require a particular stage of infection, which may be longer 
than desirable for a potential sampling method for diagnostics. 
Further field testing in live animals that are known to be MV 
positive is required to properly assess the utility of nasal swabs 
Figure 4.4.1 Melt curve of MVV Pol qPCR products during 
testing of sheep tissues. qPCR testing of DNA extracted from 
lung samples using primers designed for amplification of a Pol 
gene nucleotide sequence (Chapter 4.2.10). Two products were 
produced by assay, the correct MVV Pol product at approximately 
76oC (yellow) and an unknown product at approximately 89oC 
(blue). 
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as a diagnostic and to assess sensitivity and specificity against 
the current serological tests. Ideally, a longitudinal study should 
be carried out with regular nasal swabs taken following 
experimental infection to determine the length of time post-
infection at which virus becomes detectable from nasal swabs. 
Souza et al. (2015) recently reported detectable virus within 
saliva of infected animals. Oral swabs therefore may also 
provide another minimally taxing route of sample collection and 
could be integrated into the previously suggested study.  
The longitudinal study carried out in this chapter has highlighted 
the variability in detectability of MVV within known seropositive 
rams between multiple tissues and bodily fluids. Inability to 
identify any trends within these rams uniformly housed and 
cared for over a 28 month period suggest that changes in 
antibody titre and viral loads are strongly influenced by 
individual factors (e.g. genetic resistance or lung worm 
burden). The finding of 100% detectability of virus within RNA 
from swabs is of vital importance. As nasal swabs do not require 
professional training or qualifications to collect, the use of 
swabs could significantly reduce costs of monitoring animals. 
This in turn could incentivise greater uptake in the UK of control 
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Chapter 5: Regression Modelling of Impact 
of MVV Infection of Milk Yield and SCC 
5.1 Introduction  
To date, some of the main identified economic impacts of SRLVs 
are reductions in birth weight, growth rates and potentially 
fertility, in sheep and goats (Dohoo et al. 1982; Arsenault et al. 
2003; Peterhans et al. 2004). In addition to these, the impact 
on milk yield has been investigated on several occasions, 
although there have been inconclusive findings into the 
differences of milk yield between SRLV seropositive and 
seronegative animals. Contributing factors for the observed 
differences in studies have yet to be determined. Similarly, 
multiple factors have been identified as playing a role in milk 
yield changes in infected animals such as SRLV induced mastitis 
and reduced lactation periods (Pekelder et al. 1994; Gregory et 
al. 2009; Martínez-Navalón et al. 2013). 
Of the studies into variation of milk yield during SRLV infection, 
there have been several studies reporting reduced milk yields 
in seropositive ewes/does. These studies are summarised in 
Table 5.1.1, the reduction in milk seen in these studies ranged 
from 6-30% in seropositive ewes and does.  
In contrast, Nord and Dnøy (1997) found there to be no 
significant difference in milk yield between seropositive and 
seronegative does under the age of four over two consecutive 
years. In animals five years of age, they initially reported a 
significant increase in yield of those seropositive suggesting an 
age-dependent effect, but this difference was not seen the 
following year. Similar reports of no significant changes in milk  
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Table 5.1 Studies of decreased milk yield in SRLV seropositive 
ewes and does. Listed are 7 studies reporting decreased milk yield 
in association with SRLV infection. Studies multiple values of change 
are due to differences viewed in different lactation periods of the 
same cohort of animals. 
 
yield in goats are present in the current literature (Smith and 
Cutlip 1988; Nord and Dnøy 1997; Kaba et al. 2012). 
It has been suggested that lower growth rates observed in 
lambs infected with SRLV can be attributed in part to reduced 
milk yields and indurative mastitis associated with infection 
(Keen et al. 1997). Lipecka et al. (2010) investigated the impact 
on milk yield within two selectively bred meat sheep breeds, 
from which they found little difference between yields collected 
from seropositive and seronegative animals. This would 
therefore suggest that reduction in growth rates of lambs born 
to seropositive ewes is not a result of reduced milk production. 
In addition, the study completed by Lipecka et al. also 
investigated the impact of SRLV infection on SCC in milk (a 
 
  Number   
Species Source Flocks Individual Country 
Seropositive 
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marker of udder health commonly used by milk processing 
companies to set safety limits for human consumption of milk). 
Quantifying the number of somatic cells consisting largely of 
macrophages, leukocytes and lymphocytes, the SCC has been 
used an indicator of infections within mammary tissue. Although 
once thought possible for use in detection of mastitis in animals, 
publications reporting isolation of pathogens causing mastitis 
from milk samples with low SCC and lack of isolation from milk 
samples with high SCCs suggest otherwise (Leitner et al. 2001; 
Albenzio et al. 2002; Nunes et al. 2008), although, SCC of bulk 
milk samples can be used as an estimate of prevalence of 
mammary infections within a flock. To date, majority of 
threshold values proposed for differentiating healthy and 
infected ewes lie within the range of 2.5 x 105 and 5.0 x 105 
cells/ml (Souza et al. 2012). 
Lipecka et al. (2010) investigated the impact of natural infection 
on SCC in two sheep breeds over 2 months of lactation. When 
comparing seropositive and seronegative animals of both 
breeds, there was a significant increase in SCC seen during the 
first month of lactation. A similar increase in SCC has also been 
reported in CAEV infected goats (Ryan et al. 1993). Despite 
these studies showing evidence of SRLV infection causing 
increased SCC, as with milk yield, contrasting results have also 
been reported in situations where no differences in SCC were 
seen between seropositive and seronegative does (Turin et al. 
2005; Kaba et al. 2012).  
In this chapter, the objective was to quantify the impact of SRLV 
infection within a dairy flock consisting of 319 milking East 
Friesian X Lacunae ewes, with a focus on milk yield and SCC. 
To carry this out a multivariable regression model was 
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constructed using milking data collected over a period of 
multiple years during and prior to the diagnosis of MVV in some 
animals within the flock.
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5.2 Materials and Methods 
5.2.1 Data Collection and Organisation  
Individual SCC and milk yield records were analysed from a 
dairy flock of 319 milking East Friesian X Lacunae ewes recently 
identified as MV infected via routine serological screening for 
the presence of MVV antibodies. Data variables collected are 
listed in Table 5.2.1.1 
Table 5.2.1.1 Data variables acquired from dairy flock of 319 
milking ewes following MVV outbreak.  
 
Individual somatic cell counts (SCC) were calculated from 5ml 
milk samples collected by the farmer from both mammary 
glands of each ewe and pooled together in a single collection 
pot. SCC analysis was conducted by the commercial milk 
laboratory ‘Quality Milk Management Services’ (QMMS) 



























Milk Last Lactation 
Total Yield in Lactation 
Average Daily Yield (Last 14 Days) 
Average Daily Yield (Last 21 Days) 
Average Daily Yield (Last 30 Days) 
Milking Days in Lactation 
Previous Lambing Date 
Last Lambing Date 
 
SCC 29th June 2015 
SCC 15th June 2016 
SCC 16th March 2017 
SCC 8th May 2017 
 
Optical Density Value 
MVV Diagnosis (0.6 Threshold Value) 
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milk yield records were collected daily by an automated milk 
meter system integrated into the parlour management system 
(DeLaval – DelPro3.0). Individual Maedi Visna ELISA tests were 
carried out on milk samples collected in the same manner as 
that described above and analysed by SAC diagnostics service 
using the ELITEST-MVV/CAEV (HYPHEN Biomed), a 
recombinant ELISA using the capsid p28 core protein and a 
peptide derived from the immunodominant region of the viral 
transmembrane protein gp46.  
Differentiation of seropositive and negative ewes by ELISA was 
carried out as recommended by the manufacturer using an 
optical density threshold of 0.6 for confirmation of positivity.  
5.2.2 Descriptive Analysis  
Analysis was carried out using Microsoft Excel 2013 and 
Graphpad Prism 7.03 (Graphpad Software).  
5.2.3 Statistical Modelling 
Multivariable regression modelling was used to predict the 
impact of MV status on total milk yield and SCC and estimate 
variation between ewes seropositive and seronegative for MVV. 
Model construction and regression analysis were carried out 
using MLwiN version 3.00 (University of Bristol, Bristol, UK). For 
these models single level fixed-effect structures were used, with 
individual ewes as the unit of data. Models were constructed by 
backwards selection. Variables considered included age (1-9 
years), duration of lactation period (milking days), MVV status 
(positive or negative), somatic cell counts (March and May, 
2017) and total yield in lactation. During construction, model fit 
was assessed by normality of residual histograms, which 
assesses suitability of model for analysis for associated data set.  
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Models took the form: 
yi = β0 + β1x1 + … + ei 
 
Key: 
yi = Outcome variable (i.e. milk production or SCC) 
β0 = intercept  
β1 = effect of explanatory variable on outcome variable 
(parameter estimates) 
x1 = explanatory variable (e.g. age or lactation number) 
ei = residual term quantifying difference between observed 
outcome and predicted outcome values 
 
Parameter estimates quantify the change in outcome value 
associated with a one-unit change in an explanatory variable, 
whilst all other explanatory variables are held constant. Finally, 
upon construction of models, predictions were obtained using 
the ‘Customised Predictions’ facility in MLwiN estimating the 
mean predicted values for the total milk yield and May SCC of 
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5.3 Results 
5.3.1 Descriptive Analysis  
70 of 319 tested milk samples were confirmed positive for 
presence of MVV using the ELITEST-MVV/CAEV test (HYPHEN 
Biomed). Overall, this translated to a seroprevalence of 22%. 
MVV was seen in all age groups (1-9 years old) with a 
prevalence range of 18-50% between ages (Figure 5.3.1.1).  
In June 2015, SCC measured identified 3 ewes with SCC greater 
than 250,000 cells/ml (Figure 5.3.1.2a). Number of ewes 
showing SCC above this level increased in subsequent time 
points with 7, 12 and 65 ewes showing SCC above 250,000 
cells/ml in June 2016, March 2017 and May 2017, respectively. 
Number of seropositive ewes within these numbers was also 
seen to increase with time. In June 2015, June 2016, March 
2017 and May 2017 seropositive ewes with SCC above this 
threshold value were 1, 3, 4 and 8, respectively. At the final 
time point, when comparing MVV seropositive and seronegative 
ewes, the mean value for seropositive animals (148,800 
cells/ml) was lower than that of seronegative animals (383,500 
cells/ml) (Figure 5.3.1.2b). 
Comparison of the distribution of milk yield (Figure 5.3.1.3) and 
SCC (Figure 5.3.1.2c) against age of individual ewes showed 
non-linear relationship between each variable and age. To 
account for this finding in model construction, age was treated 
as a categorical variable.   












Figure 5.3.1.1 Age distribution and seroprevalence of 319 
ewes. Graphs plotting the (A) number of ewes seropositive or 
seronegative (determined by ELISA) or (B) percentage of seropositive 













































Figure 5.3.1.2 Descriptive graphs of SCC in 319 dairy ewes. 
Graphs showing (A) distribution of SCC for 319 ewes at four time 
points (June 2015, June 2016, March and May 2017), red line denotes 
suggested threshold for indicator of infection at 250,000 cells/ml (B) 
distribution of SCC at May 2017 in MVV seropositive and seronegative 
ewes (C) distribution of SCC in May 2017 against age of individual 



























Figure 5.3.1.3 Rate of milk production between age groups. 
Graph plotting the milk yield per milking of 319 dairy ewes against 
individual age. Milk yield per milking day was plotted instead of total 
yield as lactations interrupted mid cycle and would therefore not be 
representative. Graph was plotted to illustrate non-linear relationship 
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5.3.2 Total Milk Yield Model 
Construction of the final model for estimation of the impact of 
MVV on milk yield included the variables lactation number, 
milking days in current lactation period and MVV status. Data 
from 319 ewes was included within the model, the explained 
variance (R2) was calculated as 0.937 and residual plots showed 
normal distribution indicative of good model fit (Figure 5.3.2.1). 
Parameters estimates and their standard errors are listed in 
Table 5.3.2.2. 
In comparison to ewes in their first lactation, the model 
predicted greater milk yields in ewes during their 2nd to 5th 
lactation period with a peak in yield seen during the third 
lactation. For ewes in their 6th to 8th lactation period, the model 
predicted a reduced milk yield compared to ewes in the first 
lactation. The reduction observed was greater in later lactation 
periods, although these predictions were not found to be 
significant. The number of milking days in the current lactation 
period showed a positive association with milk yield.  
The presence of MVV had showed a negative association with 
milk yield in dairy ewes within the model. Predictions estimated 
a total milk yield of 283.282L and 264.589L in seronegative and 
seropositive ewes, respectively (Figure 5.3.2.3). An unpaired t 
test using the calculated milk yield showed the reduction caused 
by SRLV infection to be significant (p<0.005) which was further 
supported by calculated confidence intervals. Therefore, 
infection with MVV was predicted to cause a 6.60% reduction in 
milk yield in dairy ewes. 
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Figure 5.3.2.1Residual histogram for a regression model 
predicting total milk yield. Normality of distribution used as an 
indicator of model suitability for data sets. 
 
 
Table 5.3.2.2 Parameter estimates for a regression model 
predicting total milk yield. Predictions were based on data from 















   
 
Model Term Coefficient SE 
Total Milk Yield 
Intercept 
Fixed Effects  
  Lactation Number 1 
  Lactation Number 2 
  Lactation Number 3 
  Lactation Number 4 
  Lactation Number 5 
  Lactation Number 6 
  Lactation Number 7 
  Lactation Number 8 
  Milking Days 
  MVV Status Negative 









































Figure 5.3.2.3 Mean predicted total milk yield in MVV 
seropositive and seronegative ewes. Predictions of total milk 
yield (L) in a lactation period based on regression model construction 
from data collected from 319 dairy ewes. Error bars illustrate 95% 
confidence intervals. Unpaired t test carried out calculated a p value 
of 0.0027.    
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5.3.3 SCC Model  
A model was constructed to predict the impact of MVV infection 
on somatic cell count in May 2017. Data was collected from 188 
dairy ewes (seropositive ewes, n=54, 28.7%), the explained 
variance (R2) was calculated as 0.936 and residual plots showed 
weak normal distribution indicative of reduced model fit (Figure 
5.3.3.1). Parameter estimates and their standard errors are 
listed in Table 5.3.3.2.  
The model assessed impact of lactation number on the somatic 
cell count. When compared to ewes in their first lactation 
period, individuals in lactation period 3-7 showed reduced 
somatic cell count. Strong association was noted in ewes in the 
4th, 5th and 7th lactation periods with SCC. Lactation periods 2 
and 8 show an increased SCC when compared to ewes in the 
first lactation although this was not significant. Days in milk 
during the current lactation showed a negative association with 
SCC while March 2017 SCC was predicted as having a significant 
positive association with SCC in May 2017.  
Ewes seropositive for MVV showed a negative association with 
SCC when compared to seronegative animals. The mean model 
predictions for MVV status generated SCC of 4.70x105 cells/ml 
and 2.39x105 cells/ml for seronegative and seropositive ewes, 
respectively (Figure 5.3.3.3). The model predicted a drop in 
SCC of 50.93% in animals infected with MVV although 
confidence intervals suggest this to not be significant.  
 





Figure 5.3.3.1 Residual histogram for a regression model 
predicting total SCC. Normality of distribution used as an indicator 
of model suitability for data sets. 
 
Table 5.3.3.2 Parameter estimates for a regression model 
predicting total SCC. Predictions were based on data from 188 dairy 




















Model Term Coefficient SE 
Log10 May 2017 SCC 
Intercept 
Fixed Effects  
  Lactation Number 1 
  Lactation Number 2 
  Lactation Number 3 
  Lactation Number 4 
  Lactation Number 5 
  Lactation Number 6 
  Lactation Number 7 
  Lactation Number 8 
  Milking Days 
  March 2017 SCC 
  MVV Status Negative 



































































Figure 5.3.2.3 Mean predicted SCC in MVV seropositive and 
seronegative ewes. Predictions of SCC (Log10 1000 cells/ml) in a 
lactation period based on regression model construction from data 
collected from 188 dairy ewes. Error bars illustrate 95% confidence 
intervals. 
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5.4 Discussion 
Two multivariable regression models constructed to estimate 
the impact on MVV infection on milk yield and SCC in sheep 
predicts a significant reduction in both values in seropositive 
ewes. Models’ suitability and fit were assessed upon 
construction. Residuals were assessed as part of this process 
and histograms plotted to evaluate normality. Histograms 
showed normal distribution indicative of model suitability. 
Models may have been improved with inclusion of further 
variables not recorded within the present data set such as 
number of lambs, with ewes bearing more lambs showing 
increased yields (Pollott and Gootwine 2004), or presence of 
mastitis, which as previously described has been shown to 
result in reduced yield and increased SCC. 
Reports to date have provided conflicting results to the effect of 
infection on milk yield with factors such as shorter lactation 
periods, occurrence of mastitis and breed being identified as 
explanatory variables for these inconsistencies. Despite this, 
the majority of studies seem to point towards a reduced milk 
yield in affected animals. In support, this study reports a model 
in which MVV infection caused an estimated reduction in milk 
yield of 6.60% when compared to uninfected individuals using 
multivariable regression modelling. 
With regards to MVV infection in ruminants, another factor of 
importance to the dairy industry is the reported shortening of 
lactation period (Martínez-Navalón et al. 2013). Due to the 
nature of data collection for this study it was not possible to 
ascertain the complete length of the lactation period for 
seropositive animals. Therefore, the 6.60% drop in yield 
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predicted within these models demonstrates an immediate 
comparable difference between seropositive and seronegative. 
The true impact of MVV within the ewes of this study may 
therefore be greater than what has been predicted within this 
model. 
The impact of MVV on SCC was also of interest in this study. 
The current literature shows little research into the impact of 
SRLVs on SCC in sheep and goats, although these studies have 
suggested that infection results in markedly increased SCC in 
infected animals compared to non-infected individuals (Ryan et 
al. 1993; Lipecka et al. 2010). The model constructed in this 
study utilised data collected from 188 dairy ewes undergoing an 
outbreak of MVV. The model proposed a decrease in SCC in 
seropositive animals when compared to seronegative. 
Predictions estimated this decrease to be 50.93%, although this 
was unlikely to be of significance. The 188 ewes included in this 
model account for 58.93% of the ewes available. The limiting 
factor in this model was inclusion of the March 2017 SCC 
variable. Despite effectively halving the N number for this 
model, March 2017 SCC variable was necessary as it allowed 
for accounting of natural individual variation between ewes, 
improving reliability of model findings. The large predicted drop 
in SCC in the constructed model, although not significant for 
this model, is worth further investigation. 
The decrease in SCC demonstrated in this model may suggest 
MVV to possess immunosuppressive effects within infected 
hosts. Immunosuppressive actions are not uncommon within 
lentiviruses, HIV being the most widely known example, with 
other examples include BIV, SIV and FIV (Zagury et al. 1993; 
Rezikyan et al. 1995; Kalvatchev et al. 1998; Vahlenkamp et 
al. 2004). Myer et al. (1988), once suggested a small 
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immunosuppressive role for a South African strain of MVV but 
no further instances have been reported in recent years.  
In addition to the models constructed during this project. The 
suitability of the threshold value for confirmation of infection for 
a SRLV diagnostic assay was carried out. Modified models did 
not show any significant changes in parameter estimates for 
included variables. Importantly, no marked improvement in 
model fit was observed that would support adjustment of 
threshold. Interestingly all modifications resulted in reduced 
impact of MVV infection on milk yield and somatic cell count.  
The results of this study support the findings of several previous 
studies that state SRLV infection results in a reduced milk yield 
in infected animals (Smith and Cutlip 1988; Krieg and Peterhans 
1990b; Martínez-Navalón et al. 2013). The impact predicted in 
this model may have been less than previously speculated, but 
as stated above this may be due to variables that were unable 
to be accounted for within this model.    
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Chapter 6: General Discussion 
MVV in the UK, is a problem on the rise (Ritchie et al. 2010). 
An infection with no cure or vaccine. It has an asymptomatic 
latency period of several months to years in length, in which 
dissemination throughout a flock can occur unknowingly, 
culminating in a flock prevalence of up to 85% or higher. On 
appearance of clinical signs such as fever, laboured breathing 
or progressive wasting resulting in the animal’s condition 
progressively degrades until eventual death. The economic 
impacts of infection have been characterised as increased 
mortality rates, reduced fertility, reduced birth weight and 
reduced growth rate (Dohoo et al. 1982; Burmeister 2001; 
Arsenault et al. 2003; Peterhans et al. 2004). Despite these 
present risks associated with infection, the current control 
schemes in place to control virus spread (MV/CAE accreditation 
scheme and MV monitored-free sheep health scheme) have low 
uptake among farmers with only an approximated 8.5% of 
holdings taking part in the MV/CAE accreditation scheme (SRUC 
2020). To provide farmers a more comprehensive 
understanding of the current impacts of MVV infection within UK 
sheep and to identify areas of potential improvement in current 
monitoring and control systems. 
Four aims were put forward for investigation: the design and 
testing of a qPCR diagnostic assay for detection and 
quantification of an unknown strain of MVV (Chapter 2), the 
implementation of an AI trial as a means to assess the risk of 
sexual transmission of MVV in natural mating behaviour 
(Chapter 3), the assessment of a longitudinal data set collected 
from a group of MVV seropositive rams over a period of 28 
months as a case study of morbidity and mortality due to the 
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disease (Chapter 4) and to estimate the impact of MVV infection 
on milk yield and somatic cell count within a milk production 
system consisting of 319 dairy ewes suffering a MVV outbreak 
(Chapter 5). The results of these findings are discussed here. 
6.1. Establishment of a Diagnostic for MVV 
In Chapter 2, a qPCR assay was designed for detection of an 
unknown strain of MVV circulating within the UK in 2014. 
Designed to target proviral DNA within blood samples collected 
from seropositive rams, testing showed successful amplification 
of virus within DNA and RNA of blood and DNA of multiple 
tissues/swabs (Section 4.3.3-5). The use of qPCR-based assay 
allowed for the quantification of viral loads within tested 
samples and was successful for DNA and RNA levels within 
tested blood samples. Unfortunately, it was noted that DNA 
samples extracted from tissue samples (i.e. lung, mediastinal 
lymph node and testicle) showed near consistent amplification 
of an unknown product. The presence of this unknown product 
was also seen in samples testing negative for MVV infection, 
therefore suggesting that the product was the result of a 
random segment of sheep genomic DNA. Unfortunately 
attempts at identification of product using sanger sequencing 
techniques failed to retrieve any sequence data.  
Proviral loads obtained from testing blood DNA, when compared 
to those reported in previous studies, were found to be higher 
by at least a factor of 101, and in some cases, by a factor of 104 
(Reina et al. 2008; Niesalla et al. 2009; Rachid et al. 2013; 
Crespo et al. 2016). Although this could be attributed to 
concurrent lungworm infestation or assay targets, it is 
important to note that should such low proviral loads have been 
present in this study, the qPCR designed would not have been 
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able to detect them due to loads being below the threshold 
range of detection for this assay. This is of even more relevance 
for the findings of Chapter 3, as studies showing lowest viral 
loads were from measurements of blood proviral loads in the 
weeks and months following experimental infection (Reina et al. 
2008; Niesalla et al. 2009; Rachid et al. 2013). The highest 
proviral DNA load seen within blood samples in these studies 
(approximately 1.6 x 101 copies per ng of DNA) were reported 
in animals from a herd recording 100% seroprevalence and 
were likely infected for a longer period of time resulting in 
higher loads (Crespo et al. 2016).  
Before future use of this qPCR, it would be recommended that 
tests be carried out in animals of known infected status during 
the period following infection. This is important as should the 
qPCR not be able to identify animals with low level infection, it 
would likely lead to persistent flock infections, ultimately 
requiring complete replacement of sheep/goats to ensure 
complete viral removal. Adaptation of qPCR to a nested PCR 
(nPCR) set up may combat this problem, for purely diagnostic 
purposes, although difficulties associated with such a change 
include increased processing time, occasional difficulty in 
interpretation and  the requirement for a greater 
comprehension of the target sequence (Demeuse et al. 2016). 
This later point is of particular relevance in SRLVs due to high 
degree of variation between strain (Ramírez et al. 2013).  
Blood and tissues selected for testing were chosen for the 
known tropism of SRLV and due to previous reports showing 
successful detection. One sample, that could not be collected 
within the group of seropositive rams within this study but has 
been collected for viral detection is milk (Extramiana et al. 
2002b; Mazzei et al. 2005). It would be interesting to determine 
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if this qPCR could be used for diagnostic testing of milk sample 
as this is an easily obtained sample from dairy systems. One 
difficulty that may arise in such a test would be strain specificity 
of assay. Adjadj et al. (2019) recently compared efficacy of 
qPCR methods in milk vs serology, although they showed 
detection in both, milk testing had lower sensitivity and 
specificity. Despite this, bulk milk testing could be used as an 
indicator of viral presence within a flock. 
Of great interest in this study is the detection of MVV in RNA 
extracted from 100% of the nasal swabs (n=13) that were 
collected. Nasal swabs collection has less experience 
requirements and less individual limitations than either blood or 
milk sampling and can be collected by farmers. As such, fees 
associated with MVV testing of animals could be reduced. Souza 
et al. (2015) has also reported successful detection of SRLV 
from saliva samples. Oral swabs were collected as part of this 
study following euthanasia of seropositive rams (nasal and oral 
swabs collected simultaneously). Due to project restrictions, 
swabs were not tested for detectable virus. Therefore, future 
testing of these swabs, which can be cross referenced with 
results of this study can be carried out at a later date. It is 
relevant to mention, that techniques used to collect saliva in the 
previously mentioned study likely provided larger sample size 
that obtained by swabbing (Souza et al. 2015). In addition, 
nPCR was carried out on samples, and therefore together, this 
may suggest that if virus is present within saliva, it could be 
below the detectable threshold of the designed qPCR although 
testing would be required for confirmation.  
The initial difficulties observed in developing the current qPCR 
assay highlights one of the key difficulties with using PCR based 
assays for detection of SRLVs currently in the UK. PCR based 
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techniques require accurate known sequences for reliable 
detection of targets, which is difficult for SRLVs due to their high 
variability (Ramírez et al. 2013). In addition, other than a single 
full genome subtype A1 virus identified nearly 30 years ago, 
little is known about current circulating strains within the UK 
(Sargan et al. 1991). The strain identified in this study, 
although only partially sequenced could provide some insight. 
Following phylogenetic analysis, sequences showed similarities 
with both A1 and A19 subtypes. Similarities with A1 strains is 
not surprising due to known worldwide prevalence and previous 
identification in UK (Shah et al. 2004a). What is surprising is 
clustering observed with subtype A19 (Figure 2.3.4.1), a strain 
that has only been reported in animals in Italy. Although this 
could be argued to be due to random bias of sequenced 
sections, especially as subtype A19 has only been reported in 
goats (Colitti et al. 2019). It does pose the question if said strain 
and others are currently present within the national flock.  
Overall, this study hoped to put forward a diagnostic for 
universal detection of SRLV strains, at least within the UK. The 
results reported together suggest the feasibility of producing 
such a test is low. For such a test, there a several obstacles tht 
would have to be addressed. For example, first, all circulating 
strains would need to be identified and confirmed detectable by 
test. Second, routine checking for introduction of new or 
variable strains would be required to maintain efficacy of test. 
And three, production costs and maintenance costs likely to be 
greater than economically feasible. Together these factors 
imply that using current technologies, the production of a 
universal PCR-based SRLV diagnostic for use in the current 
market is unlikely. 
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6.2. Intermittent Infectiousness of Hosts 
In Chapter 3, an AI trial to evaluate the risk of sexual 
transmission of MVV as a model for natural mating was carried 
out. Semen was collected from 13 seropositive rams and used 
to inseminate an experimental group of 12 naïve ewes. Bloods 
were collected weekly for a period of 7 weeks and tissue 
samples collected at post-mortem were tested for detection of 
virus by ELISA and qPCR with no detection of virus noted in 
inseminated ewes (Section 3.3.3+5). 
DNA and RNA were extracted from semen for testing by qPCR 
for presence of virus. None of the 13 rams showed detectable 
virus within semen samples, although 6 of them showed 
detectable virus in epididymal washes. Washes were taken at 
post-mortem of rams, one day post-semen collection therefore 
sudden changes in viral loads is unlikely to have occurred. Due 
to the diluting effect of fluids from the extraseminal vesicles 
added during natural ejaculation, the epididymal wash results 
suggest that virus is present within semen samples but is below 
the detectable level of the current qPCR diagnostic (Cornwall 
2009). The studies reporting proviral DNA loads within blood 
sample outside of the detectable range of the diagnostic 
designed in this study, as previously mentioned above, add 
support to this statement. 
de la Concha-Bermejillo et al. (1996) and Preziuso et al. (2002) 
have both reported on the detectability of MVV in semen of 
rams. These studies reported intermittent shedding of virus in 
semen. Interestingly, they associated presence of virus in 
semen to detection of B. ovis infection of epididymis. These 
findings suggest that secondary infection within MVV infected 
individuals can trigger an inflammatory response which may 
165 | P a g e  
 
‘activate’ infected monocytes resulting in viral production and 
presence within surrounding tissues. Interestingly, Grego et al. 
(2018) reported a similar finding in animals suffering lung 
parasitism, which resulted in high loads when compared to 
other infected individuals. With this study, evidence of lung 
worm infestation was present within histological slides prepared 
from lung sections collected from rams (n=11/15). In addition, 
reported viral loads within blood samples were higher than 
reported within the literature. Together, these would align a 
similar situation to that observed in B. ovis infected epididymis, 
where lung worm infestation produces an inflammatory 
response within affected lungs. Next, lymphocytic infiltration 
occurs resulting in recruitment of latently infected 
monocyte/macrophages resulting in activation of latent virus. 
Such a model of infection could arguably explain the consistent 
detectability of viral RNA in nasal swabs seen in this study.  
Unfortunately, in this study no epididymal tissue samples were 
collected from rams at post mortem, only washes. Samples 
would have allowed for histological assessment of the 
epididymis to quantify health of tissue within these seropositive 
rams. Interpretation of these results with regard to previous 
reported association of epididymitis and increased viral loads 
would have greatly aided the findings of the AI trial in this study 
(de la Concha-Bermejillo et al. 1996; Preziuso et al. 2002). The 
results as they stand suggest that the risk of sexual 
transmission in a natural mating setting is low when using 
semen from seropositive rams. But results suggesting low 
semen viral loads may not represent the whole picture, 
therefore this study should be repeated using seropositive rams 
showing high viral load, whether this be the result of natural 
disease progression or following B. ovis inoculation.  
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6.3 Attempting Control of Transmission 
Inability to treat or cure infection of SRLVs in infected animals 
has shifted focus to preventative measures to control spread of 
infection. In the UK, two programmes (MV/CAE accreditation 
scheme and MV monitored-free sheep health scheme) are in 
place to aid in identification of viral infection and reduce spread. 
Despite this, prevalence has been reported to be on the rise 
(Ritchie et al. 2010). Therefore, identification of risk factors for 
infection can aid in the improvement of control techniques in 
addition to the current schemes in place. One example of such 
factors is housing of animals. Illius et al. (2020) highlighted this 
factor, it was found through mathematical modelling, that 
housing animals as little as 1 week of the year was sufficient in 
producing Ro for infection >1. The findings of this study in 
conjunction with available literature also suggest one such 
factor to be secondary infection within infected tissues causing 
increased viral load and potentially leading to increased 
infectivity of individuals (i.e. increase venereal shedding, or 
nasal shedding). 
TMEM154 genotyping was carried out in 27 seropositives ram 
as part of this study. One ram (Ram 27) was homozygous K35, 
which has been reported to provide increased resistance to 
infection (Heaton et al. 2012; Molaee et al. 2018). In addition, 
it has been suggested that the K35 TMEM154 genotype is able 
to control infection as shown by reduced viral loads in 
homozygous individuals when compared to heterozygous or 
other individuals (Alshanbari et al. 2014). Results for ram 27 
were found to support this finding, with proviral DNA and viral 
RNA showing a reduction to undetectable levels between April 
2015 and December 2015.  
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Interestingly, out of the remaining 26 rams, 20 (76.9%) were 
heterozygous for the resistant haplotype (K35). The high 
frequency of this haplotype in this group suggests that 
implementation of a selective breeding policy could be 
successful for selection of TMEM154 resistance. This could be of 
interest to commercial flock. The high prevalence of the 
resistance haplotype suggests there would be limited difficulty 
in finding desired genetics and could add value to animals, 
especially for breeding ram flocks, although there would be cost 
associated for genotyping of individuals. Uptake of such a 
system in breeding flocks alone would provide a lot of aid, as 
selection of homozygous rams to be consistently used for 
breeding each year would cause a continual accumulation of 
homozygous individuals in the national flock, reducing overall 
risk of infection. In addition, the prevalence of heterozygous 
animals within the seropositive group when compared to 
homozygous supports TMEM154 providing resistance to 
infection with the circulating strain of MVV identified in this 
study.  
6.4 SRLV Impact in Dairy Systems 
To date, the impact of SRLV infection on milk yield is a topic of 
debate (Greenwood 1995; Nord and Dnøy 1997; Juste et al. 
2020). In this study, a milk production dataset was received 
from a flock of ewes currently experiencing a MVV outbreak. 
Using regression modelling, an estimated decrease of 6.60% in 
milk yield was calculated.  
Interestingly, a regression model estimating the impact of MVV 
on SCC in milk from infected ewes, calculated infection to cause 
a 50.93% decrease in SCC, although this was not found to be 
significant. This suggests an interesting scenario of 
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immunosuppression, which has once been previously 
suggested, although not in recent years (Ryan et al. 1993). 
Immunosuppression is not an uncommon trait of lentiviruses 
(HIV, SIV, FIV, BIV), but no strong evidence has been provided 
for such a role in SRLV infection. Although thought not 
significant for the model produced here the sheer reduction 
predicted is interesting. In addition, insignificance could be due 
to insufficient data variables present within the model. It could 
be interesting to repeat such a model with a greater number of 
constituent ewes and a greater span of recorded variables.  
In dairy systems, the importance of SCC is as an indicator of 
milk quality. The recommended threshold values for milk have 
yet to be fully characterised for sheep, although the majority of 
results suggest a threshold value within the range of 250,000 
and 500,000 cells/ml (Souza et al. 2012) In regard to the 
findings from this study, it could suggest that SCC of milk 
collected from seropositive ewes may not be representative of 
the true quality due to an immunosuppressive effect. 
6.5 Future Work 
Results described here have highlighted areas of interest where 
further research could provide important insight of SRLV 
infection within small ruminants. In addition, areas of work that 
could not be carried out due to various restrictions during this 
study could show some interesting results.  
A 2014 circulating strain of MVV was partially sequenced and 
characterised as part of this study. Efforts to complete this 
sequence would provide some critical insight into the current 
circulating strains within the UK. Sequence data identified 
during this study came from NGS data of RNA extracted from 
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lungs and mediastinal lymph node of seropositive rams. 
Acquisition of complete viral genome could be carried out 
through further NGS analysis of this data set (e.g. de novo 
assembly). In addition, gene expression analysis could be 
carried out using this data set comparing expression with lung 
and mediastinal lymph of 3 infected rams.  
Following the euthanasia or death of seropositive rams, a 
multitude of tissue samples and swabs were collected for later 
testing. Of these only lung, lymph, testicle, semen, nasal swabs 
and epidydimal washes were tested. Testing of remaining 
samples should be carried out, especially as several of these 
samples (saliva, heart, kidney, liver, joint cartilage) have been 
previously reported as showing detectable virus. This would 
provide a more comprehensive understanding of the complete 
disease status within the seropositive rams of this study.  
The detection of virus with nasal swabs is very important in this 
study as it provides a non-invasive, potentially cheaper means 
of testing animals for infection. Animals in this study were 
infected for a period of at least 28 months and showed signs of 
lung worm infestation which may have caused a spike in viral 
load. Therefore, it is unknown how reliable nasal swabs would 
be for detection of infection during early stages. Future testing 
of nasal swabs from known infected animals would be prudent, 
after which if results were promising, a longitudinal study of 
infection could be carried out with regular nasal swabs to 
determine the period of time required before detectability. 
Genotyping of TMEM154 within UK flocks could prove useful, as 
it would calculate the prevalence of resistance genes present 
within the national flock. Should levels be found to be sufficient, 
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this could pave the way for proposing selective breeding for 
SRLV resistance.  
6.6 Conclusion 
In this study we partially characterised the impact of a 
previously unidentified circulating strain of SRLV within the UK. 
We developed a qPCR assay that showed efficacy in detecting 
said strain within both blood and tissue of infected rams. While 
sequence of studied virus showed similarities with previous UK 
strains of virus, the similarities seen with virus previously only 
reported in Italy raises concerns over the current efficacy of 
preventative measures within the UK. The findings of detectable 
virus within nasal swabs and the high prevalence of TMEM154 
mutations linked to resistance to infection provide important 
avenues for betterment of control within the UK. Although 
further work is required to corroborate the results reported in 
this study, they are still promising. In addition, the evidence 
that TMEM154 may be able to reduce impact within individuals 
by reducing viral loads highlights the potential of a selective 
breeding program for SRLV resistance. Further, our findings of 
reduced milk yield within ewes infected with a UK strain of virus 
can be used to provide further clarification of production 
impacts to farms. With regards to farms, we also showed low 
risk of sexual transmission via a natural mating route using AI 
with semen of infected rams. Although, further study is required 
to look into variable viral loads within semen, the finding that 
at least a perceived ‘low viral load’ semen can be used to 
provide an avenue of genetic rescue for farmers, especially 
pedigree breeding ram systems where rams suffer large drops 
in financial worth following diagnosis. Overall it is our hope that 
the findings of this study can be used to aid in the furthering of 
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understanding into the current state of SRLV infections in the 
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Appendices  
Appendix 1: Reference Sequences 
Table of SRLV sequence used for qPCR and phylogenetic 
analysis. 
 Accessions Species Genomic 
Region 
Country  Year 
 
AFRICA 
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Appendix 2: Unknown Viral Sequence 
Alignment of 10 fragment sequences of a circulating SRLV strain 
within the UK. Sequence is aligned against the previously 
sequence full genome UK strain of MVV (EV1) (Sargan et al. 
1991) 
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Fragment 6: 188 bp – Pol gene 
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